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ABSTRACT
Triazole fungicides, such as tebuconazole, have been pivotal in the control of both foliar
and seed/soil-borne diseases of many crops, including cereals, since their introduction
in the 1970s. Although routinely applied as a foliar spray, tebuconazole is also used as
a seed treatment. The systemic nature of the fungicide may confer protection of plants
from disease during the early stages of development. However, application rates are
limited to between 1 and 7 g active ingredient (AI) per 100 kg of seed due to seed
application causing reduced germination and stunting during early plant development.
A novel technique whereby fungicides, including tebuconazole, are encapsulated using
yeast cells as pre-formed microcapsules may provide a solution to the problem of
phytotoxicity and allow seed treatments to be applied at higher rates, resulting in a
reduction in total fungicide application required during the growing season. Several
batches of microencapsulated tebuconazole were produced using yeast from different
sources. These where tested for their potential for uptake, retention and subsequent
delivery of the fungicide. The release of tebuconazole from the different yeast batches
into water was assessed over a time course using liquid-liquid extraction (LLE) and GC-
MS. Results showed no differences in the release characteristics of tebuconazole
observed between batches. Further to this the age of the batches tested was found to
have no effect on release of tebuconazole into water, suggesting shelf-life would not be
a problem with this technology. Repeated washing of a sample of microencapsulated
tebuconazole with water suggested that the novel formulation could provide the gradual
delivery of tebuconazole.
An investigation of the phytotoxic effect of tebuconazole, applied as seed treatments at
higher than recommended rates (40 g AI per 100 kg seed), showed the
microencapsulated formulation had a significantly reduced impact on germination and
early plant development, when compared to two commercial formulations of the
fungicide, Mystique and Raxil. Further analysis, of the amount of tebuconazole
accumulated by plants grown from treated seed, using solid phase extraction (SPE) and
GC-MS), showed there to be initially less fungicide in plants treated with the
microencapsulated formulation. As plant development continued, the amount of
tebuconazole recovered from plants treated with both the microencapsulated and
conventional formulations became similar. Variation in the results, between replicate
samples and also between growth stages led to a series of experiments investigating
the possible effect of the growth environment and seed sowing density on tebuconazole
uptake. However, no significant effects of these factors were observed.
A comparison of the uptake of seed-applied microencapsulated and conventional
formulations of tebuconazole between 2 and 19 weeks after sowing, showed there to be
no significant differences between formulations used in the concentration of the
fungicide accumulated in plants. However, a pronounced increase in plant accumulation
of the fungicide was consistently observed between 17 and 19 weeks. It was suggested
that this might be associated with roots becoming densely packed within the compost,
encouraging fungicide uptake from the compost in the localised dressing zone around
the seed. It was shown that tebuconazole became readily bound to the loam-based
compost used during the research. Experiments conducted in 1m columns, containing
tebuconazole applied to specific compost layers within the columns, confirmed the
ability of wheat roots to recover the fungicide from the compost when they made
contact with the specific layers.
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CHAPTER 1: GENERAL INTRODUCTION
1.1 GENERAL INTRODUCTION
"In agriculture, the conditions and rules have changed in an
unprecedented way over recent years. Not only have the rules
changed, but alternative techniques are increasingly challenging the
chemical approach to disease control. Chemical crop protection has a
vital role in securing healthy food supplies for a growing global population.
We have to make the point again and again: without chemically
protecting our agricultural commodities there would not be enough food
to eat."
th
(From the Welcome Address of Jost Harr, Chairman of the 10 IUPAC
Congresson Chemistryof Crop Protection,2002 (Harr, 2002).
Increases in world population have made it vital that the production of
food is as efficient as possible (Hazell and Wood, 2008). For most of
recorded history increases in global population have averaged below
0.2% per annum (Hewitt, 1998). However, the advent of improved
medical techniques and increased birth rates allied with an increased
ability of food growers to produce a more varied array of crops at
consistent yields and quality, has led to a rapid population increase
since the early 19th century (Hewitt, 1998; Hazell and Wood, 2008). The
majority of this initial increase was in what the United Nations, now
class as developed countries; Europe, the former Soviet Union, N.
America, Australia, New Zealand and Japan (Hewitt, 1998). The current
world population is estimated to be at 6.7 billion and is predicted to
increase, if present growth rates continue, to between 9.5 and 10.5
billion by the year 2050 (Anon, 2009). However, by the year 2100 only
a small proportion of the total global population will be living in these
regions with the majority living in the developing world (Hewitt, 1998;
1
lOB, 2008). This increase in population will demand a linked increase in
the quantity of food required. However, despite the development and
improvement of every aspect of food production, leading to huge
increases in the amount of food produced over the past 50 years, there
is still food insecurity (Strange and Scott, 2005). Food is not uniformly
distributed throughout the world and not all that is produced is
consumed, meaning that there is a surplus of food in some places and
a chronic shortage in others (Hewitt, 1998; Strange and Scott, 2005).
This imbalance impacts the developing world hardest of all, where the
majority of the world's undernourished population exist. Over 800
million people suffer from malnutrition (Delmer, 2005; Strange and
Scott, 2005), many of these people live in developing counties, where
losses due to plant disease are substantially higher (Strange and Scott,
2005). These losses also often occur in the poorest of the developing
countries, which are unable to afford expensive crop protection
chemicals and which can least afford the loss. A distribution map of the
countries with the highest percentages of undernourished people is
given in Figure 1.1 (Waller et al., 2002; lOB, 2008). As the most fertile
and irrigable lands come under greater pressure to meet food
production requirements, lower yielding land must increasingly be
bought into use. This in turn means that economically sound production
of crops relies more than ever on fertiliser application but also on the
reduction of losses due to disease (Hazell and Wood, 2008).
2
Figure 1.1 A distribution map showing the percentage of the population that are
undernourished in the countries of the world 2002-2004 (FAO, 2008).
1.2 LOSSES AND IMPACT ON YIELD ASSOCIATED WITH
PLANT DISEASE
It is estimated that between 31 and 42% of all crops produced
worldwide are lost as a result of disease, insects and weeds. Of this
total, 14.1% are lost to plant disease equating to approximately $220
billion worth of crops pre-harvest (Ghini et al., 2008). These losses
impact greatly on global food production and represent a significant
threat to global food security (Strange and Scott, 2005). Predictions of
the world's ability to produce enough food to sustain the predicted
population increases vary from those that foresee no problem to those
that predict a major shortfall (Hewitt, 1998). Estimations show that only
a proportion of the land available for cultivation is actually employed in
food production; being approximately 25% in S. America, 20% in Africa
and slightly more than 45% in Asia. Overall, it is estimated that 23% of
the global total available arable land would need to be used for arable
crop production by 2050 to feed predicted population levels (Weber,
1994; Hazell and Wood, 2008). However, the ecological impact of using
these lands would be likely to be severe and it is more likely that food
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requirements will be met through increases in yield and the use of
technology or methods to restrict losses (Hewitt, 1998; Hazell and
Wood, 2008). Of the total necessary additional increases in production,
only up to 26% can be achieved by expanding cultivated areas and
14% through the intensification of production process. This means that
up to 60% of the required increase must be attained by increasing the
yield of the crops grown (Strange and Scott, 2005). Public investments
in modern scientific research for agriculture have led to dramatic yield
breakthroughs in the 20th century. The story of English wheat, for
example, is typical. It took almost 1000 years for yields to increase from
0.5 to 2 t ha", However, with the advent of modern plant breeding,
improved agronomy and development of modern fertilisers and
agrochemicals during the last 40 to 50 years yields have further
increased to an average 7.9 t ha' (HGCA, 2010). Much research and
investment has gone into efforts to increase yields using several
strategies. However, this huge goal may only be attained by the use of
better fertiliser and seed stock and through the reduction of pre and
post harvest losses due to pathogens (Jerqensen and Olesen, 2002). It
is therefore paramount that crop protection measures available are as
effective as possible and that the correct measures are integrated and
employed where and when they are needed.
1.3 CROP PROTECTION
Pathogens have challenged farmers since the first crop plants were
domesticated during the transition to agriculture that occurred globally
starting 12,000 years ago (Balter, 2007; Stukenbrock and McDonald,
2008). Control of diseases in plants is defined as "keeping disease
severity below the level at which it may become economically
significant" (Roberts and Boothroyd, 1972). Control measures may be
split into several sub groups: regulation, cultural, physical, chemical and
biological (Jones and Clifford, 1978; Heitefuss, 1989; Hewitt, 1998).
Broadly, plant disease control follows one of two epidemiological
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principles; either to reduce the amount of disease causing inoculum
present or to slow its rate of increase thus reducing the likelihood that
inoculum may reach sufficient levels to cause disease (van der Plank,
1968). Every control measure affects the pathogen either directly or
indirectly by targeting susceptible hosts or altering the hosts
environment (Roberts and Boothroyd, 1972); There are seven principle
methods of achieving this control.
I. Exclusion - cultural measures such as quarantining
foreign plant material, certification for pathogen free seed
stocks and the practice of barrier cropping to prevent the
dispersal of a pathogen (Heitefuss, 1989; Mathews,
2002).
II. Eradication - killing the pathogen, e.g. through physical
means, during the survival phase of its life cycle, including
approaches such as soil treatments, thorough tillage, crop
rotation and eliminating alternative hosts/sources of
inoculums (Martin and Woodcock, 1983; Katan et al.,
1987; Heitefuss, 1989)
III. Therapy - Therapeutic application of agents such as
fungicides, antibiotics and bio-control agents to eradicate
established disease (Narayanasamy, 2001).
IV. Vertical Resistance - Breeding crops resistant to
infection by a specific race of pathogen (Parlevliet and
Zadoks, 1977; Ma and Michailides, 2005).
V. Horizontal Resistance - Breeding crops resistant to all
races of a pathogen (Ma and Michailides, 2005; Wyand
and Brown, 2005).
VI. Protection - Application of chemical agents to prevent
infection process of pathogen (Roberts and Boothroyd,
1972; Narayanasamy, 2001).
VII. Avoidance - Planning of sowing date to reduce exposure
of crop to disease causing inoculum (Roberts and
Boothroyd, 1972; Hewitt, 1998; Narayanasamy, 2001; Ma
and Michailides, 2005).
The use of cultural and physical practices to control the prevalence of
pathogens varies in their effectiveness to reduce diseases
(Narayanasamy, 2001). Indeed, used individually they are ineffective as
a control strategy, the use of an integrated approach, employing a
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combination of several different forms of control is almost always the
most efficient and cost effective method to control disease (Hewitt,
1998). Though there is extensive literature available on the interactions,
advantages and disadvantages of the different options for disease
control, the scope of this project is primarily concerned with the use of
chemicals to protect crops from disease.
1.3.1 Chemical control measures for crop protection
The use of chemicals as plant protection agents must be carefully
thought out. The relevant advantages and disadvantages of chemical
use must be considered and if used in combination with other control
methods they may provide excellent levels of pest and pathogen
control. A chemical pesticide may be defined as a substance which kills
harmful organisms which are free living at some stage in their life cycle.
They may be classified by name referring to the type of pest that they
control for example; insecticides, acaricides, nematicides, rodenticides,
fungicides and herbicides. Some of the chemicals used can fall into
several of the categories but all pesticides need to meet certain criteria
to be successful (Mogul et al., 1996). The use of chemicals may be
further sub-divided into three main modes; Eradicative, Protective and
Curative (Jones and Clifford, 1978; Hewitt, 1998; Strange and Scott,
2005). These distinctions are important as they will dictate the manner
by which the chemical is employed:
Eradicative methods encompass the use of chemicals outside the plant
to destroy potentially disease causing pathogens before they actually
cause disease, for example a seed treatment. They may also be used
to destroy a pathogen that is in the colonisation stage of its life cycle,
for example, the use of fungicides to control mycelial growth of powdery
mildew.
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Protective methods employ chemicals that are applied to the surface of
the plant to be protected. Agents in this group are applied
prophylactically and provide protection against attack and invasion by
plant pathogens such as fungi. The pest or pathogen that this type of
treatment protects against generally penetrates the plant epidermis in
some way in the initial stages of infection (Hewitt, 1998); a good
example of this is the penetration peg of an appressoria produced by
an attacking fungal pathogen such as powdery mildew (Heitefuss,
1989). As such the attacking pest or pathogen is rapidly killed as a
result of being in contact with the chemical agent.
Curative methods use chemical agents that may help prevent further
damage or loss of yield in plants that have already become infected by
a pathogen. As such these agents must be able to penetrate the plant
epidermis to become effective from the inside out or systemic. Many of
the most effective fungicides could be classed within this group. They
may be used to target a single pathogen during critical periods of
infection, for example an outbreak of a disease epidemic.
With some agents, of which fungicides are an example, the definitions
of eradicative, curative and protective may become blurred. In some
instances the chemical agent may perform well at controlling disease
once it is established but may also be employed as a pre-emptive
treatment to help prevent the disease becoming a problem in the first
place (Heitefuss, 1989; Narayanasamy, 2001). Chemical agents that
possess this ability are highly sought after for obvious reasons. For a
chemical to be employed as an agent for the control of disease, be it in
a role as an eradicative, protective or curative role, it must meet some
basic requirements. A general summary of these ideal targets may be
seen in Table 1.1
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Table 1.1 A Summary of ideal targets for chemical plant protection agents
(Narayanasamy, 2001).
Attribute Type of Product Improvement
Safety • Safe to user and consumer
• Environmentally acceptable
• Broad disease control spectrum
• Control period and reliability
Performance increase
• Ability to overcome resistance
• Reduced levels of phytotoxicity
Use • Compatible with other products
• Easy to use formulation
• Low cost (compared to commercial
formulations:
Cost - Low required dose + number oftreatments
- Cheap cost of purchase and
application
1.4 FUNGICIDES AS CHEMICAL CONTROL AGENTS
"Fungicides are agents of natural or synthetic origin which can act to
protect plants against invasion by fungi and/or to eradicate fungal
infection" (Hewitt, 1998). Since their discovery fungicides have been
used and developed continually alongside other agrochemicals as
agents to increase yield, and quality of produce. Pressures such as
increasing world population and the need to produce better quality
produce for lower costs have pushed fungicide usage and development
from the start (Hazell and Wood, 2008). Some of the first and oldest
recorded uses of fungicidal chemicals employed elemental sulphur and
copper compounds (Ogawa et al., 1977). The wild predecessors to
present day food crops would have been susceptible to many types of
plant disease long before humans began to cultivate them for food
production (Hollomon and Wheeler, 2002). Powdery mildew certainly
affected plants grown by the Romans and Greeks who used sulphur to
control the disease (Martin and Woodcock, 1983; Hollomon and
Wheeler, 2002). Formulations such as lime-sulphur, first formulated in
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the early 19th century, improved the potential array of agents available
for the treatment of powdery mildew (Martin and Woodcock, 1983).
However, it was not until the discovery of the first organic fungicides in
1934 that the speed of development of chemical agents for the
treatment or prevention of plant disease increased (Hollomon and
Wheeler, 2002).
1.4.1 Modern fungicide formulations
The discovery of the systemic antibiotic agent griseofulvin, although
never widely employed in plant protection strategies, was an important
breakthrough as it illustrated the potential for systemic fungicides that
could be used to treat plant diseases (Hollomon and Wheeler, 2002).
This stimulated the subsequent development of several systemic
compounds. During the 1970s and 80s the triazole (sterol de-
methylation inhibitors or DMls) were introduced and have played an
important role in the treatment and control of major plant diseases.
Triazoles belong to the azole family of fungicides and contain five
number rings incorporating three nitrogen atoms. Some triazoles have
been employed effectively as clinical fungicides for medical
applications, for example, fluconazole, which has been used
successfully in the treatment cryptococcosis and coccidioidomycosis
and can be administered orally and intravenously (AI-Mohsen and
Hughes, 1998). Triazoles are active against ergosterol biosynthesis
(Ergosterol biosynthesis inhibitors or EBls), this class of fungicide
inhibits the demethylation of sterols in fungi. Ergosterols are the
predominant type of sterol in most fungal species and are responsible
for the maintenance of membrane structure and function (Iris and
Loeffler, 1993; Turner et al., 2000). Specifically, DMI fungicides bind
with the active site of 14a-demethylase, which catalyses the C-14
demethylation of 2,4-methylene dihydrolanosterol, inhibiting the action
of the haem prosthetic group within the cytochrome P-450 complex
within the enzyme. The presence of the fungicide in this position blocks
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the binding of an activated oxygen molecule which is required for the
hydroxylation of the 14a-methyl group on the developing sterol
molecule. This inhibition results in an accumulation of C-14 methyl
sterols and a subsequent depletion of ergosterol, disrupting membrane
function and activation chitin and ~-1,3 glucan synthesis ultimately
preventing fungal growth (Kang et al., 2001; Griffiths et al., 2003). Their
systemic nature, broad range of action against several important
pathogens, such as rust, smut, bunt and mildew, of food producing
crops and longevity of effective use have made triazoles pivotal in
integrated control strategies against plant diseases (Cremlyn, 1991;
Morton and Staub, 2008). In 2005 this class of fungicide accounted for
over 20% of total fungicide sales worldwide (Morton and Staub, 2008).
1.4.2 Tebuconazole usage
First reported in 1986, tebuconazole (a triazole fungicide) was
introduced by Bayer CropScience in South Africa in 1988.
Tebuconazole is a systemic fungicide with protective, curative and
eradicative modes of action and is rapidly adsorbed into vegetative
parts of the plant and translocated principally acropetally. Active against
a wide range of pathogens in many crops including cereals,
tebuconazole is used to treat Tilletia spp., Ustilago spp., Urocystis spp.,
Septoria nodorum (seed borne), rusts (Puccinia spp.) and powdery
mildew (Blumeria graminis) to mention a few (Tomlin, 2009).
Tebuconazole has been used consistently in the UK over the past 16
years with total use increasing over the past six years - Table 1.2.
Table 1.2 A summary of tebuconazole usage in the UK between 2004 and 2008
(Pesticide Usage Statistics, 2010)
Year Total Area Treated (hal Total Weight Applied (kg)
2008 2,384,270 190,727
2006 1,952,362 153,186
2004 1,668,704 126,430
2002 1,603,103 118,175
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In 2006, 97.3% of the total area of arable crops planted was treated
with fungicides. In total, 79.61 tonnes of raw (i.e. unformulated)
tebuconazole was applied, to fields in the U.K. This equated to 3.3% of
the total fungicides applied to arable crops in the UK ranking the 6
th
most used Active Ingredient (AI) (Garthwaite et al., 2010).
1.5 APPLICATION OF FUNGICIDES
Application of fungicides for the control of plant pathogens can be
undertaken using various means. Principally there are three main forms
of application - either as seed treatments, foliar sprays or as a
combination of these (Hewitt, 1998; A.A.B., 2010). Often pesticides are
applied to crops via broadcast (spraying) methods, Table 1.3 lists some
of the common formulation types currently used.
Table 1.2 Common agrochemical formulation types (adapted from Lainsbury. 2009)
Formulation Type Description
EC Emulsifiable Concentrate
ES Emulsion for seed treatment
EW Oil in water emulsion
LS Solution for seed treatment
FS Flowable Concentrate (for seed treatment)
WP Wettable Powder
The scope of this research is primarily aimed at the use of fungicide
formulations as seed dressings. Such applications have been primarily
employed as a method of protecting seedlings from diseases caused by
seed and soil-borne pathogens (Taylor and Harman, 1990; McGee,
1995). However, more recently, this form of fungicide application is
routinely employed to apply systemic materials (Hewitt, 1998). Seed
treatment with agrochemicals has been an effective way to control
many pests and diseases in plants for several years. Crops including
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cereals, cotton, oilseed rape, potatoes and sugar beet, benefit from the
use of seed treatments (Hewitt, 1998).
Many of the substances or formulations employed as seed treatments
today are systemic in nature and include a wide range of active
ingredients including fungicides such as tebuconazole, fluquinconazole
and triticonazole. Such substances provide excellent broad spectrum
activity against a wide range of pathogens and are especially effective
during the early stages of growth (Brandl and Biddle, 2001). The use of
fungicides, such as triazoles, as seed treatments can also provide
convenient and economically beneficial application options. This sector
of the fungicide market has showed considerable growth globally from
€560 million in 1994 to €780 million between 1994 and 1999 (Hicks,
2000). Systemic treatments also confer benefits in terms of their
toxicological and ecotoxicological impact when compared to other
commercial methods of application, such as spraying (Asrar et al.,
2004). There are many advantages to the use of seed treatments over
other methods of application available, the main example being the
ability to target application of treatments in a specific environment. The
inherent inaccuracy of the use of sprayers for the application of plant
protection chemicals, due to factors such as spray drift and problems
with adhesion of materials to plant surfaces means that, often, a higher
application rate is required to achieve an adequate level of protection
(A.A.B., 2010). Although the advent of systemic materials has reduced
required application rates, factors such as the environmental and
economic impact of the use of these chemicals are still of concern
(Hewitt, 1998; Hicks, 2000). The total amount of active ingredient
applied to a crop, and subsequently the environment, may be greatly
reduced by the use of systemic products as seed treatments. Further
advances in the formulation of systemic fungicides that may give a slow
release of the chemical into the environment, possibly conferring an
improved and prolonged level of protection against disease, have
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One limitation of this type of treatment, even when using fungicides that
are systemic in nature, is that the level of protection offered to the plant
is typically only significant in the early stages of plant growth. The
effectiveness of the treatment declines due to environmental
degradation of the active ingredient (AI), low uptake efficiency and short
half lives of the AI in the plant tissue itself. These chemicals may also
be subjected to leaching, evaporation and degradation by photolysis,
hydrolysis and microbial actions, all of which decrease the amount of
available AI that reaches the desired target (Mogul et al., 1996). Allied
with this, it has proved difficult to maintain significant levels of AI in the
plant as it matures, especially in later growth stages as the plants
biomass increases (Ashley et al., 2003). Aside from the issue of
maintaining a reasonable concentration of AI in the plant as it grows
there is also the problem of phytotoxicity causing stunting and
emergence problems in young plants. Many systemic treatments,
especially seed treatments, may have a phytotoxic effect on plants,
examples include triarimol, tridemorph and azepine-A2151. All have
been found to cause phytotoxic effects when applied at necessary dose
rates to attain adequate disease control (Maude et al., 1984). This is an
issue in itself but it also limits the amount of AI that may be applied
directly onto the seed potentially decreasing the potential for disease
control. Therefore Als used for seed treatments are preferably required
to cause low levels of phytotoxicity and provide an adequate level of
protection from pests and/or disease (Brandl and Biddle, 2001).
further increased the potential for the use of seed dressings (Bahadir,
1990; Asrar et al., 2004).
1.6 TEBUCONAZOLE AS A SEED TREATMENT
A commercially available formulation of tebuconazole, used as a seed
treatment formulation exists in the form of a flowable suspension called
Raxil produced by Bayer CropScience. Registered for use in over 100
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countries on over 90 crop types, Raxil is one of the main formulations
used in the prevention of seed and soil borne diseases in cereals such
as Tilletia spp., Usti/ago spp., Septoria spp. (BayerCropScience, 2010).
Tebuconazole is nominally applied as a seed hygiene treatment at a
rate of between 1 and 7.5 g AI per 100 kg seed (BayerCropScience,
2010). Although no longer employed as a single AI product Raxil still
exists as a formulation incorporating tebuconazole in mixtures with
other Als. Many chemicals used in disease control can be phytotoxic to
plants as well as the disease causing organisms the agent is applied to
treat. Tebuconazole, like several other triazoles, can have a phytotoxic
effect on plants. This problem is especially serious for seeds that have
a higher water content which may be easily penetrated by applied
fungicides causing injury to the seed endosperm (McGee, 1995).
Excessive application of tebuconazole can cause damage to seeds and
reduce germination. This effect is caused by the inhibition of gibberellin
synthesis by the blocking of P450 dependant mono-oxygenases which
inhibits the oxidation of kaurene to kaureonic acid (Rademacher, 2000).
Gibberellin hormones play a vital role throughout plant development,
and are vital for processes such as seed germination, stem elongation
flower induction, anther development and seed and pericarp growth
(Hedden and Kamiya, 1997). Triazole fungicides can also inhibit
demethyl-sterol synthesis in plants. The recommended rate of
application for tebuconazole as a seed treatment is between 1 and 7.5
9 of AI/100 kg of wheat seed, applied at this rate tebuconazole is
effective against many early season diseases affecting food crops such
as powdery mildew (Asrar et al., 2004; Tomlin, 2009). However
application of the fungicide in this manner requires a further foliar
application of the treatment later in the growing season to maintain
adequate levels of protection against plant diseases (Mogul et al.,
1996)
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1.7 CONVENTIONAL VERSUS NOVEL FORMULATIONS OF
AGROCHEMICALS AS SEED TREATMENTS
The science of pesticide formulation is a broad and varied field covering
aspects not only of development, production and storage of the
formulations but also the interaction of the pesticide with the
environment, including effects on plants, insects, animals, soil, air and
water (Walker et al., 2001; Markus and Linder, 2006). The choice of
formulation is influenced by several factors. The physical and chemical
properties of the pesticide must be considered. The crop to be treated
and biological/environmental properties of the pesticide (crop
selectivity, transport through soil/ground water and LDsofor mammalian
and non-mammalian species) are also important. Finally the economic
cost of the above is also an important consideration (Markus and
Linder, 2006).
Often applications are performed at very high and potentially toxic rates
to attain a high enough initial concentration of the chemical to be
effective against the target disease (Kydonieus, 1980). This type of
application usually results in a rapid decrease in available
concentrations of the fungicide and subsequent repeats of the
treatment later in the growing season to maintain disease control
(Markus and Linder, 2006). Novel formulations must therefore be
designed to meet several simultaneous demands of efficacy and
suitability to mode of application (e.g. seed dressing) whilst minimising
environmental impact (Markus and Linder, 2006).
Depending on the method by which a chemical control agent, such as
tebuconazole, is employed, up to 90% of the total applied may be lost
before the AI reaches its target objective and the desired effect is
produced (Mogul et al., 1996). Attaining the desired biological response
at the right concentration and at the correct time is more complicated.
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To combat these difficulties agents may need to be applied regularly
and non-specifically. This increases the cost of the treatment and also
results in other undesirable effects such as increased selective
pressure on pathogens. This may lead to potential problems with
fungicide efficacy and may also produce adverse effects on the plant,
for example stunting (Mogul et a/., 1996). The emergence of technology
whereby the release rate of these chemicals can be controlled and
sustained has the potential to alleviate many of the inherent problems
and inadequacies (Mogul et a/., 1996).
One of the ways by which the ideal situation of reduced phytotoxicity
and prolonged disease protection may be obtained is by controlling the
rate at which the AI is made available to the plant. The principal
advantage of controlled release formulations of these chemicals is that
much less chemical may need to be applied overall to attain the same
effect (Kydonieus, 1980). Allied to this is the potential for the extension
of the half-life of some of the more volatile compounds used. The AI is
loaded into a carrier which then allows the molecule to be released in a
controlled and sustained manner. Conversely the AI could be applied at
higher rates without risking adverse phytoxicological (plant damage) or
environmental effects whilst, at the same time, conferring longer term
protection with a higher level of AI available for longer periods of time
(Markus, 1996; Markus and Linder, 2006). By encapsulating the AI its
application to a soil environment, as a seed dressing may result in the
release of the AI by diffusion after hydration, in a sustained manner.
The effects of leaching, environmental degradation and evaporation
should also be reduced. The use of such formulations should therefore
mean that each application would be far more efficient per unit weight
whilst also providing longer protection per unit applied. Saturation of the
ecological environment could also be reduced, meaning less risk of
leaching of harmful pesticides into waterways and drinking water
supplies. If these formulations could be shown to reduce reliably the
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leaching affect observed with some of these treatments, these
chemicals could in turn be used, reliably, near irrigation canals/other
water ways and also near crops that might be sensitive to the treatment
(Mogul et aI., 1996)
Apart from the advantages listed above there also exists the possibility
of combining incompatible pesticides allowing for a more
comprehensive strategy to be employed against potential pathogens
and pests (Asrar et al., 2004). The use of synthetic chemicals, such as
fungicides, to increase yields by reducing the impact of plant
pathogens, is considered vital to produce adequate food stocks
(Gonzalez-Rodriguez et al., 2008). The use of fungicides specifically, is
pivotal in the control of both pre and post harvest pathogens that can
have Significantly detrimental effects on production (Clarke et al., 1997).
However, many of the chemicals used for these applications are not
only toxic but also persistent in nature. Food is the main source of
exposure of the general population to pesticides and accounts for more
than 90% of total exposure (Gonzalez-Rodriguez et al., 2008).
Pesticide residues in food and crops are as a direct result of the
application of these chemicals to crops growing in the field but also
from crop residues in the soil environment of fields where food crops
are grown (Businelli et al., 1992). As a result, there is a growing desire
to reduce the amount of pesticide use in agriculture (Freidberg, 2003).
Fungicide application may also result in exposure of the general
population to toxic compounds. Controlled release formulations of
agrochemicals that allow less total chemical to be applied to the
environment may help provide the answer to this problem.
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1.8 MICROENCAPSULATION OF AGROCHEMICALS AS
CONTROLLED RELEASE FORMULATIONS
1.8.1 Theory of microencapsulation
The microencapsulation of materials has evolved from examples in
nature, where numerous examples exist ranging from macro to nano
scale. The simplest examples of these are a bird egg or plant seed on
the macroscopic scale and a cell and its contents on the microscopic
scale (Bishop et al., 1998; Hemsley and Griffiths, 2000). The
development of microencapsulation began with the preparation of
microcapsules containing dyes which were incorporated into paper for
copying purposes and replaced carbon paper (Schleicher and Green,
1956). The pharmaceutical industry has long used microencapsulation
for the preparation of capsules containing active ingredients, though as
time passed, a variety of new technologies have been developed in this
field (Ghosh, 2006). The approach of microencapsulating active
materials has subsequently been utilised in a variety of applications in
industries including agricultural products, food, cosmetics and textiles
(Ghosh, 2006). Microencapsulation may be described as a process of
enclosing micron sized particles, of solids, droplets of liquid or gases in
an inert shell, which in turn isolates and protects the material from the
external environment (Benita, 1996). The process also provides the
possibility of combining the properties of different types of, otherwise
incompatible, material (e.g. inorganic and organic chemicals). This
possibility has implications for the agrochemical industry and
specifically the formulation of fungicide materials for use as seed
treatments, where often, the most effective treatments available involve
a combination of different active ingredients (Taylor and Harman, 1990;
Benita, 1996; Brandl and Biddle, 2001; Ghosh, 2006).
The resultant products of the microencapsulation process are termed
microcapsules which, nominally, are of around a micron in size and
have a spherical or irregular shape. The core or intrinsic part of the
microcapsule, contains the active ingredient (e.g. a fungicide), while the
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shell or extrinsic part, protects the core area from the external
environment, this is summarised in Figure 1.2 (Benita, 1996; Gouin,
2004; Ghosh, 2006).
Internal (intrinsic) space
in which a material may
be encapsulated
External {extrinsic) shell
Figure 1.2 Generalised schematic of a microcapsule
For successful encapsulation there must be a sufficient degree of
compatibility of the material to be loaded with in the core of the
microcapsule. Pre-treatment of the core material is often required to
facilitate increased encapsulation efficiencies and the size of the core
material may also play a role in subsequent levels of diffusion and
permeability especially in formulations where controlled release is
desirable (Benita, 1996; Asrar et aI., 2004; Ghosh, 2006). The release
of an encapsulated material is also governed by the thickness of the
shell wall and this is an important criterion for choosing an appropriate
microcapsule for industrial applications (Ghosh, 2006). The morphology
of microcapsules may differ significantly and are dependent on the core
material and are classified as three main types summarised in Figure
1.3. Mononuclear (core-shell) microcapsules contain the shell around
the core, poly-nuclear contain multiple core structure contained within
an external shell. In matrix encapsulation the core material is distributed
homogenously throughout the shell material.
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Microcapsule
Figure 1.3 Generalised morphology of different types of microcapsules. Adapted
from (Ghosh, 2006).
1.8.2 Advantages of microencapsulation
Generally speaking, the use of microencapsulation to deliver active
materials such as agrochemicals to the environment has many potential
advantages, these are summarised below (Ghosh, 2006).
• Protection of unstable and/or sensitive materials from their
environment.
• Better processability (improving solubility, dispersibility and
flowability.
• Enhancement of half-life by prevention of degarding reactions.
• Controlled, sustained and/or timed release
• Safe and convenient handling of toxic materials.
• Controlled and targeted delivery of materials.
When the material employed is a chemical pesticide, e.g. a fungicide,
the use of microencapsulation may confer several further, more specific
advantages (Kydonieus, 1980; Markus and Linder, 2006), these are
summarised below;
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• An extension in the duration of activity of the active ingredient for
an equal rate of application and a decreased cost associated
with this.
• Controlled timing and rate of active ingredient release.
• Reduction in phototoxic effects associated with the application of
several chemical agents to plants or seed.
• Protection against environmental degradation of the active
ingredient by processes such as oxidation, hydrolysis, photolysis
and microbial metabolism.
• Increased convenience of use and handling by conversion of
liquid materials into solids or flowable powders.
Many formulations of microencapsulated pesticide are manufactured for
their ability to release the active material in a controlled manner.
However, some formulations of fungicides, such as foliar sprays, are
required to release the encapsulated active ingredients as quickly as
possible to facilitate better uptake by target pathogens before factors
such as wash off induced by rainfall or watering cause a reduction the
amount of chemical available (Benita, 1996). The potential advantages
of applying microencapsulated formulations of fungicide treatments are
clear. However, there are some disadvantages associated with this type
of formulation. The cost of producing, processing and testing controlled
release formulations may be higher when compared to conventional
forms of the fungicide (Kydonieus, 1980). There may be an
environmental impact caused by the use of non-biodegradable or
harmful materials as microcapsules. Similarly, additives and solvents
used to increase the efficiency of the loading process during
microencapsulation may also be hazardous, not only to the
environment, but also to operators using the product and the plant to
which the product is being applied (Tewes et 81., 2006). This problem
may, however, be overcome by the use of biodegradable
microcapsules such as yeast.
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1.8.3 Yeast cells as preformed microcapsules
The potential for the use of microorganisms, such as yeast, to be used
as preformed natural and biodegradable microcapsules for the
controlled delivery of active materials has first recognised in the 1970s.
Early work on yeast cells (Saccharomyces cerevisiae) showed that,
when pre-treated with a plasmolyser, the cells were observed to be able
to retain water soluble flavour compounds (Serozym Laboratories,
1973). Other research carried out in 1970s by the company Swift and
Co., used specially pre-prepared yeast containing high lipid
concentration (>40%) to encapsulate lipophillic materials (Swift and
Company, 1977). Subsequently, there have been several examples of
synthetic polymeric delivery vehicles investigated for the delivery of
pharmaceutical materials (Langer and Peppas, 2003; Langer and
Tirrell, 2004). Increasing amounts of research into the use of
microorganisms for this application, especially for the application of
molecules such as bioactive proteins and vaccines have been carried
out over the past 15 years. The use of yeast cells for this purpose could
include the production and subsequent release of a desirable active,
such as a vaccine, in-situ within the environment of application, such as
the human gut (Blanquet et al., 2004).
Yeast are unicellular fungi, averaging approximately 5 micrometers (for
Saccharomyces spp.) in diameter, confined by a rigid cell wall which
protects the internal membrane and organelles from the external
environment. The cell wall is composed of complex and highly linked
glucan, mannan and chitin and is approximately 100-200 nm thick
comprising 15-25% of the dry mass of the cell. In live yeast cells, the
cell wall surrounds the much thinner «10 micrometers) plasma
membrane which consist of a typical bi-Iayer unit membrane comprising
(of) phospholipids, sterols and neutral lipids, mainly by triacyl glycerols
and sterol esters (Nelson et al., 2006). The structure of a typical yeast
cell can be seen in Figure 1.4. A freeze fracture cryo scanning electron
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micrograph (SEM) image is seen in Figure 1.5. The image shows the
exposed internal contents of a yeast cell. It is these contents which are
removed to allow the microencapsulation of materials to take place
within the cell wall of the yeast cell. The cell membrane provides the
main barrier to the uploading of active ingredients into the yeast's
structure and inactive yeast is therefore more effective at carrying Als
(Nelson et al., 2006).
Figure 1.4 Diagrammatic representation of structure of a typical yeast cell (adapted
from Duckham et al., 2003)
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Figure 1.5 A cryo SEM image of a typical yeast cell (Saccharomyces cerevisiae)
showing the cell wall and exposed internal contents within the cell membrane.
Reproduced with permission, (Duckham et al., 2003)
1.8.4 Microencapsulation in yeast cells
Yeast cells are one of the most important classes of micro-organism
with applications in the brewing, ethanol production, baking and
recombinant protein and biopharmaceutical industries (Nelson et al.,
2006). The encapsulation of chemicals in microorganisms was
established as a patented technology in the late 1980s by AD2 Ltd.
(AD2, 1987). The technology became commercialised in subsequent
years initially for the delivery of flavour volatiles but in more recent
times, for other Als (Duckham et al., 2003). The process involves the
cytoplasmic contents of the cell being removed and the material to be
encapsulated taking its place (Nelson et al., 2006). Yeast used could be
the industrial bi-product of other primary industrial processes and, as
such, the yeast would be available in large quantities and at low, cost-
effective prices. The size and physical make (lipid content) up of the
yeast microcapsules could also be controlled easily in vitro by altering
the nutrient balance in the fermentation medium (Nelson et al., 2006).
The use of specific yeast strains grown on high nitrogen media enabled
the accumulation of high concentrations, upwards of 40%, of lipid
material. These strains (Torulopsis lipofera and Endomyces vernalis)
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were able to accumulate lipophillic compounds such as dyes, vitamins
and drugs by dissolving the Als in the lipid globules found in the
cytoplasm (Swift and Company, 1977). This technology progressed
further when AD2 Ltd. proved it was possible to encapsulate llpophillic
substances in yeast cells with less than 5% lipid content (Nelson et a/.,
2006). This allowed the use of yeast strains that were already being
employed in other industries such as brewing, bio-ethanol production
and baking, including the Saccharomyces species (Nelson et a/., 2006).
The encapsulation of lipid soluble compounds has been found to be
possible in either living or dead yeast cells (Bishop et a/., 1998) The
technique for encapsulation of essential oils and other chemical was
confirmed by the presence of droplets found within the 4-5 micron yeast
capsule by Bishop et at. (1998). Yeasts from several different
processes have been tested for this application. Bi-product yeast from
bio-ethanol production is non-viable due to its prior treatment, other
yeasts used in the past have been still living when used (Duckham et
a/., 2003). However, the specifics of the release mechanism are not
fully understood (Duckham et a/., 2003). It is hoped that by
microencapsulating Als such as fungicides the yeast can offer some
form of protection from environmental effects and that a more
prolonged and controlled release can be achieved (Salvage, 2004).
A company called Micap PLC, formerly based in Runcorn, England
developed and patented a novel microencapsulation technology
(Pannel, 1987). Micap, the registered trade name for the technology,
used yeast cells to enclose active ingredients. The encapsulation
process (using strains of the yeast Saccharomyces cerevisiae available
as bi-products from the baking and brewing industries) has been
described (Bishop et a/., 1998; Nelson et a/., 2006) and is summarised
in Figure 1.6 The process involves the mixing of the active to be
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encapsulated with yeast and water in the presence of a loading solvent.
The mixtures are then separated by centrifugation and spray dried prior
to use.
Encapsulation levels generally attained 20 to 40 % (w/w) but can
sometimes reach 80 % (Nelson and Crothers, 2003). The technology
has been used successfully in the food industry where it has been used
to encapsulate essential oils and synthetic flavours and protect them
from evaporation. These molecules can then be released from the
capsules on contact with the moist tongue surface without the yeast cell
being disrupted (Nelson and Crothers, 2003). The release mechanism
is not by cell fracture but by diffusion, and the yeast cells are able to
withstand high pressures and shear forces (Nelson and Crothers,
2003). The structural integrity of the capsules is vital to protect the
active molecules during the application process.
Active Water +
•
Additional
formulation
.Spray Drying
!
EJ
Product
Figure 1.6 Process steps in the Micap yeast-based encapsulation process
(Adapted from Pannel, 1987)
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Yeast cells can be used to encapsulate a wide range of commercially
important active ingredients, including fungicides (Nelson and Crothers,
2003). The yeast cells are indeed an ideal vehicle for the delivery of
fungicides as they have some natural bio-adhesive effects (Nelson and
Crothers, 2003), which would allow them to stick to the surface of the
plant tissue. In addition, in suspension, agglomerates of yeast cells
disperse very quickly to one or two cells, which are approximately five
microns in diameter (Nelson and Crothers, 2003). These characteristics
suggest the feasibility of good delivery as the yeast cells which are
small enough not to clog the equipment used by growers during a
spraying process. Unfortunately Micap PLC ceased trading in 2007,
within the period of the research undertaken for this project.
1.9 DETECTION AND EXTRACTION OF FUNGICIDE
RESIDUES
1.9.1 Detection
Fungicides are used widely in agriculture to control a variety of
diseases and belong to various chemical classes including triazoles,
benzimidazoles and carbamates (Sanchez-Brunete et al., 2002). There
are many, varied, published methods for the extraction, detection and
quantification of fungicide residues in plants, vegetables, fruits, soil,
water, and even honey bees (Hiemstra et al., 1995; Torres, 1997; Wu et
al., 2001; Rial-Otero et al., 2004; Khummueng et al., 2006; Charlton
and Jones, 2007). Conventional methods for the detection and
quantification of fungicide residues usually consist of the following
steps: sampling and sample preparation, liquid-liquid partition and
cleanup followed by determinative procedures (Sherma, 1975). There
are several detection techniques available for the detection of fungicide
residues. These can include the use of analytical techniques such as
reverse phase high performance liquid chromatography (RP-HPLC)
with column switching and diode array detection (DAD) (Michel et al.,
2006). Techniques using LC-MS/MS have also been reported as a
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method of for assessing systemicity of fungicides in wheat plants
without the use of radio-labelled compounds and/or efficacy tests
(Klittich et a/., 2008). There has also been some research into the use
of molecular methods for the detection of fungicide residues (Danks et
a/., 2001). However, the pre-eminent technique employed in the
detection and quantification of fungicide residues, and pesticide
residues in general, is Gas Chromatography Mass Spectrometry (GC-
MS) (Scott and Gutnikov, 2000).
The introduction of gas chromatography in the 1960s revolutionised
residue detection methodology (Fong et a/., 1999; Scott and Gutnikov,
2000). Gas chromatography has very low detection limits and it is for
this reason that it has evolved as the method of choice for pesticide
residue analysis (Seiber et a/., 1999). The principle of GC is to focus on
the unique structural features of each analyte and allow detection of
these even if other chemicals are present at higher concentrations
(Seiber et a/., 1999). This is achieved by separating the compounds so
that they may be presented to the detector (e.g. mass spectrometer) for
identification. Samples, dissolved in a small volume of solvent (e.g.
methanol or dichloromethane) are injected into the GC through a plastic
membrane seal into a heated glass injector column where they become
vaporised. The subsequent vapour is then forced down a column by a
constant flow of analytical grade helium (or nitrogen). A thin liquid
phase coating the inside of the column absorbs each chemical element
of the injected samples to different degrees allowing the different
components to travel down the capillary column at different rates. The
column is installed in an oven maintained at a sufficient temperature to
prevent the sample from condensing; the manner in which the
temperature of the oven changes during an analytical run can be
adjusted to optimise the separation of the samples.
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The column terminates within a component of the MS known as the
source, which is under a constant vacuum and high temperature,
samples are transferred to this section of the GC-MS via heated
transfer line again to prevent samples from condensing. Molecules of
the compounds that have exited the column are bombarded with a
constant stream of electrons, generated by a filament similar to that
found in a light bulb, turning the molecules into ions. The ionised
sample components exit the source under the influence of an electrical
field forming an ion beam which is then focussed by a series of charged
plates known as lenses and onto the mass analyser by the electrical
field generated by four, charged rods known as a quadrupole. On
entering the mass analyser a complex series of varying electrical fields
consisting of radio frequencies and maintained static electrical voltage
allow ions of a certain mass, dictated by the mass spectroscopy scan
program, to pass. These ions enter the detector where they are
accelerated onto a conversion dynode forming electrons, which
continue onto a phosphor. Electrons striking the phosphor emit light
which is converted into a measurable electrical signal by a
photomultiplier and analysed (Fisons GC 8000 operating manual,
2005). Using GC-MS both qualitative and quantitative analysis may be
performed on many fungicide residues including the analysis of multiple
residues (Sanchez-Brunete et al., 2002).
1.9.2 Extraction
Despite the selectivity and sensitivity of analytical techniques, such as
GC-MS, there is often a requirement for the pre-concentration of trace
amounts of compounds due to their low concentrations encountered.
This is especially true in the analysis of water samples (Rial Otero et
al., 2003). Furthermore, high levels of other components often
accompany analyte of interest and may make subsequent detection
more difficult. In the past, liquid to liquid extraction (LLE), usually
involving organic solvents has been a staple means of removing
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analytes of interest from sample materials (Camel, 2003; Rial Otero et
aI., 2003). More recently solid phase extraction (SPE) has been
employed to selectively remove and also concentrate the analyte of
interest from samples whilst simultaneously removing other interfering
compounds and improving detection limits (Liao et al., 1991; Rial Otero
et al., 2003). The first experimental applications of SPE started over 50
years ago. However, the technique only became widely used as an
alternative to LLE for the sample preparation in the mid 1970s (Lika,
2000). SPE has been shown to be an applicable tool for the extraction
and purification of analytes in many different applications (Kakallkova et
al., 1996; Bernal and Del Nozal, 1997; Bernal et al., 1997; Herrero et
al., 2006).
1.9.2.1 Solid Phase Extraction(SPE)
The principle of SPE is similar to that of LLE involving the partition of
solutes between two phases. However, instead of two immiscible liquid
phases, such as water and dichloromethane, SPE involves the
partitioning between a liquid (sample matrix) and a solid (sorbent)
phase (Camel, 2003). The basic approach involves passing a liquid
sample through a column containing an adsorbent which retains the
analyte which are then subsequently recovered or eluted from the
sorbent bed using an appropriate solvent.
An SPE method comprises a series four successive steps; the sorbent
bed is first conditioned using an appropriate solvent followed by a
further volume consisting of the same solvent as that of the sample.
This step of the method is vital as it serves to wet and to remove air
from the sorbent bed, activate (solvate) functional groups of sorbent
bed and to remove any impurities remaining after production of the
cartridge (Lika, 2000). During extraction the cartridge must not be
allowed to dry out between samples as this may lead to poor retention
30
of analytes and subsequent lower than optimum recoveries. Similarly, if
the cartridge is to be used repeatedly then appropriate care must be
taken to re-condition the sorbent bed between samples (Rial Otero et
al., 2003).
The sample is then passed through the SPE cartridge in an appropriate
volume of solvent, (ranging from 1-1000 mL depending on application)
this may be achieved using gravity, pumping, vacuum aspiration or by
an automated system. This step concentrates and retains the analyte
on the sorbent bed (Camel, 2003). Trace elements are usually
adsorbed onto the solid phases of the cartridge through Van der Vaals
forces or hydrophobic interactions, especially if the sorbent bed is
highly non-polar or reverse phase (Lundgren and Schilt, 1977). This
second step is commonly followed by a third step, where by the sorbent
bed is 'washed' by passing a further volume of solvent with a low
elution strength through the cartridge. This eliminates any matrix
components that may be retained within the sorbent bed and may also
remove excess water left in the cartridge which may have an adverse
effect on subsequent extract concentration and/or hinder analysis
(Camel, 2003).
The fourth step consists of the elution of the analyte from the sorbent
bed using a suitable volume of solvent to ensure a dilute final
concentration of analyte to solvent, an appropriate flow rate of elution
solvent through the sorbent must also be used to ensure efficient
elution. For the elution phase of the method to be effective the analyte
must have a high solubility in the solvent selected to ensure efficient
partioning from the sorbent bed into the solvent. The elution solvent
must also be selected to elute the target analyte only (Camel, 2003).
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1.9.2.2 Advantages of SPE
The use of LLE to extract concentrations of analyte from samples are
often time consuming and labour intensive, especially if high numbers
of replicate samples are to be analysed. The use of SPE is beneficial
for a number of reasons; LLE uses comparably high volumes of
solvents, SPE reduces total volumes required and the associated
expense of disposal (Majors, 1986). SPE also allows the simultaneous
extraction, concentration and removal of interfering compounds into a
final sample volume smaller than that of the initial sample. Further to
this, SPE offers a high degree of selectivity compared to other
extraction options, such as LLE, by only pre-concentrating trace
elements of interest and avoiding elution and subsequent detection
problems associated with major ions (Castillo et al., 2001). This facet of
SPE may also allow a further degree of speciation for compounds,
whereby analytes that may hinder subsequent detection may be
removed individually thus further increasing potential limits of detection
for the analyte of interest (Gonzalez-Toledo et al., 2001).
1.10 UPTAKE AND FATE OF FUNGICIDES IN PLANTS
1.10.1 Uptake pathways
For the most part, fungicides are synthetic man-made chemicals and,
as such, would not exist in the environment naturally. It is therefore
reasonable to think of fungicides applied, even intentionally, to the
environment as a form of pollutant in so far as without human
intervention, these compounds would not be present naturally. The
uptake of organic chemical compounds, such as fungicides, into plants
is a complex combination of numerous factors (Trapp, 1995). The topic
of the accumulation of pesticides in food crops, their persistence and
fate in the environment and methods for the determination of these
residues has been the topic of a huge amount of research (Gonzalez-
Rodriguez et al., 2008).
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There are at least three principle pathways by which chemicals may
transit from the environment into plants.
• Root uptake into conduction channels and subsequent translocation
by the transpiration stream, as a result of desorption of chemicals
from the soil via water or air in the soil.
• Uptake of chemicals from compounds in the surrounding air,
through the plant epidermis or via natural openings such as
stomata.
• External contamination of shoots by soil or dust resulting in uptake
by retention on and subsequent penetration through the plant
cuticle. A summary of these pathways is depicted in Figure 1.7. In
most cases the uptake of a chemical into a plant is facilitated by a
combination of these pathways (Topp et al., 1986).
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Figure 1.7 A summary of the principle pathways for the uptake of organic
chemicals by plants. (Adapted from Collins et al., 2006)
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The scope of this research is primarily concerned with the uptake of
fungicides applied to the soil as seed treatments and not via other
means. Uptake of fungicides from the soil occurs via the root system of
the plant and is predominately a passive process. Uptake occurs via the
vapour or water phases of the soil by the process of diffusion. There
are, however, some exceptions to this, most notably some hormone like
chemicals such as the phenoxy acid class of herbicide for which there
has been shown some evidence of active uptake (Bromilow and
Chamberlain, 1995). Roots provide anchorage, permit storage of
energy rich molecules and undergo a physical as well as a chemical
interaction with the soil. As with the visible, aerial parts of plants, the
root architecture of each species of plant may differ greatly (McFarlane,
1995a). The manner in which the roots develop is driven by a variety of
factors such as genetically controlled branching characteristics, radial
growth, development of secondary cell walls and layering of suberin.
Root development is also driven by other factors such as soil
characteristics, available nutrients, water, pathogens, meteorology and
solar radiation (Amir and Sinclair, 1991). Root growth provides a
continually changing source of nutrients, water and also other
compounds such as chemicals in the soil (McFarlane, 1995a).
Many plants develop unicellular extensions of the epidermal cells
known as root hairs a short distance from the root apex. These cells
dramatically increase the total surface area of the interface between the
roots and the soil environment. Root hairs are in a constant flux, dying
and being regenerated, as they develop into new areas of soil. This
coincides with the zone of maximum water and cation uptake. It is
through this zone that the majority of uptake of anthropogenic
chemicals occurs (McFarlane, 1995a). Cell walls between the cortex
cells are porous, often containing voids where several cells adjoin.
Water containing dissolved solutes moves freely from the soil solution
to the interior of the roots via the capillary spaces between these cells.
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This is known as apoplastic movement. This movement, summarised in
Figure 1.8, is stopped before entry into the plants vascular system at
the endodermis where a band exists of waxy material formed around
anticlinal walls of these specialised cells called the casparian strip. At
this point dissolved solutes carried into the plant via the roots must pass
through at least one cell membrane to move into a plant's vascular
system. This is classed as symplastic movement. The pace of this
movement has been shown to be affected only by the rate at which
water moves through the plant driven by evaporative loss of water from
the leaves i.e. transpiration (McFarlane, 1995a). Experiments involving
the uptake of non-ionised chemicals from a hydroponic solution into
plant roots have shown that the process consists of two components.
Firstly equilibration, where chemical concentrations in the aqueous
phase of the plant root and the surrounding solution become balanced.
Secondly, sorption of the chemical onto lipophillic root solids found in
the cell membranes of and cell walls of cells in the roots (Paterson et
al., 1991). Once in the roots the chemical may then disperse to other
areas of the plant via the plants vascular system.
Endodermis
easpaden strip
Movement of water and solutes from
--+ soil into plant vascular system
(apoplastlc then symplasdc)
Figure 1.8 Wheat root cross section showing the route of water and dissolved
solutes from the soil into the plant. (Adapted from McFarlane, 1995a)
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1.10.2 Factors affecting uptake
There are several factors affecting the degree to which a chemical is
available for uptake from the soil. Initially, uptake is governed by the
physiochemical properties of the chemical in question. This is
highlighted, in the first instance, where chemicals are taken into the
roots and travel, via the apoplastic pathway to the endodermis. Here,
they are then required to cross a cell membrane to enter into other
parts of the plant. The implication of this is that for a compound, such
as a seed applied fungicide, to be successfully taken in by the plant to
provide protection from pathogens it must be lipophylic to a high
enough degree to achieve this transition across the membrane. For this
reason, lipophilicity is one of the principle factors governing the uptake
of chemicals into plants from the environment (Bromilow and
Chamberlain, 1995). The degree of lipophilicity may be measured by
assessing a chemicals 1-octanol/water partion co-efficient or Kow,
previous experiments have shown there to be a linear relationship
between Kow and the accumulation of non-ionised chemicals in roots
(Briggs et al., 1983). Chemicals that have higher Kow have a higher
tendency to bind with lipid elements in the roots and subsequently enter
the plant. Chemicals with a Kow value of >4 have a high likelihood of
partitioning into plant roots and subsequently into the rest of the plant
(Wild and Jones, 1992). Contrary to this, chemicals that are highly polar
or lipophillic appear to cross the cell membranes of the endodermis less
efficiently. Reasons for this are unclear but it is hypothesised that such
compounds possessing these characteristics may become retained in
the lipid rich cell membranes to a greater extent than those possessing
a lesser degree of polarity and lipophilicity (Bromilow and Chamberlain,
1995). Chemicals enter the plant as dissolved solutes in water through
the roots the level of water solubility of a given chemical is also
important. Ultimately, it is a combination of water solubility and lipid
solubility which determine the degree to which a chemical is able to
enter the plant and move within it (McFarlane, 1995b).
36
1.10.3 Movement of solubilised chemicals within the plant
Water and dissolved solutes are transported in the transpiration stream
upwards within the plant from the roots to other areas, this is termed
acropetal transport (Collins et a/., 2006). This is driven by the rate of
transpiration. A relationship for predicting concentrations of chemicals
in the transpiration stream from the concentration of the chemical in the
soil solution and the Kow of the chemical was derived by Briggs et a/.
(1983). The research undertaken investigated the uptake of a limited
number of non-ionised chemicals into barley plants. The findings of the
work showed that the transpiration stream concentration factor (TSCF),
could be predicted by dividing the concentration of the chemical in the
xylem sap by its concentration in the external solution. This was found
to be at a maximum for chemicals with a log Kow of around 1.8 (Briggs
et a/., 1983). Different work by other authors have found potentially
large differences in results especially for compounds at the higher and
lower end of the log Kow scale (i.e. >4 or <1) (Hsu et a/., 1990; Burken
and Schnoor, 1998). This suggests that the model is not perfect and
differing local concentrations of lipids and other solutes in the plant may
change the way in which a chemical moves through the plant.
Once in the transpiration stream solubilised chemicals are transported
throughout the plant and may become concentrated in plant shoots as
well as other areas. This accumulation may take place as a result of
equilibration of the chemical between the aqueous phase of the plant
shoot aqueous phase and the xylem. This can be affected by lipid
concentrations in the shoot and the relationship, or stem concentration
factor (SCF) has been shown to be linear when compared to the log
Kow of the compound (Barak et a/., 1983; Briggs et a/., 1983). The effect
of lipid concentrations in the stem, on uptake, will increase as a
chemical moves further up the stem. As a result of this, highly lipophillic
compounds (log Kow >4) are unlikely to perform well as systemic
products as they would have to be applied at significantly higher
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concentrations to permit an even distribution throughout the plant
(Uchida, 1980; McCrady et a/., 1987).
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1.11 GENERAL AIMS AND OBJECTIVES
The aim of the research was to assess the release and uptake of
tebuconazole from a novel formulation of the fungicide. Yeast cells
were used as microcapsules to allow the production of a
microencapsulated form of the fungicide. The main premise behind the
production of this formulation was that the yeast cells would be able to
provide protection of the fungicide from degradation but also confer a
more controlled and sustained release of the AI into the environment. It
was hoped to be able to demonstrate improved levels of crop safety by
reducing the effect of phytotoxicity associated with tebuconazole when
applied as a seed dressing. It was also hoped that the new formulation
could be shown to provide tebuconazole available for plant uptake for a
longer period then existing formulations of the fungicide. The main
research objectives were as follows:
• To assess the release characteristics of tebuconazole from the
yeast microcapsules into water.
• To select and optimise a suitable method for the detection and
quantification of tebuconazole released from microcapsules into
water.
• To assess the release and uptake into plants of tebuconazole
from the yeast microcapsules when applied as a seed dressing
and compare this to fungicide release and uptake from a
commercially available formulation.
• To select and optimise an easily repeatable and accurate
method for the extraction and quantification of tebuconazole from
treated plant samples.
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CHAPTER 2 -IN VITRO MICROENCAPSULATED
TEBUCONAZOLE RELEASE INTO WATER
2.1 INTRODUCTION
The use of fungicides to provide effective control of plant disease
remains vital. Yield reductions are estimated to be 20% in the major
food and cash crops worldwide (Oerke et al., 1994; Oerke and Dehne,
2004). The use of single target site fungicides, including triazoles, has
steadily increased since their introduction in the 1960s and this class of
fungicide tended to replace older multi site actives (Guiliano et al.,
2000). However, these older formulations still play an important role in
fungicide mixtures, especially when employed in anti-resistance
strategies. Despite the launch of Qol fungicides (strobilurins) in the late
1990s and early 2000s, serious resistance problems with these
compounds, has ensured that triazoles still have an important role to
play in current crop protection strategies. The imminent launch of
succinate dehydrogenase inhibitors (SDHls) fungicides will, however,
still permit a market for triazoles as the new formulations will be sold as
a mixture of the two active ingredients.
Triazole fungicides, such as tebuconazole (Figure 2.1), provide
excellent control of a wide range of diseases, particularly in early crop
growth stages (Asrar et al., 2004). However, increasing attention is
being directed to reducing the cost and amount of pesticide used in the
protection of crops. As much as 90% of applied conventional
agrochemicals never reach their target objective in sufficient time and
concentration to provide the desired effect (Mogul et al., 1996). The
resultant over application of agrochemicals is undesirable in terms of
both cost and environmental impact and may be reduced by the use of
novel formulations of fungicide. One such approach is that of
microencapsulation - where the active ingredient is released over a
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prolonged period of time. Various microencapsulation processes have
been described for the encapsulation of pesticides (Markus, 1996), one
example being the use of yeast cells as bio-capsules.
CI
Figure 2.1 The chemical structure of the triazole fungicide tebuconazole
(P.P.D.B., 2010).
In an agricultural sense the use of microencapsulation, giving a more
prolonged and controlled release, may have other benefits. The use of
fungicides, such as tebuconazole, as seed treatments has the ability to
control a wide range of plant diseases especially in early growth stages
(Asrar et a/., 2004). The effectiveness of these seed treatments can be
nullified over time by influences of environment, poor uptake efficiency
and potential short half life of the AI in plant tissue. It is also difficult to
maintain an effective concentration of active within the plant due to
increasing plant size and mass (Asrar et a/., 2004). Many of the
chemical formulations used as actives, including seed treatments, are
also phytotoxic to plants and, as such, must only be used in limited
concentrations, higher rates of use are also potentially damaging to the
environment, even in the case of systemic products (Asrar et a/., 2004).
The use of microencapsulation could therefore prove beneficial as a
more controlled release could provide a solution to many of these
issues as well as providing other benefits such as prolonged disease
protection (Salvage, 2004).
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Several batches of microencapsulated tebuconazole were produced
using a method patented and developed by Micap PLC. Yeast obtained
from different sources was evaluated by Micap and unpublished
research suggested that waste yeast from the process of bio-ethanol
production may be the most efficient type to use due to improved levels
of release of the active observed from this type of yeast and also due to
the low cost of the material (Duckham and Wheeler, 2005a). This type
of yeast was used in the preparation of a new microencapsulated
tebuconazole sample for the purposes of this research. The
formulations being tested could be used as a spray or seed dressings
and the release of tebuconazole from the yeast microcapsules is
dependent on their hydration. The interaction between the yeast
microcapsules and leaf or seed surface and the surrounding
environment will dictate the amount of tebuconazole available for
uptake by the plant. As release of tebuconazole from the yeast
microcapsules is dependent on the presence of water, this will be the
medium linking the microcapsules to the surrounding environment. An
understanding of the release profile in water may help in the further
understanding the behaviour of microencapsulated tebuconazole
formulations in actual application.
Several experiments were undertaken to assess the release
characteristics of tebuconazole from the yeast microcapsules into
water. Reliable and accurate extraction, detection and quantification
methods were first developed to allow this release to be assessed.
Yeasts from different sources were formulated to contain tebuconazole.
Several batches were initially assessed including formulations of
different ages to investigate if the type and storage of yeast had any
effect on the release of the fungicide. A formulation of
microencapsulated tebuconazole was also tested for its potential to
release tebuconazole over a sustained period.
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2.2 SUMMARY OF AIMS AND OBJECTIVES
• Develop a reliable extraction, detection and quantification
method for tebuconazole in water.
• Test and explain the release kinetics of tebuconazole from Micap
formulations in water.
• Examine the release properties of several batches of
microencapsulated tebuconazole from different yeast sources.
• Examine the potential effect of formulation age on the release of
tebuconazole.
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2.3 MATERIALS AND METHODS
2.3.1 Production of microencapsulated tebuconazole samples
A S g aliquot of technical grade tebuconazole (manufactured by 8ayer
8ayerCropScience, supplied by Micap PLC., Runcorn, England) was
weighed and added to a 10 mL volume of acetophenone. The solution
was mixed using a heated (40·C) magnetic stirrer and further 1 g
aliquots of tebuconazole added until the solution was saturated. A yeast
(washed Aventine Saccharomyces cerevisiae) slurry was produced by
the mixing of yeast and sterile distilled water (SOW) at the ratio of S:3
water:yeast. The slurry was mixed using an overhead stirrer and paddle
in a heated water bath (4S·C) for 30 min. The tebuconazole solution
was added to the yeast slurry at a ratio of 1:2 solution:slurry and left to
mix for a minimum period of 12 h. Yeast cells were recovered by
centrifugation at 3400 g for 20 min at room temperature. The resultant
pellet was washed by re-suspension in SOW, and adjusted to contain a
maximum of 20% solids prior to spray drying. A 80chi 8-290 laboratory
scale mini spray drier (Postfach, Switzerland) was used to form a dry
powdered sample of microencapsulated tebuconazole.
Finished samples were assessed in triplicate for their tebuconazole
content by solvent extraction. A SOmg (±O.OSg)sample of the yeast
was weighed into a 2 mL Eppendorf tube and hydrated with 3S0 IJLof
SOW. A vortex mixer was used to agitate the sample and, after 30 min
standing time, 1.4 mL methanol (MeOH) added. The sample was mixed
again and then sonicated (sonicleaner 644i sonic bath, Ultrasonics Ltd.
Kettering, England) for 30 min. The yeast was removed from the
sample by centrifugation (22,660 g for S min) and the supernatant
filtered using a nitrile filter and syringe. The pellet was re-suspended in
a fresh 1.4 mL volume of MeOH and the supernatant recovered in the
same manner. The replicate samples were then analysed using Gas
Chromatography linked to a flame ionisation detector (GC-FIO) method
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developed by Micap PlC for the purpose. An aliquot of 1 III was
injected using a split injector (250°C) onto a HP-5 column (Agilent
Technologies, Stockport, England) with dimensions of 30 m length x
0.32 mm internal diameter x 0.25 urn film thickness. The column was
installed in an Agilent 6890N gas chromatograph fitted with an
autosampler and splitlsplitless inlet and FlO (Agilent Technologies,
Stockport, England). The software package GC ChemStation was used
to program the equipment. An initial start temperature of 50°C (hold
time 2 min) increasing at a rate of 10'C min" to a maximum of 300°C
(hold time 2 min) was used. The carrier gas used was Helium at a flow
rate of 1 ml min". The detector (FlO) was set at a temperature of
300°C with gas flows set at 30 ml min" H 2, 400 ml min" Air and 45 ml
min" N2. The results were processed to give the percentage active
loaded into the yeast and also the efficiency of the extraction. Results
of the GC-FIO analysis were quantified by comparison with standards of
know concentration allowing an estimation of the amount of
encapsulated fungicide to be made.
2.3.2 Aqueous in vitro release testing of Micap formulation
The release kinetics of the tebuconazole from the dry yeast cells into
water was assessed. Three batches of microencapsulated
tebuconazole (Table 2.1) produced from different yeast sources were
initially tested. Tebuconazole is frequently applied as a spray at a water
volume of 200 l ha" containing 1 l of a commercial tebuconazole
formulation such as Folicur which is manufactured to contain 250g l-1
tebuconazole. As such, the fungicide active ingredient is applied at a
rate of 1.25 g i'. The Micap formulations to be assessed were
prepared to be equivalent to this application rate.
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Table 2.1 Sample details of microencapsulated tebuconazole formulations tested in
preliminary release experiments
Batch Tebuconazole Mass
encapsulated equivalent to Yeast sourceNumber (%) 1.25 9 L ·1 ( g)
4292 9.6 0.65 Baker's yeast(autolysed)
3122 19.0 0.33 Baker's yeast (non-
autolysed)
4282 21.7 0.29 Bi-product Bio-ethanolproduction
A preliminary experiment was carried out to test the different batches of
microencapsulated tebuconazole for their ability to release
tebuconazole into an aqueous solution. Three batches of
microencapsulated tebuconazole were weighed (Table 2.1) and mixed
with 50 mL of SOW in 50 mL plastic Sterilin universal tubes and mixed
using a vortex mixer. Each replicate sample was analysed over a time
course - 5, 15, 30, 60, 240, 480 and 1440 min respectively. At each
sampling point the samples were centrifuged for 5 min at 3400 g and a
5 mL aliquot removed and set aside for extraction. A 5 mL volume of
fresh SOW was added to each sample which were then re-suspended
using a vortex mixer and set aside until the next sampling point. Ouring
the course of the same experiment the pH of the solutions was also
monitored. The pH was recorded at the start of the time course and at
each sampling point thereafter.
2.3.3 Extraction and quantification of tebuconazole
Samples were analysed by GC-MS and needed extraction prior to
analysis by using an LLE method with dichloromethane (OCM).
Quantification of sample fungicide concentrations was performed by
comparison with known quantities of tebuconazole prepared as
standards. The external standard series was run as part of the
sequence of samples being analysed by GC-MS. The peak area for the
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external standard, observed on the GC-MS chromatogram, was
recorded and compared to the peak area obtained for tebuconazole in
the sample, allowing the amount of tebuconazole in the sample to be
calculated.
Initial results obtained allowed for the quantification method to be
refined by the addition of an internal standard. An internal standard
consists of a compound that is structurally and chemically similar, but is
not identical to the compound of interest in the samples (Skoog et al.,
2007). The internal standard was added to each sample during the
extraction process. As such, any loses of analyte during the extraction
technique will be paralleled by losses of the internal standard
compound. The internal standard used was chosen to provide a GC-MS
signal that was similar to the analyte signal, but, sufficiently different so
that the two signals were readily distinguishable from each other.
Once analysed the ratio of the analyte GC-MS signal can be compared
to the internal standard signal, which is of known concentration. This
data can be compared to the GC-MS signal retrieved from a standard
containing known concentrations of both the internal standard and the
analyte, thus allowing quantification of the analyte of interest in the
samples. The ratio of the internal standard is compared to the analyte in
the standard is compared to the ratio of internal standard and analyte in
the sample allowing the concentration of the analyte of interest in the
sample to be calculated. The numerical data required to do this is taken
by analysing the peak area seen on a chromatogram obtained from the
sample and the standard. The equation used to calculate the amount of
tebuconazole recovered from samples in IJg/sample is as follows:
47
Peak Area Tebu,coftazoli (sample) Pt:ak Ar~a Flusilazole (stmtdan-l)
rPeak Area Tebuconflzo/e (standard) Penk Area Flusilazote (sample)
The internal standard chosen was flusilazole, another triazole fungicide,
as can be seen from Figure 2.3 and Table 2.1, flusilazole is relatively
similar in structure and properties to tebuconazole allowing co-analysis
of the two compounds to be made.
Table 2.2 Chemical properties of tebuconazole and flusilazole
Name
Property Tebuconazole Flusilazole
Chemical Group Triazole Triazole
CAS No. 107534-96-3 85509-19-9
Chemical
C16H22CIN30 C16H1sF2N3SiFormula
Molecular Mass
(g mol") 307.82 315.39
Melting point CC) 105 53.2
Boiling point CC) Decomposes before Decomposes before
boiling boilin_g
Solubility in water
36 41.9at 20°C (I-IgmL- 1)
Solubility in DCM
High (200) High (250)
_CmgmL -1)
Octanol-
water p 5.01 x 103 7.41 x103partition
coefficient
(Kow)at LogpH 7, P 3.7 3.8720°C
Notes on table: A solubility of <50fJgmC1 in water is classed as low. A 'high'
solubility in OeM (dichloromethane) is classed as any solubility limit ~200g C1•
A Kow (Robertson and Pope) of over 10 dictates a high degree of
hydrophobicity and a high soil sediment adsorption co-efficient. (Adapted from:
The Pesticide Properties Database PPDB, 2010).
Knowing the chemical properties of tebuconazole and f1usilazole,
detailed in Table 2.1, it was possible to predict how the tebuconazole
and internal standard would act in solution and therefore plan an
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extraction technique. A solvent liquid-liquid extraction method was used
for the extraction of the fungicide from the water phase of the solution.
Tebuconazole and flusilazole are relatively hydrophobic with a Log P of
3.7 (see Table 2.2) the presence of an organic, non-polar, solvent such
as di-chloromethane (OCM) would cause the fungicide to preferentially
dissolve into the non-polar OCM.
F F
Figure 2.3 The chemical structure of the fungicide flusilazole (adapted from
PPDB, 2010).
A 5 mL volume of OCM was measured into glass test tubes. Aliquots (5
mL) from the aqueous samples were then added to the OCM and
thoroughly mixed using a vortex mixer. A volume equivalent to 100 I-Ig
of PESTANAL Flusilazole Analytical Standard (Riedel-de-Haen, Seezle,
Germany) dissolved in methanol was added at this point to act as an
internal standard. As OCM is immiscible with water the samples formed
two distinct phases allowing the transfer of approximately 2 mL of this
phase into GC-MS vials using a Pasteur pipette.
2.3.4 GC-MSmethod for the detection of tebuconazole released
into water
An aliquot (1 I-II)was injected using a split injector onto a ZB1 column
(Phenomenex, Macclesfield, England). The column was 30 m in length
with an internal diameter of 0.25 mm and a 0.25 I-Im thick
dimethylpolysiloxane non polar stationary phase. The column was also
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fitted with a 1 m long retention gap to prolong its useful life. The column
was installed in a Fisons (Fisons Scientific Instruments, Manchester,
England) GC BOOO series GC fitted with a Fisons ASBOOauto sampler
and linked to a Fisons MD BOO mass spectrometer. The software
package MassLynx v3.2 (Micromass, Manchester, UK) was used to
program the equipment and also to analyse the results. The oven
program was set up to start at 140'C and increase in temperature at a
rate of 12.5'C min -1 to a maximum temperature of 2BO'C. The
temperature program held this temperature for 4 min before cooling. A
helium gas column head pressure of 22.5 p.s.i. and an injector
temperature of 250'C were used. The mass spectrometer was operated
in full scan and electron impact positive (EI+) mode with a source
temperature of 200'C.
2.3.5 Analysis of tebuconazole release into water from
microencapsulated formulations between 2 - 30 min
Following the first time course investigation, a second experiment was
performed to analyse tebuconazole release between 2 and 30 min (5
replicates per time point). The same method detailed earlier in this
section was used for the extraction, detection and quantification of
tebuconazole from the water phase of the samples. As all three batches
of yeast tested in the initial experiment behaved in the same manner,
only one batch (#42B2) of the Micap formulation was tested in this
instance. In this method individual samples were used for each data
point rather than re-suspending the yeast pellet after each sampling
point. A further experiment examined a time course with sampling
points at 30, 60, 120 and 240 min. Although the experiment could have
been taken further in terms of the time course, the results seen in the
preliminary experiments performed up to this point in the research
pointed towards there being very little change after 240 min point.
Similar to the experiment examining the earlier stages of the time
course this experiment followed the same protocol and methods as the
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first two but had more sampling points and more replicates at each
point. Again only a single batch of yeast (#4282) was tested.
2.3.6 Assessment of the effect of microencapsulated formulation
age/storage on tebuconazole release into water.
A new formulation (batch 8129 containing 11.1% tebuconazole w/w) of
microencapsulated tebuconazole was prepared following the same
procedure as described previously in section 2.3.1. Samples of the new
batch of microencapsulated tebuconazole where accurately weighed
out to be equivalent to the other batches being tested. Batch 8129 was
tested against three older formulations to ascertain if there were any
differences in release between them. Samples were taken over a time
course with sampling points at 2, 6, 10, 15, 25, 30, 60, 120 and 240
min. The sampling and extraction method followed the same protocol
as described earlier in this chapter.
2.3.7 Assessment of the potential for sustained release of
tebuconazole from microencapsulated formulations into
water.
Five weighed samples of microencapsulated tebuconazole batch
(#4282), containing an equivalent of 2 mg total of the fungicide, were
placed into individual (five) centrifuge tubes. To these 50 mL of SDW
was added and then the sample was mixed for a few seconds using a
vortex mixer. The samples were then left for 30 min then centrifuged for
3 min at 3400 g. A 5 mL aliquot was then taken from each sample and
partioned with 5 mL of oeM in preparation for analysis using GC-MS.
After being centrifuged each sample was re-suspended in a fresh 50
mL volume of sterile water using a vortex mixer. The samples were set
aside for a 30 min period after which the process was repeated. Each
replicate sample of yeast was washed a total of 30 times and the
amount of tebuconazole determined. Due to the number of washes
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needed the experiment was undertaken over a 48 h period. When left
overnight samples were left dry in sealed tubes at 4·C. Freezing was
considered as an option, although this was dismissed as the samples of
the yeast may have become damaged by the freezing process
subsequently, affecting the results
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2.4 RESULTS AND DISCUSSION
2.4.1 Confirmation of detection of tebuconazole and flusilazole
using GC-MS
The validity of the GC-MS method was tested by analysing standards of
tebuconazole and flusilazole at a concentration of 20 I-Ig mL-1.
Standards were prepared using PESTANAL Tebuconazole/Flusilazole
Analytical Standard at a concentration of 1 mg mL-1 in methanol and
diluted as required. This allowed a standard chromatogram and spectra
of tebuconazole and flusilazole to be recorded.
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Figure 2.4 Chromatographic analysis of a standard containing the fungicides
flusilazole (6.96 min) and tebuconazole (7.69) min at a concentration of 201-19rnt,".
The results of initial GC-MS runs to detect tebuconazole are shown in
Figure 2.4. The mass spectra of the peaks were analysed and were
shown to be that of tebuconazole (Figure 2.5) and flusilazole, (Figure
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2.6). A standard curve was determined by analysis of a series of
standard vials consisting of varying concentrations of tebuconazole and
the same concentration of flusilazole.
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Figure 2.5 Mass spectrum of tebuconazole obtained from GC-MS analysis.
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Figure 2.6 Mass spectrum of flusilazole obtained from GC-MS analysis.
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Figure 2.7 displays a calibration curve obtained form analysing a
standard series containing known concentrations of tebuconazole. As
can be seen from the figure the ratio of tebuconazole to flusilazole
increased in a linear fashion over the the standard series. The minimum
concentration of tebuconazole detected in this standard series was 2 I-Ig
mL-1 of tebuconazole, the GC-MS peak from this standard was easily
detectable above the baseline of the chromatogram. This suggests that
the limit of detection for tebuconazole using this GC-MS method would
be lower than 2 I-IgmL-1. The LOD was deemed sufficiently sensitive to
allow detection of tebuconazole release into water.
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Figure 2.7 GC-MS analysis of a standard series containing a fixed amount of
flusilazole and increasing amount of tebuconazole
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2.4.2 Assessment of release of tebuconazole from
microencapsulated formulations into water
2.4.2.1 pH testing
Changes in the pH can affect the level of solubility of components
within a solution. Different batches of the Micap formulation were
suspended in water and the pH of the suspensions recorded. Three
batches of microencapsulated tebuconazole in yeast were tested in
triplicate. As the different batches provided by Micap each contained
differing percentages of tebuconazole, the samples where adjusted to
make the total amount of active ingredient equivalent between batches.
The pH in all three suspensions tested decreased after the addition of
the microencapsulated tebuconazole, as can be seen in Table 2.4.
Over the period of the time course the pH then remained relatively
constant in all three suspensions. Although the exact cause of slightly
lower pH seen in the solutions after the addition of the Micap
formulations is not known, it was not thought to be significant. The
change in pH was minimal and was not likely to affect the solubility
levels of components in solution.
Table 2.3 Average pH of three suspensions of microencapsulated tebuconazole
recorded over a time course. Results are an average of three replicate samples
Time (min) 0 10 60 240 480 1440
Yeast Batch pH
4292 6.40 5.90 6.10 6.20 6.10 6.10
standard deviation 0.57 0.10 0.00 0.57 0.00 0.00
3122 6.20 5.20 5.20 5.40 5.50 5.40
standard deviation 0.10 0.57 0.10 0.00 0.00 0.00
4282 5.80 4.80 5.10 5.20 5.30 5.30
standard deviation 0.20 1.52 0.10 1.00 0.00 0.00
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2.4.2.2 Assessment of tebuconazole release into water over a
time course.
The ability of three formulations of microencapsulated tebuconazole
(4282, 21.7% AI; 3122, 19.0% AI and 4292, 9.6% AI) to release
tebuconazole into water was tested and the different batches compared
to each other. Formulations were weighed to be equivalent to a
commercial application rate, mixed with water then sampled over a time
course. The amount of tebuconazole released was quantified by Ge-
MS and the use of an external standard series as detailed earlier.
Results obtained from this initial experiment (Figure 2.8) showed that in
the early stages of the time course the solution had an average
tebuconazole concentration of 436, 335 and 281 ~g mL-1 (batches
4282, 3122 and 4292 respectively). All three batches being tested
followed the same trend; the concentration of tebuconazole in solution
decreased quickly over the early part of the time course. There was no
discernable difference in the concentration of tebuconazole released
from the different formulations all three batches behaving in a similar
way. After a period of 240 min the concentration of tebuconazole in
solution appeared to reach a constant state. After 1440 min or 24 h the
level of the fungicide observed in solution remained stable at an
average concentration of 41, 49 and 46 ~g mL-1 (batches 4282, 3122
and 4292 respectively).
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Figure 2.8 Mean concentration of tebuconazole released into water from three
different microencapsulated tebuconazole formulations over a time course (Each data
point represents an average value from 3 replicate samples. Error bars show standard
deviation ).
It was suggested that the high concentrations of tebuconazole released
from yeast microcapsules seen in Figure 2.8 could be attributed to the
age of the formulation. Testing the potential shelf life of the Micap
formulations was also of interest. A new batch of microencapsulated
tebuconazole was also assessed. Batch 8129 (11.1% active) was
tested alongside three older batches (4282, 3122 and 4292), each
having been produced a minimum of 2 years before testing, to
ascertain any potential differences the age of the formulations might
have on their performance. The data seen in Figure 2.9 clearly
illustrates that there was no detectable differences between
tebuconazole release from the new formulation and the other three
older formulations. The new formulation, batch 8129, followed the same
trend as the other formulations. This showed that the age of the batch
being tested had no effect on tebuconazole release characteristics into
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solution. The trend observed by all formulations was identical to results
seen in the previous experiment. An initial release of tebuconazole at
high concentrations early in the time course then fell to lower levels
over 10-20 min. It was also possible to conclude that the percentage of
tebuconazole encapsulated within each formulation had no effect on
the amount released (i.e. that a higher percentage encapsulation did
not equate to a higher release of tebuconazole into water). The release
mechanism has been shown in previous research to be one of diffusion
and is not associated with the fracture of the yeast cell wall. In fact, the
yeast cells have been shown to have the ability to withstand high
pressures and shear forces (Nelson and Crothers, 2003).
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Figure 2.9 Mean concentration of tebuconazole released into water from a new
batch of microencapsulated tebuconazole (8129) compared against 3 older samples
over a time course. Each data point represents an average value of 3 replicate
samples. Error bars show standard deviation.
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The results seen in Figures 2.8 and 2.9 confirmed that all four
formulations tested were able to release tebuconazole into an aqueous
solution. The timing of release was near instantaneous after the
addition of the SOW. The profile of the release of tebuconazole into
water was, however, unexpected as all four formulations tested
released tebuconazole into the surrounding aqueous environment at
concentrations that appeared to be many times higher than the
published solubility rate for tebuconazole in water of 36 I-Ig mL-1
(P.P.D.S., 2010). For this reason the experiment was further repeated
twice to verify the authenticity of the findings. The analyses of these
experiments gave identical results and, as such, have not been given.
2.4.3 Short time course analysis of tebuconazole release into
water from microencapsulated formulations.
The release characteristics of the Micap formulations of tebuconazole
seen in Figures 2.8 and 2.9 showed little difference between different
batches of the Micap product. As such it was thought reasonable that
further research could be performed on one of the formulations (batch
#4282). Two further experiments were undertaken to further investigate
the unexpected result seen in the initial experiments. The experiments
followed the same format and method as before but incorporated a
higher number of replicate samples and more sampling points during
the time course to further examine the release kinetics observed in the
preliminary experiments. Quantification of tebuconazole in samples
from these experiments used the internal standard method during Ge-
MS analysis. The use of an internal standard for these samples should
allow greater accuracy for the estimation of tebuconazole
concentrations released into water.
As can be seen from Figure 2.10 the results obtained (aimed at
analysing the early stages of tebuconazole release in more detail) were
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concurrent with those seen in the preliminary experiment shown in
Figure 2.8. Average concentrations of 502 to 370 I-Ig mL-1 were
observed after suspension for between 2 and 6 min. The upper values
recorded equate to nearly 14 times more tebuconazole in the solution
than the published solubility limit for tebuconazole in water of 36 I-Igrnt,
1 (P.P.D.B., 2010). Finding the same levels of tebuconazole in solution
using the internal standard method of sample analysis confirmed that
the results were authentic and not merely a sampling or calibration
artefact. Observation of the second half of the time course showed that
the average concentration of tebuconazole recovered from the solution
steadily decreases and stabilises, as seen in Figures 2.8 and 2.9.
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sample of microencapsulated tebuconazole (batch #4282) over a time course
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The internal standard system was also used to determine the
concentration of tebuconazole in water over a longer time course. The
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change in the concentration of the fungicide in solution over the time
course, shown in Figure 2.11, followed the same trend as seen
previously. At the 30 min time point, the concentration of tebuconazole
recovered from the solution was higher than the published solubility
limit. Over the course of the experiment, the concentration of
tebuconazole decreased and after 4 h, had reached a level of around
36 I-Ig mL-1.
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Figure 2.11 Mean concentration of tebuconazole released into water from a
sample of microencapsulated tebuconazole (batch #4282) over a time course of 30 -
240 min (Each data point represents an average value of 5 replicate samples. Error
bars show standard deviation, line of best fit is logarithmic).
The occurrence of the 'super-saturated' solutions observed in the
analysis of release of tebuconazole from microencapsulated
formulations may be attributed to several causes. The process by which
the Micap formulations are manufactured may have led to excess un-
encapsulated tebuconazole being held on the surface of the yeast cells.
This tebuconazole may have been released into solution when the
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formulation was hydrated causing a phase separated suspension of
tebuconazole to form within the solution itself. The chemical properties
of tebuconazole, as detailed earlier in this chapter (Table 2.2), show
that the molecule has a high Kow value and is highly hydrophobic. As
such the tebuconazole may have formed micelle like structures or
droplets within the solution. These pockets of highly concentrated
tebuconazole could have ended up in aliquots of the supernatant taken
from the early stages of the time course and led to the high
concentrations of tebuconazole observed in solution.
Research performed by Micap PLC. investigating the release of the anti
cholesterol agent fenofibrate from yeast microcapsules when delivered
to the duodenum by (Nelson et al., 2006) showed an initial release of
the active from the yeast followed by a period of sustained release over
the course of time. Described in the article as a 'burst effect' the results
published closely followed the profile observed in Figures 2.8 and 2.9.
Unpublished research carried out by Duckham and Wheeler at Micap's
laboratories into the release of benzyl alcohol and limonene from
Saccharomyces cerevisiae also had similar findings. Results obtained
showed initial concentrations to be up to five times higher than those
recorded later in the time course. Reasons for this were attributed to
non-encapsulated material held on the surface of the yeast cells
(Duckham and Wheeler, 2005). Similar research carried out into the
release of limonene from yeast cells found that the process was driven
by diffusion but also dependant on the porosity of the cell wall. This in
turn was driven by the degree to which the yeast cells had become
hydrated (Normand et al., 2005; Dardelle et al., 2007).
Research into the release of agrochemicals from other types of
controlled release formulation into water have generally found the
process to be that of diffussion following Fick's first law. The law
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essentially states that the diffussion will be from a region of high
concentration to a region of low concentration (Markus and Linder,
2006). However, release of chemicals from such formulations is not
often easily explained by simple models and is affected by factors
individual to each formulation (Fernandez-Perez et 81., 1998; Perez-
Martinez et 81., 2001; Singh et 81., 2009a). Nevertheless, as can be
seen in Figure 2.11, after an incubation period of 240 min the
concentration of tebuconazole in solution equilibrated, to around the
published solubility limit for tebuconazole in water. Again, exact reasons
for this are unclear; however, the highly hydrophobic nature of the
tebuconazole may cause the excess tebuconazole in solution to re-
encapsulate by a physical partition effect, from the solution back into
the yeast cells themselves, paralleling the encapsulation phenomenon.
Research carried out by Nelson and Crothers (Nelson and Crothers,
2003) pointed out the role of swelling and disruption of the yeast cell
wall caused when spray dried formulations were hydrated. It was
argued that this disruption might provide a route by which encapsulated
materials could re-enter the yeast cells. Overall, the results show that,
when hydrated, the Micap formulations release an initial burst of
tebuconazole. Where the microencapsulated formulations were
required to be used with water (e.g. a spray application) a minimum
stabilisation period of 4 h could be used to allow the concentration of
tebuconazole to reach a steady state. Where the formulations were
employed as a dry seed treatment the initial burst effect was unlikely to
adversely affect the performance of the formulations as the
tebuconazole will be released in the proximity of the seed. Although soil
holds an inherent level of moisture, this will not be close to the total
volume of available water tested in these experiments. When treated
seeds are watered, there will be an increase in the water content of the
soil around the seed causing the formulations to release tebuconazole
into the environment. The tebuconazole would be released into the
immediate environment of the seed and then reach a state of
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equilibrium as the immediate area around the seed would become
saturated with the fungicide.
2.4.4 Assessment of the potential for sustained release of
tebuconazole from microencapsulated formulations into
water.
An investigation was undertaken to quantify the release of active
ingredient from a sample of microencapsulated tebuconazole when
repeatedly washed to simulate release in the environment. A weighed
sample of Micap (batch #4282 equivalent to a total of 2 mg
tebuconazole was repeatedly washed with volumes of SOW and the
resulting samples extracted into OCM and analysed by GC-MS as
described in section 3.7.
The results (Figure 2.12) show a similar profile to those seen
previously. Samples taken early in the experiment, i.e. after only one or
two washes, showed high levels of tebuconazole in solution. Over the
course of the experiment the concentration of tebuconazole, recovered
from the solution after each wash sequence, gradually became lower
and lower. After 30 washes the average concentration of tebuconazole
recovered from the sample was 28.4 I-IgmL-1• This is slightly lower than
the published solubility limit of tebuconazole in water of 36 I-IgmL-1•
Thus, the Micap formulation displayed good potential for providing a
sustained and prolonged release of active ingredient. The formulation
of the Micap yeast tested in this instance was still delivering
concentrations of tebuconazole over 28 I-Ig mL-1 after 30, repeated
washes, totalling 1.5 L. The total of the tebuconazole recovered from
the solution was 1695 I-Igover 30 sequential washes. As a total of 2
mg of tebuconazole was used in this experiment, the total tebuconazole
recovered from the yeast was 84.7% of the total available. This
indicates that micro-encapsulated tebuconazole in yeast cells provided
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the potential for gradual sustained release of active ingredient over a
considerable time window - the active molecule is not released
immediately on contact with water. However, the formulation still allows
release of tebuconazole showing that, once encapsulated the fungicide
does not remain permanently bound within the yeast cells. Research
carried out into the sustained release of benzyl alcohol and limonene
encapsulated in yeast when repeatedly washed found similar results
(Duckham and Wheeler, 2005a).
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Figure 2.12 Mean amount of tebuconazole released into water from a sample of
microencapsulated tebuconazole repeatedly washed in SOW Each data point
represents an average value of 5 replicate samples. Error bars show standard
deviation.
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2.5 CONCLUSIONS
The principal aim of the research described in this chapter was to
understand the release kinetics of microencapsulated tebuconazole
produced by Micap into an aqueous solution. The initial burst release
effect in the preliminary experiments was unexpected. This may be due
to the formation of micelle like structures of hydrophobic tebuconazole
soon after the formulation has been hydrated. The initially high
concentrations of tebuconazole released from the yeast microcapsules
observed after only a short period of time in solution equated to a large
proportion of the total tebuconazole applied. These areas of highly
concentrated tebuconazole were sampled in the earlier stages of the
time course and caused the increased concentrations of tebuconazole
observed. Such structures are likely to disperse quickly in the solutions
and therefore posed no problem for the ongoing research.
Observations of the amount of tebuconazole released from several
different batches of the Micap formulations showed that there was no
difference between them. A new formulation of the Micap product was
also tested alongside the older ones to ascertain if the age of the
product had any effect on performance. As with the previous
experiment there was no difference observed between the new
formulation and the older three tested. This showed that the
formulations were not affected by age in terms of their behaviour in
solution. Most commercially available fungicides formulations have a
minimum shelf life of two years (Robertson and Pope, 2006). As
batches 4292 and 4282 were a minimum of two years old at the point of
testing it is thought reasonable that the age of the formulations can be
discounted as a factor for results obtained.
As the formulations behaved in a similar manner in solution any of the
formulations available could be used in the ongoing research. One
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formulation (batch 4282), a bi-product of bio-ethanol production and
thus potentially cheap to obtain, was selected for further testing to
examine, in further detail, the burst release effect seen in the early
experiments. The results from these experiments were consistent with
those seen before. The same formulation was tested for its ability to
release tebuconazole into solution over a sustained and prolonged
period. The batch tested performed well releasing nearly the entire
amount of tebuconazole held within it over a large number of washes.
Ultimately, the release of any encapsulated product from a
microcapsule into water will be subject to several driving forces such
the lipid and water solubility limits of the compound and the rate at
which the microcapsules become hydrated sufficiently to allow diffusion
of the AI out of the microcapsules to occur. It would appear that in this
instance, release of tebuconazole from the yeast microcapsules into
water was achievable. To provide an improvement over existing
formulations the novel formulation would be required to release a high
percentage of the total microencapsulated fungicide they contained. It
is also proposed that the encapsulated formulations would need to
sustain the release of active molecules over a prolonged period; this
would also appear to be feasible. The release profiles observed also
suggest that there would be good potential for plant uptake of
tebuconazole from the microencapsulated formulation via the water
phase of the soil and the plant root system. The manner in which
tebuconazole was released from the yeast microcapsules, whereby a
large proportion of the tebuconazole contained within the yeast was
released into solution, should be beneficial for the subsequent
availability of the fungicide for plant uptake when applied as a seed
treatment.
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CHAPTER 3: DETECTION AND ANALYSIS OF UPTAKE
OF SEED APPLIED TEBUCONAZOLE FORMULATIONS
3.1 INTRODUCTION
In the U.K. over 90% of wheat seed sown is routinely treated with a
fungicide for seed hygiene reasons as an insurance measure against a
wide range of seed borne diseases. The cost of this application
(ranging from £40-150Itonne of seed) is relatively small in comparison
to foliar applied alternatives. This is primarily due to the fact this method
is more targeted in its application and as such requires less AI to attain
the same effect (Clark ef al., 2004). Where systemic products are used
as seed treatments a further potential benefit of this type of application
is the protection of young plants from early season foliar diseases
alongside protection from seed borne pathogens (Brandl and Biddle,
2001). This method of employing systemic fungicides is not, however,
without its drawbacks. Many systemic fungicide formulations,
tebuconazole included, are known to cause problems with seed
germination and development if applied at excessive concentrations.
This effect is termed phytotoxicity and in practice means that, often,
fungicide application rates are limited in an effort to reduce this effect. It
is therefore difficult to apply systemic fungicides at sufficient dose rates
to maintain effective levels of fungicide in plants as they develop to
protect them against non-seed borne diseases (Bahadir, 1990;
Fullerton et a/., 1995; Asrar ef al., 2004; Karabulut ef a/., 2006).
The problem of phytotoxicity may be increased if application of the seed
treatment is not performed correctly (Ashley et al., 2003). In addition,
effects of other factors such as environmental degradation, poor uptake
efficiency, short half life of Als in the environment and plant tissue and
reduction in dose as plant biomass increases further decrease the
effectiveness of seed applied fungicides whilst also increasing the need
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for higher application rates (Mogul et al., 1996). Maintenance of
adequate levels of chemical in plant tissue can be easily attained by a
further application of fungicides as a foliar spray at a later stage during
the growing season. However, increased concerns for the amount of
agrochemicals applied to the environment from several viewpoints such
as effects on local wildlife (Charlton and Jones, 2007), fungicide
residues in food (Gonzalez-Rodriguez et al., 2008) and water ways
(Bermudez-Couso et al., 2007) make less targeted application methods
such as spraying less desirable. Allied to this, there is an increased
cost associated with a further application of fungicide making a single,
seed application more desirable (Mogul et al., 1996).
Tebuconazole is a widely used systemic fungicide often applied as a
seed treatment to several types of crop (Asrar et al., 2004). A
commercially available formulation of tebuconazole called Raxil is
produced by Bayer CropScience in the form of a flowable suspension.
Although no longer marketed as a single AI product (it is now
formulated as a combined formulation with other Als such as
prothioconazole and triazoxide) for the purposes of this research an
experimental sample of the tebuconazole only formulation was
obtained. The recommended application rate for tebuconazole is
between 1 and 7.5 g AI per 100 kg of seed (Tomlin, 2003). Applications
of the fungicide at this rate do, however, require a subsequent foliar
application in order to provide adequate levels of protection against
disease later in the growing season. Application at greater dose rates to
achieve adequate protection, reducing the need for repeated
application, causes associated effects of phytotoxicity and is therefore
not possible. A tebuconazole formulation that allowed higher dose rates
to be applied whilst alleviating the negative effects of phytotoxicity could
provide a solution to this problem whilst also reducing overall cost and
risk to the environment (Markus, 1996).
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It was hypothesised that the microencapsulated formulation of
tebuconazole produced using the method developed by Micap may be
able to provide the optimum combination of the higher application rates
combined with reduced levels of phytotoxicity. Further to this, when
applied at higher rates it was also suggested that an adequate level of
disease protection could be maintained for longer periods reducing the
need for further applications. Previous research carried out at the
University of Nottingham had shown microencapsulated formulations
applied as a seed dressing to be more effective than commercial
alternatives at controlling foliar diseases such as powdery mildew. The
results of the trials carried out showed that lower application rates of the
Micap product were equally effective at controlling the pathogen when
compared to dose rates up to four times higher (Rossall, pers. com.).
Micap in partnership with the agrochemical company Nufarm, were also
interested in producing a microencapsulated formulation to be
comparable to another commercial seed treatment formulation, Jockey,
which is a combination of fluquinconazole and prochloraz produced by
BASF, may be applied at higher rates than tebuconazole at up to 75 g
AI per 100 kg of seed (BASF, 2010). This aim was never realised due
to the fact that Micap PLC ceased to exist as a trading company in
2007.
In an effort to verify if the improved efficacy results could be attributed
to increased availability and uptake of tebuconazole from the
microencapsulated formulations a series of experiments were
undertaken. A reliable method for the extraction, detection and
quantification of the fungicide was first optimised. There are several
methods in the literature for the recovery and analysis of specific
organic chemicals from plant material (Yunis et al., 1991; Rial Otero et
al., 2003). Previous studies involving the extraction and quantification of
organic chemical residues in plants have involved several extraction
and purification steps to remove the majority of potentially interfering
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compounds, which may be present at higher concentrations than the
compound of interest itself and thus interfere with subsequent detection
(Rial Otero et al., 2003). A method commonly employed uses a liquid-
liquid extraction as a prior isolation step using solvents such as
methanol and DCM followed by further concentration and purification
using solid-phase extraction (SPE) (Bernal and Del Nozal, 1997). The
amount of analyte in resulting aliquots of solvent are then determined
using by further analysis using a technique such as GC-MS.
A trial to assess whether the microencapsulated formulations could be
applied at higher rates without having a phytotoxic effect on emerging
plants was also performed. Followinq this a detailed assessment of the
level of fungicide uptake, distribution of the fungicide within plants and
potential effect of different growth condition on uptake was carried out.
These results were compared to those from plants treated with
commercially available formulations of tebuconazole, Raxil and
Mystique. Plant uptake and distribution of organic chemicals such as
fungicides occurs via a number of pathways. Fungicides applied as a
seed treatments are taken in from the soil via the plants root system.
This process has been shown to be a passive, diffusive one, whereby
the chemical is taken up via the water phases of the soil (Colllns et al.,
2006). The water and solutes taken in by the roots are then transported
acropetally to the rest of the plant mainly via the apoplastic pathway
and transpiration stream (Trapp, 1995). For a compound such as
tebuconazole to enter a plant via the root system it must first cross at
least one cell membrane. Due to the high lipid content of cell
membranes it is a combination of a compound's solubility in water and
lipid solubility that will determine its mobility within the plant (McFarlane,
1995b). The polarity of the chemical may also affect its ability to cross
hydrophobic lipid membranes. Molecules with a log Kow of between
2.15 and 3.62 have been demonstrated to possess a high potential for
root uptake and subsequent in-planta translocation (Duarte-Davidson
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and Jones, 1996). As tebuconazole has a log Kowof 3.7, it should
demonstrate good uptake and translocation ability.
3.2 AIMS AND OBJECTIVES
This section of the research aimed to investigate the following:
• Develop and refine a reliable method for the efficient extraction,
detection and quantification of tebuconazole from plant samples.
• Assess the potential phytotoxic effect on emerging plants of
different formulations of tebuconazole when applied at a higher
than recommended rate.
• Assess the ability of the microencapsulated formulation of the
fungicide to release tebuconazole available for plant uptake
when applied as a seed dressing, the rate of this uptake and
how the amounts of resulting tebuconazole in plant material
compare to those of plants grown from seeds treated with
commercial formulations of the fungicide.
• Examine distribution and amount of accumulation of the
fungicide within individual plant/leaf samples.
• Investigate potential effects of environmental factors on the rate
of tebuconazole uptake.
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3.3 MATERIALS AND METHODS
3.3.1 GC-MS method development
Previous research has shown average tebuconazole residues
recovered in green forage to be as low as 17 mg/kg of plant tissue
(FAD, 1994). It was also unknown how formulations of tebuconazole
(both commercial and microencapsulated), applied as a seed dressing
would behave and the amounts of fungicide that would accumulate in
plant tissue. The existing GC-MS method (Chapter 2 - section 2.3.4),
although adequate for the detection of tebuconazole released into
water, would need to be improved to detect the lower concentrations
expected from treated plant samples. An improvement in
chromatographic quality - peak height and shape - and hence a lower
limit of detection could be achieved by optimising the temperatures the
GC-MS was operating under. Different combinations of a) start
temperature and b) temperature ramp (rate of temperature change)
were assessed to improve the GC-MS method. Initially, the sensitivity of
the method was improved by changing the injection system from a split
injection, where a proportion of a sample is prevented from entering
onto the GC-MS column to a splitless injection whereby the entire
sample is analysed. Additionally the mass spectrometer was
programmed to analyse samples in selected ion monitoring mode
(SIM), whereby only ions of interest, as found during initial GC-MS
analysis (detailed previously in Chapter 2 - Figures 2.5 and 2.6), were
detected.
An experimental planning software package, Design Expert 7 (Stat-
Ease Inc, Minneapolis, USA) was used to design a two factorial
experiment including replicate analysis points, based around the
temperature conditions (start temperature, 140·C, temperature ramp,
12.5·C) used in the original GC-MS method (Chapter 2). A start
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temperature range of between 100 and 180°C and a temperature ramp
of between 5 and 20°C min" were assessed. A standard of analytical
grade tebuconazole and flusilazole (Riedel-de-Haen, Seezle, Germany)
dissolved in HPLC grade methanol (Fisher Scientific, Loughborough,
U.K.) at a concentration of 2 lJgmL-1of each fungicide was used for the
optimisation; An aliquot (1 ul) of the standard solution was injected in
splitless mode using a Fisons (Fisons Scientific, Manchester, England)
AS8000 autosampler onto a ZB1, 30 m x 0.25 mm ID x 0.25 prn
dimethylpolysiloxane non polar stationary phase column (supplied by
Phenomenex, Macclesfield, England). The column was installed in a
GC 8000 series gas chromatograph linked to a Fisons MD 800 set to
operate in SIM mode (m/z 125, 250,233 and 315) and electron impact
positive (EI+) mode with a source temperature of 200·C. The peak
areas of the results were obtained using MassLynx v3.2. This data was
then further analysed using Design Expert 7 to gauge the improvement
in chromatography which was assessed using the following criteria;
increase in peak height, increase in peak area, decreased area:height
ratio (a marker of peak resolution) and decreased retention time. The
amount of tebuconazole was then quantified based on a comparison of
the peak areas obtained from chromatograms.
After the initial assessment a second experiment was performed
centred around the temperature combination that had shown the
greatest improvement in chromatography. A response surface quadratic
design was used to assess the effect of an initial oven temperature of
between 100 and 125°C and a rate of oven temperature increase of
between 15 and 22.5 °C min". All other experimental conditions were
the same as used in the initial experiment.
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3.3.2 Finalised GC-MSmethod
The following GC-MS method was used for the analysis of
tebuconazole amounts in all plant samples and subsequent research.
An aliquot (1 I-II) of each sample was injected (injector temperature
280·C) in HPLC grade methanol by an AS 3000 autosampler (Thermo
Fisher Scientific, Loughborough, England) using a splitless injection
onto a ZB1-lnferno column (30 m x 0.25 mm 1.0. x 0.25 I-Im film
thickness dimethylpolysiloxane non polar stationary phase -
Phenomenex, Macclesfield, England), selected for its high maximum
operating temperature of 460·C and fitted with a 1 m long retention gap
to prolong its useful life. The column was installed in a Trace GC Ultra
gas chromatograph (Thermo Fisher Scientific, Loughborough, England)
set to start the analysis at 125·C and increase to 325·C (maintained for
2 min before cooling) at a rate of 24·C min". The column was linked to
a Thermo DSQ II mass spectrometer (Thermo Fisher Scientific,
Loughborough, England) operated in selected ion monitoring (SIM)
mode (m/z 125, 250, 233 and 315) and electron impact positive (En
mode with a source temperature of 200·C. The carrier gas was helium
used at a column head pressure of 22.5 p.s.i. The software package
Xcalibur v.2 (Thermo Fisher Scientific, Loughborough, England) was
used to program the equipment and also to analyse the results.
3.3.3 Validation and optimisation of method for extraction and
purification of tebuconazole using methanol extraction and
SPE based systems.
Solvent extraction followed by further cleanup and concentration of the
fungicide, performed using solid phase extraction (SPE), was selected
as the method for recovery and analysis of tebuconazole from treated
plant samples. Methanol was selected for this purpose due to its
miscibility with water (high water content of plant material) and the high
solubility of tebuconazole (and f1usilazole) in this solvent. The validity
and accuracy of a method for the recovery and purification of
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tebuconazole from solution, using SPE, was tested and refined using
known concentrations of fungicides dissolved in methanol. The method
was also required to reliably extract f1usilazole, to be used as an
internal standard, from samples. The similar chemical properties of
tebuconazole and f1usilazolesuggested that they should be eluted from
the SPE cartridge at the same time. Strata-X™ 33 IJm reversed phase
polymeric sorbent SPE cartridges with a 200 mg absorbent limit, a 6 mL
capacity and a pore size of 88 A (Phenomenex, Macclesfield, England)
were selected for this purpose. These were used connected to a
BOchner flask under vacuum to draw the solvent volume through the
cartridge.
A series of 5 individual, randomly selected, cartridges were tested
repeatedly for their ability to retain both tebuconazole and f1usilazole.A
4 mL volume of HPLC grade methanol (Fisher Scientific,
Loughborough, U.K.) followed by 10 mL SOW was used to condition
and activate each cartridge prior to use. Replicate (5) samples of 5 mL
50:50 methanol/SOW (v/v) containing 1 IJg each of tebuconazole and
f1usilazole were passed through each cartridge. Each sample volume
was followed by a wash step consisting of 2.5 mL of 50:50 SOW:
methanol. The fungicides were then recovered from the cartridge using
4 mL of HPLC grade methanol which was collected and the analysed
by GC-MS as detailed previously in this chapter. The method is
summarised in Figure 3.1.
The SPE extraction method was improved by assessing the optimum
volume of methanol required to elute fungicides from the sorbent bed of
SPE cartridges. Replicate 5 mL volumes of 50:50 methanol/water v/v
containing a total of 1 ).Jgeach, tebuconazole and f1usilazole, were
passed through randomly selected cartridges. After the wash step,
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detailed above, 4 mL of HPLC grade methanol, was passed through the
cartridge and the elutant collected in five 400 IJLfractions. Each fraction
was then analysed for its tebuconazole and flusilazole content using the
GC-MS method previously detailed in this chapter.
Condition/equilibrate
2
Sample loading
3
Wash
4
Elute
4ml
MeOH
10ml
SOW
1
2.5 m150:50
MeOH:SDW
4ml
MeOH
1 1 1
•
•
• •
• • • • •
.' . • •
•
. • •
.
• Analyte of interest
Elutant 1 Elutant 2
1 1: } Sample debris
Strata -x sorbent bed Discard GC-MS
Figure 3.1 Summary of SPE extraction method used to recover and concentrate
fungicides from aqueous solutions prior to quantification of fungicide amount using
GC-MS analysis (adapted from Camel, 2003)
3.3.4 Preparation of fungicide treated seed stocks
Wheat seeds (Triticum aestivum L cv. Claire) were treated with different
formulations of microencapsulated tebuconazole and two commercial
ones (Table 3.1). Amounts of each formulation, containing different total
amounts of the fungicide, were adjusted to be equivalent to each other
and applied at the required dose rate expressed as grams of active
ingredient per 100 kg of seed. Calculated amounts of each formulation
were added to 100 g seed in glass powder jars. The jar was then
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sealed and vigorously shaken continuously for a minimum period of 5
min until all seeds were coated. Where a liquid formulation had been
applied seeds were placed on foil and dried for 12 h in a laminar flow
cabinet Samples of the same seed were also professionally treated
using a Hede 11 (spinning disk) seed coating drum by a third party
(Eurofins-Agrisearch based in Melbourne, U.K.). Treated seed samples
were stored out of direct sunlight at room temperature, in sealed glass
containers.
Table 3.1 Fungicides used for seed dressing
Name/active Percentage AI Supply
company
Microencapsulated 16.3 Micap
tebuconazole (batch #4564)
Mystique (tebuconazole) 25 Nufarm UK
Raxil (tebuconazole) 25 BayerCropScience
3.3.5 Analysis of total amount of tebuconazole carried on seeds
treated with fungicides
The thousand grain weight and average number of seeds contained in
a 100 g mass of wheat seed (variety Claire) was calculated using a
Contador seed counter (Pfeuffer. Kitzengen, Germany). It was then
possible to estimate the amount of tebuconazole per seed at a given
application rate. This was also confirmed in the laboratory, seeds
treated with three formulations of tebuconazole (Table 3.1) applied at a
rate of 40 g active ingredient (AI) per 100 kg of seed, using the seed
coating method and those treated commercially were tested. A series of
5, randomly selected seeds from all three treatments were hydrated
with 5 mL SDW over 24 h. An aliquot (200~1) of flusilazole at a
concentration of 20 ~g mL-1was added, to act as an internal standard.
Samples were then partitioned with 5 mL DCM, thoroughly mixed using
a vortex mixer and incubated for 48 h. The high Kow or Log P of 3.7 for
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tebuconazole and 3.87 for f1usilazole combined with a solubility limit of
200 and 250 g L-1 for tebuconazole and f1usilazole in DCM (PPDB,
2010) would see the compounds preferentially dissolve into the DCM
from the water phase of the samples. Samples were then transferred
into 2 mL GC-MS vials using a glass Pasteur pipette and analysed
using the GC-MS method set out previously in this chapter.
3.3.6 General plant growth method
All plants grown for the purposes of this project have been grown using
the same method unless otherwise stated. The research was carried
out solely on wheat plants grown from seeds (variety Claire) provided
by Plant and Crop Sciences the University of Nottingham. John Innes
NO.3 (consisting of 7 parts loam to 3 parts peat and 2 parts sand)
compost was used as the growth medium. Tebuconazole was applied
to the seed at a rate of 40 g AI per 100 kg of seed unless otherwise
stated using the seed coating method detailed previously in this
chapter. Plants were grown in 13 cm plastic pots at a sowing density of
s8 seeds per pot in controlled conditions with a day temperature of
18°C, a night temperature of 12°C and a day length of 12 h. The plants
were watered once, daily unless otherwise specified or required.
Where plants were grown in growth rooms or natural light (where 12 h
day length could not be achieved), light was provided by sodium bulbs
with a radiance measured at 69 urnol m2 S-1
3.3.7 Initial analysis of fungicide uptake into plants from seeds
treated with a microencapsulated tebuconazole
The release and subsequent uptake of tebuconazole into plants from
seeds treated with microencapsulated formulations of the fungicide was
tested. The experimental planning program, Design Expert 7 (Stat-Ease
Inc, Minneapolis, USA) was used to plan a two factorial experimental
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design including replicate analysis points. Factors investigated were;
fungicide dose rate (between 5 and 40 g AI/100 kg seed) applied as a
seed dressing and plant development (between growth stages (GS) 12
and 16 (Zadocks growth scale). Seed stocks were prepared using
microencapsulated tebuconazole (Micap batch #4564) applied at the
different application rates using the seed treatment method detailed
previously in this chapter. Plants were grown in until they had reached
the relevant growth stage (Zadocks Growth Scale) under standard
conditions (Section 3.3.6) in John Innes No. 3 compost. Harvested
samples were prepared for GC-MS analysis using the following,
finalised, extraction method.
3.3.7.1 Finalised solventlSPE method for extraction of
tebuconazole from treated plant samples
Harvested samples were frozen and stored at -20°C until required.
Stored samples were thawed and HPLC grade methanol (Fisher
Scientific, Loughborough, U.K.) added to the samples at a ratio of 2:1
mL solvent: g plant tissue to extract the fungicide. An aliquot (200 ~L) of
analytical grade flusilazole dissolved in methanol, equivalent to 2 ~g
mL-1, to act as an internal standard during GC-MS analysis was added
to samples which were then homogenised using a Polytron
homogeniser for a minimum time of 20 s until plant material had been
completely pulped. Samples were then diluted by 50% v/v with SOW
and the solid content removed by filtration using grade 1, 11 urn
cellulose filter papers (Whatman, Maidstone, England). Tebuconazole
and flusilazole were then concentrated from the sample using the SPE
cleanup technique detailed earlier in this chapter (Figure 3.1).
Optimisation of this method highlighted that, when 4 mL of methanol
was passed through the cartridge, tebuconazole and flusilazole were
eluted from the sorbent bed in the second 400 ~L fraction of the
solvent. Thus the first 400 ~L of solvent was discarded and the second
400 ~L collected and analysed using the GC-MS method detailed
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earlier. The remaining volume of methanol was also discarded but
remained part of the final method to re-condition the cartridge for re-
use.
3.3.8 Observations of effect of fungicide seed treatment on
emergence and development of young plants.
The effect of phytotoxicity, causing delayed emergence and plant
stunting during early growth, is one of the main problems associated
with the application of tebuconazole as a seed dressing. Use of the
microencapsulated formulations was hoped to combat this effect by
releasing the active ingredient over a sustained period. Samples of
untreated wheat seed (variety Claire) were treated with three
formulations of tebuconazole (microencapsulated tebuconazole batch
#4564 and two commercial formulations, Raxil and Mystique) at an
equivalent rate of 40 g AI/100 kg of seed. A total of 90 pots per
treatment were sown at a sowing density of 8 seeds per pot and a third
of the population (30 pots) harvested after 10, 15 and 20 days after
sowing. A population (90 pots - 8 seeds per pot) of untreated controls
were also grown and harvested at each time point. Harvested plants
were frozen and then analysed for percentage emergence
(germination) and development in terms of height, (measured from tip
of longest leaf to point of emergence from seed coat) and weight. The
results from each population were then compared against each other
and statistically analysed using the ANOVA function in Microsoft Excel.
Five replicate samples taken from each population were also analysed
for their tebuconazole content using the SPE extraction and GC-MS
method detailed earlier.
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3.3.9 Assessment of tebuconazole distribution within individual
plants
To gain a more comprehensive understanding of the uptake and
distribution of tebuconazole in young plants grown form seeds treated
with different formulations of the fungicide, individual plant samples
were analysed in more detail. Several populations of plants were grown
from seeds treated with microencapsulated tebuconazole (batch
#4564), Mystique and Raxil, applied at a dose rate of 40 g AI/100 kg
seed. Plants were grown under the same conditions stated in the
general plant growth method (detailed previously in this chapter) until
they had reached growth 12, 14 and 16 (Zadoks growth scale) and then
harvested. Replicate samples were then split into pairs of leaves based
on leaf age, resulting in plants grown to GS 12 being analysed as one
pair of leaves, plants grown to GS 14 being analysed as two, pairs of
leaves and GS 16 as 3 pairs of leaves. Leaves were analysed by
solvent extraction, SPE and GC-MS, the methods of which have been
stated earlier in this chapter (Sections 3.3.7.1 and 3.3.2).
3.3.10Assessment of tebuconazole distribution within individual
leaves
In a further investigation of the previous experiment the distribution of
tebuconazole within individual leaves was also investigated. Plants
were grown, as before, from seed stocks treated with
microencapsulated tebuconazole (batch #4564, Mystique and Raxil at
an equivalent applications rate of 40 g AI/100kg seed. Individual leaves
were split into longitudinal sections; each leaf was cut into sections
consisting of the leaf tip, middle and base. Leaf samples were also
divided into lateral sections consisting of the leaf margin and mid
section. Several samples were combined to allow for easier detection
using the GC-MS method. Prior to analysis all samples were weighed to
allow an accurate comparison to be made between samples after
solventlSPE extraction and GC-MS determination.
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3.3.11Effect of growth environment on fungicide uptake
3.3.11.1 Temperature
The effect of the environment in which the plants were grown on the
rate of tebuconazole uptake was investigated. To allow the environment
to be more closely controlled, a series of growth rooms were utilised for
these experiments. Populations of plants grown from seed stock treated
with microencapsulated tebuconazole (batch #4564), Mystique and
Raxil at an equivalent application rate of 40 g AI/100kg seed in average
(day and night) temperatures of 6, 14, 18 and 21·C. The plants were
grown till they had reached GS 14, harvested, weighed and frozen at -
20.C. Tebuconazole content of replicate samples was then analysed by
solventlSPE extraction (section 3.3.7.1) and GC-MS (section 3.3.2)
analysis as before.
3.3.11.2 Rate of transpiration
The effect of increased transpiration rates on the rate of tebuconazole
uptake into emerging plants from treated seeds was assessed. Two
identical populations of plants were grown from seeds treated with
microencapsulated tebuconazole, Mystique and Raxil as before. The
rate of transpiration was artificially increased in one population using a
pedestal fan to achieve an increased air flow whilst the other was grown
in normal conditions without increased air airflow. Plants were grown to
GS 14 and were exposed to the increased air flow from emergence to
harvesting. The amount of tebuconazole in harvested plants were
analysed in the same manner as before using solventlSPE extraction
and GC-MS analysis.
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3.3.11.3 Seed sowing density
A series of 13 cm pots were sown with seed stocks treated with Micap
tebuconazole, Mystique and Raxil at an equivalent application rate of 40
g AI/100kg seed. Seed sowing densities of 1, 3, 6, 10, 15 and 21 seeds
per pot were used. Several pots were planted at each sowing density to
allow for a minimum of 5 replicate plants to be harvested from each
treatment. The plants were grown to GS 12 in a glass house under the
conditions detailed in the general plant growth method set out earlier,
harvested and prepared for GC-MS analysis as before.
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3.4 RESULTS AND DISCUSSION
3.4.1 GC-MS method development
Analysis of a range of GC-MS temperature parameters based around
those used in the initial stages of the research (Chapter 2) showed that
there was a significant (P= <0.05) impact of the combination of start
temperature and temperature ramp on chromatographic quality. The
results of the initial parameters tested, given in Table 3.2, showed that
a combination of a lower start temperature and higher temperature
ramp returned increased peak areas and heights when compared to
other combinations. This was also the case for peak area, where a
lower value showed a better peak resolution. Conversely, the retention
time was shortened by the combination of a lower start temperature and
ramp. This, however, was unimportant as the aim of the experiment
was to improve chromatographic quality and the GC-MS used was able
to perform injections automatically using the fitted autosampler.
The results also showed that there was potential for further
improvements to be made in the method leading to a further experiment
based on the initial findings. The results of this second testing,
displayed in Table 3.3, showed that, of the new parameters, a higher
temperature ramp gave the larger peak height and ratio of peak
area:height. The results of these experiments lead to the selection of a
start temperature of 12S·C and a temperature ramp of 24·C min" for
optimum chromatographic quality, the full details of the finalised method
are detailed in the materials and method section of this chapter (section
3.3.1). The optimised GC-MS parameters allowed the detection of
tebuconazole amounts as low as 0.05 mg which was a significant
improvement on the previous method and also sufficient for the
purposes of the ongoing research.
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Table 3.2 Results of chromatographic analysis of a standard containing
tebuconazole obtained as part of the preliminary GC-MS method optimisation
experiment.
Temperature Results
Start Temp. Ramp Peak a.u.) Retention Peak ratio
Temp. ("C min -1) Height Area Time (min) Area:Height
eC)
100 5 521 5060 25.1 9.71
100 5 486 5370 25.2 10.98
180 5 240 5030 10.0 20.96
180 5 250 5260 10 21.04
140 12.5 1305 5310 9.9 4.07
140 12.5 1220 4970 9.9 4.07
140 12.5 1210 5000 9.9 4.13
140 12.5 1241 5060 9.9 4.17
100 20 2135 5360 9.5 2.51
100 20 1960 5690 9.5 2.90
180 20 536 4590 5.6 8.56
180 20 525 4372 5.6 8.32
Table 3.3 Results of chromatographic analysis of a standard containing
tebuconazole obtained as part of the from secondary GC-MS method optimisation
experiment.
Temperature Results
Start Temp. Ramp Peak 'a.u.) Retention Peak ratio
Temp. ("C min -1) Height Area Time (min) Area:Height("C)
75 15 777 3330 13.29 4.29
75 15 680 2925 13.30 4.30
75 18 1130 3510 11.68 3.11
75 25 1170 3930 9.41 3.36
75 25 1140 3060 9.42 2.68
88 20 1050 3500 10.19 3.33
100 15 490 2150 11.6 4.39
100 15 618 2770 11.6 4.48
100 25 1160 3020 8.28 2.66
108 18 1010 3260 9.84 3.23
113 22.5 1050 3630 8.3 3.46
125 15 552 2475 9.9 4.48
125 15 770 3080 9.97 4.00
125 20 1000 3040 8.33 3.04
125 25 1060 2850 7.34 2.69
125 25 1170 3270 7.35 2.79
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3.4.2 Solvent extraction and SPEmethod validation
The ability and efficiency of the SPE cartridges to repeatedly remove
and return 1 I-Igaliquots of tebuconazole and flusilazole from a solution
was tested. Randomly selected cartridges were tested with S replicate
solutions containing the fungicides and the elutants analysed using Ge-
MS. The results, given in Figure 3.2, showed that there were no
significant (P = >0.05) differences between cartridges when used
repeatedly. The percentage recovery for each fungicide, 90% (±6.5) for
tebuconazole and 90% (±S.8) for flusilazole, was deemed acceptable
for the forthcoming analysis of plant material.
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Figure 3.2 Mean recovery of 1 I-1g aliquots of fungicides tebuconazole and
f1usilazole from SPE cartridges. Results represent an average value of 5 replicate
samples per cartridge. Error bars show standard deviation.
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The elutant phase of the SPE extraction method was also tested by
GC-MS analysis as a series of fractions. The aim of the analysis was to
ascertain the volume of methanol needed to elute the tebuconazole and
f1usilazole from the SPE cartridges and thus optimise the extraction
method. The cartridges were loaded with 1 I-Igeach of tebuconazole
and flusilazole. A 2 mL volume of methanol was passed through the
SPE cartridge and collected in 400 1-11 volumes. These volumes were
analysed using the GC-MS method set out earlier in this chapter. As
can be seen from the results, in Figure 3.3, an average of 89.6% of
tebuconazole and 89.0% f1usilazolewas recovered in the second 400 1-11
fraction of methanol analysed. On average, 2.4% tebuconazole and
2.6% f1usilazole of total fungicides applied to the SPE cartridge were
recovered in the first fraction of methanol analysed. The SPE method,
detailed earlier, dictates that the first 400 1-11 of methanol eluted from the
cartridge goes to waste. The first elution fraction is likely to contain
some water left in the SPE cartridge from the sample and wash steps of
the method. Any water left in samples could be injected onto the GC-
MS column during analysis causing damage to the system; the first
fraction of methanol will remove this. As such the loss of an average of
2.5% of the total fungicide was acceptable. The remaining 1.2 mL of
methanol passed through the cartridge contained no detectable levels
of tebuconazole; however the surplus solvent volume (3.2 mL)
remained in the method to serve as a further wash and re-equilibration
step when re-using the cartridges. The results shown in Figures 3.2 and
3.3 also showed that the optimised GC-MS method was valid. Samples
contained 1 I-Ig of tebuconazole dissolved in 5 mL methanol/water,
equating to a concentration of 200 ng mL-1.
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Figure 3.3 Analysis of the amount of tebuconazole returned from fractions of
methanol recovered during the elution phase of the SPE extraction method. Each
result is the average of 5 replicate samples. Error bars show standard deviation.
3.4.3 Preliminary assessment of release and plant uptake of
tebuconazole from microencapsulated formulations of the
fungicide
The microencapsulated tebuconazole formulation produced by Micap
was tested as a seed dressing and for its basic behaviour as a
controlled release formulation. The Micap formulation was to be
compared to two commercially available formulations of tebuconazole
which were Raxil and Mystique. Although Mystique is not applied as a
seed dressing commercially it was selected for use as another
tebuconazole only formulation for comparison. Seed stocks were
initially treated with 40, 80 and 160 g AI/100kg of seed grown to growth
stage (Briggs et al.) 12 (Zadocks), harvested and prepared for GC-MS
analysis. The results (data not presented) showed that the plants
treated with 40 g a.i per 100kg of tebuconazole accumulated easily
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detectable amounts of tebuconazole when analysed using the
extraction and GC-MS method set up for the purpose.
A subsequent experiment analysed seeds treated with varying
concentrations of tebuconazole ranging from 5-40 g AI/100kg of seed
and assessed the amount of tebuconazole accumulated as plants
developed between GS 12-16. The experiment also aimed to further
test the extraction, detection and quantification method and find its limit
of detection (LOO). The results, given in Figure 3.4, confirmed that
tebuconazole was released and available for plant uptake at all
application rates tested. Higher application rates resulted in more
fungicide in plants. The amount of fungicide accumulated also
increased as the plant developed between GS 12 and 16 suggesting a
ready supply of tebuconazole and confirmed the results of the
sustained release experiment (Chapter 2) carried out earlier in the
research. The results also served to validate the solvent extraction and
SPE cleanup method. Using the finalised GC-MS method it was
possible to detect tebuconazole amounts as low as 50 ng.
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Figure 3.4 Mean tebuconazole amounts recovered from plants grown from seed
treated with microencapsulated tebuconazole (batch #4564) at increasing application
rates as the plant developed. Data points represent an average of three replicate
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3.4.4 Application of microencapsulated tebuconazole compared
with two commercial formulations of the fungicide and
assessment of uptake and effect on developing plants
Fungicides that are used as seed treatments, such as tebuconazole,
may have a delaying or stunting effect on plant emergence and early
development. One of the possible advantages of the encapsulated
tebuconazole product was that it would release the AI in a controlled
manner. This would permit for a higher rate of fungicide to be applied
without causing the negative effects of phytotoxicity. Previous results
(Figure 3.3.5) showed that there were detectable tebuconazole
concentrations in plants grown from seeds treated with the Micap
product at an application rate of 5 g AI per 100 kg of seed. However,
the purposes of the research were to test the ability of the encapsulated
formulation of tebuconazole to release the fungicide over a prolonged
period and provide protection later into the growth period of treated
92
plants. A dose rate of 40 g AI per 100 kg of seed was also thought to be
an appropriate application rate for further testing as it was significantly
higher than application rates currently used of between 1 and 7.5 g AI
per 100 g seed and compared more closely to Jockey.
3.4.4.1 Assessment of efficiency of seed dressing method and
of amount of AI per seed
The amount of tebuconazole carried by each seed, after application
using the seed dressing method was assessed to allow other results
obtained to be interpreted. It was important to determine the efficiency
and identify any potential variations the seed treatment method may
have caused. Other research carried out into the phytotoxicity of a
formulation of tebuconazole (Raxil) applied to hard red spring wheat
seed found the amount of fungicide on individual seed could vary
between 25 and 400% of the recommended application rate as a result
of the application method (Ashley et al., 2003). The known amount of
individual seed in 100 g (Table 3.4) and the amount of tebuconazole
applied (at a rate of 40 g AI per 100 kg seed) were used to estimate the
expected total per seed at 19.3 I-Ig (assuming no variation between
seed size and no losses of fungicide applied as a result of the seed
dressing process).
Table 3.4 Average grain weights for wheat seed (variety Claire)
Sample weight 1000Grain Total seeds in
Replicate Weight (g) 100g sample
1 48.7 2132
2 47.9 2093
3 47.2 2084
4 48.1 2118
5 47.9 2103
Mean 48.0 2104
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This estimate was further tested in the laboratory where tebuconazole
was extracted into DeM from replicate seeds treated at the same rate
and the amount of fungicide assessed using GC-MS. The results, given
in Figure 3.5, showed there to be no significant (P = >0.05) differences,
when analysed using a two way ANOVA, between the amount of
fungicide recovered from seeds treated with the three treatments. The
amount of tebuconazole recovered from the seeds was (18.3, 18.9 and
17.8 IJg/seed for Micap, Mystique and Raxil respectively) on average
slightly lower than the estimated amount of 19.3 IJg. During the seed
coating method it was noted that the fungicide was evenly coated on
seeds and that there was negligible residue left on the interior surfaces
of the jars used. Samples of each fungicide were also applied using a
commercial seed coating drum by a third party (Eurofins, Agrisearch)
and the amount of tebuconazole assessed in the same manner. The
results obtained showed identical results and as such have not been
included here.
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Figure 3.5 Mean recovery of tebuconazole from seeds treated with
microencapsulated tebuconazole (Micap), Mystique and Raxil as a seed dressing.
Results based on 5 replicate samples. Error bars show standard deviation.
3.4.4.2 Emergence study results
Seeds were treated at a dose rate of 40 g AI per 100 kg seed with a
batch of the Micap product (#4564 - 16.3% a.i) and two commercially
available fungicides, Mystique and Raxil. The three formulations tested
all contained only one fungicide, tebuconazole, and the amounts of
each used were adjusted to be equivalent to each other. Treated seeds
were grown in pots and harvested at three time pots (10, 15 and 20 d)
and measured for percentage germination, plant height and weight.
Analysis of the percentage emergence (germination) of plants from
seeds treated with the three formulations of tebuconazole, given in
Figure 3.6, showed that the Micap product had a significantly (P=
<0.05) lower effect compared to the commercial formulations. When
compared to untreated control plants the encapsulated formulation of
the fungicide performed equally well in terms of germination. This
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suggested that there might be a beneficial effect conferred by the
sustained nature in which the fungicide is released from the Micap
product, where the fungicide is not in direct contact with the seed coat.
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Figure 3.6 Percentage germination of seeds treated with microencapsulated
tebuconazole (Micap batch #4564) compared to two commercial formulations,
Mystique and Raxil and an untreated control. Data bars are an average of three
populations of plants. Error bars show standard deviation.
Individual plants were also measured for their development to assess
whether there was an effect caused by the different fungicide
applications. Analysis of plant height, shown in Figure 3.7, suggested
that there was a difference between fungicides, the plants treated with
the microencapsulated formulation of tebuconazole were significantly (P
= >0.05) better developed in terms of height than those treated with the
commercial formulations. Comparison between a population of
untreated control and Micap treated plants showed there to be a small
reduction in height caused by this treatment, however, the commercial
treatments were found to have a greater effect.
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of microencapsulated tebuconazole (Micap) compared to two commercially available
formulations of tebuconazole (Mystique and Raxil). (Each data point represents an
average result of 240 replicate plants grown for 10, 15 and 20 d. Error Bars show
standard error)
Analysis of the effect of the different treatments on plant development
in terms of weight, shown in Figure 3.8, gave similar results. The results
recorded for the weight of plants grown from treated seeds can be seen
in Figure 3.7. The results showed the same trend as the results seen
for plant height in Figure 3.6. Plants treated with the microencapsulated
formulation weighed significantly (P = < 0.05) more than plants treated
with the commercial formulations. The untreated control plants weighed
more than the treated plants, again suggesting that the presence of
tebuconazole was having an adverse effect on the development of
plants. The two commercial formulations behaved near identically and
statistical analyses showed no differences between these formulations.
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Figure 3.8 Differences in plant weight between plants treated with a formulation
of microencapsulated tebuconazole (Micap) compared to two commercially available
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To determine if the effects of higher germination rate and development
were a result of lower amounts of accumulated fungicide samples from
each population and treatment were selected at random and submitted
for further analysis. The amount of tebuconazole they had accumulated
was assessed using the extraction technique and GC-MS analysis as
detailed earlier in this chapter. The results, shown in Figure 3.8,
showed that there was, on average, a lower concentration of
tebuconazole recovered from plants treated with the Micap formulation
when compared with those treated with the commercial formulations.
Statistical analysis of the results, using ANOVA and a Tukey multiple
comparison test, showed there to be significantly less (P = <0.05)
fungicide in plants treated with the Micap product in the 15 and 20 d but
not the 10 d plants. This suggests that tebuconazole was immediately
available for uptake from all three treatments but that the availability of
the fungicide from the Micap formulation might be slightly lower,
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implying a slower rate of release. These results corroborate those of
Figures 3.7 and 3.8; the plants treated with the encapsulated
formulation of tebuconazole were less affected by the lower immediate
availability of the fungicide compared to those treated with the
commercial formulations. There was still, however, evidence that the
microencapsulated formulation could provide tebuconazole for uptake
over a prolonged period. Results of an experiment, detailed previously
in Chapter 2 (Figure 2.12), where the Micap formulation was repeatedly
washed with volumes of water highlighted this.
The results clearly show that the Micap treated seeds produced plants
that were less stunted in terms of emergence (plant height) and
development (plant weight). These results had a high degree of
accuracy due to the number of plants per treatment and the three
separate populations sown over a time course meaning that over 2,100
individual plants were analysed in total. A sample (5 replicates) of these
plants was also analysed by GC-MS to ascertain the amount of
tebuconazole they contained. The results seen in Figure 3.8, show that
on average less tebuconazole was recovered from the Micap treated
plants. This result is consistent with the reduced stunting and
development observed in Figures 2.5 and 2.6.
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3.4.5 Analysis of distribution of tebuconazole in plants treated
with microencapsulated tebuconazole compared to those
treated with commercial formulations
The initial experiments undertaken confirmed that tebuconazole was
being released from the microencapsulated formulation applied as a
seed dressing and moving into developing plants at comparable levels
to commercial formulations. It also suggested that this formulation had
potential for providing sustained release of tebuconazole and also
showed reduced phytotoxic effects when compared with the
commercial. To fully understand the differences observed between the
Micap formulation and commercial formulations further testing and
investigation were undertaken. The uptake of systemic fungicides from
the soil occurs apoplastically and the fungicide is distributed throughout
the plant via the transpiration stream (Collins et al., 2006). The
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distribution of resources such as water and solutes from the soil is likely
to be 2x higher in developing areas of the plant such as emerging
leaves. It follows that the concentration of tebuconazole, carried in the
transpiration stream is also likely to be higher in developing areas of the
plant (Briggs et al., 1983; Trapp, 1995). Furthermore, emerging regions
of the plant are more susceptible to diseases as they are likely to
contain lower levels of seed applied fungicide. It is, therefore, these
regions that will require the highest concentration of protective
treatments such as tebuconazole.
Up to this point in the research plant samples had been harvested and
analysed as samples of total foliage. The results showed increasing
concentrations of tebuconazole as the plant developed. However, the
distribution of tebuconazole within the plant was unknown. The
chemical properties of tebuconazole suggest that the compound should
exhibit good levels of systemic distribution within plants. However, if
tebuconazole was concentrated in the early leaves produced by the
plant and not throughout its entirety, the formulations tested would not
provide the long term disease protection for the whole plant. It was also
unknown if the lower release levels seen in the plants treated with
microencapsulated tebuconazole compared to those treated with
commercial formulations would cause subsequent differences in the
distribution of AI within the plant. Several populations of plants were
grown from seeds treated with the Micap formulation and two
commercially available formulations of tebuconazole. Plant samples
were grown to growth stage 12 (2 leaves fully emerged), 14 (4 leaves
fully emerged) and 16 (six leaves fully emerged) and harvested. Each
plant was then split into pairs of leaves separated on the basis of GS
and the tebuconazole extracted using SPE extracted and analysed
using GC-MS.
101
Results, shown in Figure 3.10, suggested there was a difference in
distribution of the fungicide in the plants depending on treatment.
Analysis of the results showed there to be significantly (P = <0.05) less
tebuconazole, when analysed using a two ANOVA, in the first two
leaves to emerge of plants treated with the Micap formulation of the
fungicide. This result is consistent with previous results (shown in
Figures 3.6, 3.7, 3.8 and 3.9) and again suggests that the Micap
formulation was releasing the fungicide in a more controlled manner
than the commercial formulations. All three formulations showed a
similar uptake profile to that seen previously (Figure 3.9) whereby the
amount of tebuconazole accumulated increased with plant age. At GS
14 there appeared to be a higher level of tebuconazole in leaves one
and two when compared to leaves three and four in all plants. Analysis
of tebuconazole content of the third, fourth, fifth and sixth leaves to
emerge in plants from plants grown to GS 16 showed them to contain
comparable amounts of the fungicide (i.e. not significant P = >0.05)
regardless of treatment. It was also noted that, by GS16, leaves 3 and
4 of plants treated with all three formulations contained comparable
amounts of tebuconazole to leaves 1 and 2 suggesting that the rate at
which tebuconazole was distributed within individual plants might
change as more water (via the transpiration stream in which
tebuconazole is carried) is allocated to growing areas of the plant. This
experiment was repeated identically (data not given) and the results
were found to be identical. There were no statistically significant
differences between the two commercial fungicides, although Mystique
was included for comparison purposes only as another tebuconazole
only formulation of the fungicide.
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Figure 3.10 Average amount of tebuconazole recovered from leaves taken from
plants treated with microencapsulated tebuconazole (Micap) compared with two
commercially available formulations (Mystique and Raxil) and grown to GS 12, 14 and
16. Data is an average of 5 replicate samples. Error bars show standard deviation.
Replicate samples of the same population of plants were analysed as
whole plants in an attempt to confirm the results seen in Figure 3.10.
Assessment of the amount of tebuconazole in whole plant samples,
presented in Figure 3.11, showed that, overall, there was significantly
less (P = <0.05) tebuconazole in plants grown to GS 12 and 14. By GS
16, there was found to be comparable amounts of tebuconazole in
plants treated with all three formulations of the fungicide, confirming the
results seen in Figure 3.10. The results of the analysis of plants as a
whole also highlighted a large increase in the amount of tebuconazole
recovered from the plants grown to GS 16 when compared to those
grown to GS 14. The reasons for this were unclear though this result
was further investigated later in the research.
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Figure 3.11 Average amount of tebuconazole recovered from total foliage treated
with microencapsulated tebuconazole (Micap) compared with two commercially
available formulations (Mystique and Raxil) and grown to GS 12, 14 and 16. Data is
an average of 5 replicate samples. Error bars show standard deviation.
Overall the results showed that all three formulations tested provided a
good level of uptake and systemic distribution of fungicide within
developing plants. There did appear to be a difference in the initial rate
of uptake of tebuconazole into plants treated with the
microencapsulated formulation, which exhibited lower levels of
fungicide uptake compared to plants grown from seed treated with the
commercial formulations in the early stages of development. However,
as the plants continued to develop the amounts of tebuconazole
became comparable in plants treated with all three formulations. This
supports the results seen previously where there appeared to be a
lower level of phytotoxicity in plants treated with the microencapsulated
formulation. Other research into the uptake and distribution of
fungicides applied as seed dressings in wheat plants have highlighted
similar findings. A study involving the uptake of another triazole
fungicide triticonazole, with similar chemical properties to tebuconazole,
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applied at an application rate of 45 g AI per 100g of seed. The
experimental method involved applying 14C-labelled triticonazole to
spring wheat seed (Triticum aestivum L.) and analysing its uptake and
distribution by measuring concentrations of radiation in different parts of
developing plants. The results showed a decreasing concentration
gradient from the oldest to the youngest leaves in the early stages of
growth, this difference became less as the plants aged (Ouerou et al.,
1998).
3.4.6 Assessment of tebuconazole distribution within individual
leaves
To further investigate the distribution of tebuconazole in plants
individual leaves were analysed. It was suggested that, as
tebuconazole is carried in the plants transpiration stream, the fungicide
may end being concentrated at the point where this stream ends, for
example leaf tips. Individual leaf samples were taken from plants,
grown to GS 12, 14 and 16 from seed treated with the same three
formulations (Micap batch #4564, Mystique and Raxil) of tebuconazole
at a rate of 40 g AI per 100kg seed, and split into three parts consisting
of tip, middle and base (of leaf). These samples were then pooled and
weighed, to allow for representative comparisons to be made between
leaf sections from different treatments, and the tebuconazole content
assessed using the SPE and GC-MS methods detailed earlier.
Analysis of the results of this experiment, given in Figure 3.12, showed
that there was significantly more (P = <0.05) tebuconazole in the tips of
leaves when compared to the base and mid sections. This supported
the hypothesis that the fungicide was being distributed within the plant's
transpiration stream and this lead to observed accumulation of the
fungicide in leaf tips. This trend was also noted across all treatments
and growth times. As with results seen previously (Figure 3.11), the
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accumulation of tebuconazole was lower in plants treated with the
microencapsulated formulation of the fungicide compared to the two
commercial formulations, the total amount of fungicide was also seen to
increase with plant age. The results seen in Figure 3.12 are also
supported by previous research carried out into the uptake of non-ionic
chemicals into barley plants from a nutrient solution. The research
investigated the relationship between the lipophilicity and
uptake/distribution of a series of different chemicals, several with a
similar log Kow to tebuconazole. The results showed that a higher
concentration of chemicals, especially those with a log Kowof more than
2, were concentrated in leaf tips than the base or midsection of the leaf
(Briggs et al., 1983).
A similar experiment examined the lateral distribution of tebuconazole
across each individual leaf. Plants were split into individual leaves and
each leaf was then further divided into longitudinal sections consisting
of leaf margins and leaf mid sections. The sections of leaves from five
replicate plants were again bulked together to facilitate easier detection
of the tebuconazole during GC-MS analysis and weighed to allow
comparisons to be made after analysis. The results of the analysis, data
not given, showed that there were no significant differences in the
amounts of tebuconazole recovered from longitudinal sections of leaf
margin and mid section.
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Figure 3.12 Amount of tebuconazole recovered from different sections of leaf
taken from plants treated with microencapsulated tebuconazole and two commercial
formulations, Mystique and Raxil. Values for GS 12 are represented in blue only,
GS14 in blue and red and GS 16 in blue red and green.
3.4.7 Effect of growth environment on fungicide uptake
The results of this experiment also raised the question of the effect
growth environment might have on fungicide uptake. If tebuconazole
was distributed throughout the plant via the transpiration stream it was
suggested that by increasing the flow rate of water through the plant
then the amount of tebuconazole accumulated may also increase. The
microencapsulated formulation of the fungicide might also be shown to
behave differently in such conditions. Analysis of the results to date
have shown there to be a high degree of variation between samples, for
example, those seen in Figure 3.11, where total tebuconazole in plants
was seen to increase sharply between GS 14 and 16. Where plants
had been grown in glass houses, changes in environment caused by
varying weather conditions might have caused this effect. To test this
hypothesis, plants treated with the three fungicide formulations at the
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same rate previously used and were grown in a series of growth rooms
with varying average temperatures between 6 and 21 cC. Plants were
grown until they had reached GS 12 and measured for weight and
height prior to extraction and analysed by GC-MS.
Analysis of the results (ANOVA), shown in Figure 3.13, showed there to
be no significant differences in the amount of tebuconazole in plants
grown in different temperatures. The suggestion that increasing
temperature would lead to an increased accumulation of tebuconazole
due to an associated increase in the rate at which plants used water
and developed appeared to be false. The results appeared to show the
opposite of this. Plants grown in the colder growth environment
exhibited higher accumulations of tebuconazole. Reasons for this were
unclear; however, a possible cause may have been that plants grown in
this temperature environment took almost three times longer to reach
GS 12, as a result of delayed emergence caused by the lower
temperatures, when compared to plants grown in warmer temperatures.
It was hypothesised that this longer growth time might have lead to the
increased concentrations of tebuconazole exhibited due to an
increased time available for fungicide uptake. Although there were no
notable differences between treatments in terms of total tebuconazole
content analysis of individual plant weight and height did show that, as
seen before in Figures 3.8 and 3.7, the weight and height of plants
treated with the microencapsulated formulation of the fungicide were
significantly (P= =0.05) better developed further supporting the
previously raised theory that the microencapsulated formulation of the
fungicide caused lower levels of phytotoxicity when compared to the
commercial formulations.
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Figure 3.13 Mean concentration of tebuconazole recovered from plants treated
with microencapsulated tebuconazole (Micap) compared with two commercially
available formulations (Mystique and Raxil) and grown to GS 12 in different
temperatures. Data is an average of 3 replicate samples. Error bars show standard
deviation.
The effect of temperature appeared to have no effect on the uptake of
tebuconazole into developing plants. However, in an effort to further
test the effect of growth environment on tebuconazole uptake an
experiment was assigned two populations of plants were grown. The
first, in an environment where airflow had been artificially increased and
the second grown under normal conditions was prescribed. Plants were
grown, as before, from seeds treated with the three formulations of
tebuconazole at the same application rate and harvested on reaching
GS 12. Samples were again weighed prior to extraction and analysis.
Analysis of the results, shown in Figure 3.14, showed no significant
differences (P = >0.05) between plants grown in an increased air flow
compared to those grown in normal conditions. These results further
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support that supposition that another factor is primarily responsible for
the rate at which tebuconazole is accumulated in plants .
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Figure 3.14 Mean amount of tebuconazole recovered from plants treated with
microencapsulated tebuconazole (Micap) compared with two commercially available
formulations (Mystique and Raxil) and grown to GS 12 in increased air flow. Data is
an average of 5 replicate samples. Error bars show standard deviation.
A third growth environment related study examined the effect of seed
sowing density on the amount of tebuconazole accumulated in
developing wheat plants. As each seed is in itself a source of
approximately 19 ~g of tebuconazole it was proposed that a higher
sowing density may lead to increased levels of tebuconazole available
for developing plants and subsequent higher levels of uptake. This
theory was tested by the analysis of plant samples grown to GS 12 in
pots with a varying seed sowing density ranging from 1-21 seeds per
pot. The samples were harvested and analysed as sample sets
consisting of five replicate samples using the GC-MS method and
extraction method set out previously. Analysis of the results, given in
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Figure 3.15, showed average amounts of tebuconazole recovered from
plants grown in pots with different seed sowing densities to be
comparable. Statistical analysis (using a t-test and tukey multiple
comparison) of the findings did show that there was slightly more (P =
<0.05) tebuconazole in plants grown in pots containing 21 seeds
compared to those containing one seed, however the difference was
negligible.
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Figure 3.15 Mean amounts of tebuconazole recovered from plants treated with
microencapsulated tebuconazole (Micap) compared with two commercially available
formulations (Mystique and Raxil) and grown to GS 12 with different seed sowing
densities. Data is an average of 5 replicate samples. Error bars show standard
deviation.
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3.5 CONCLUSIONS
The primary aim of this section of the research was to assess the ability
and level to which a microencapsulated tebuconazole formulation
applied as a seed dressing could release tebuconazole available for
plant uptake. To facilitate this aim a reliable method of extraction,
detection and quantification of fungicide residues in plant tissue was
also refined. Initial trials showed that when applied at rates of between
5 and 160 g AI per 100 kg of seed tebuconazole was released from the
yeast microcapsules and was taken in by the plants. These results also
showed that the LLE/SPE extraction, internal standard quantification
and GC-MS detection methods were suitable.
The process of uptake appears to have been facilitated by release of
the fungicide from the yeast cells into the water phase of the soil (and
from the commercial formulations tested) and subsequently into the
roots of the plant by passive diffusion. Analysis of the level of
tebuconazole in plants treated with the microencapsulated formulation
of the fungicide appeared to be initially lower than levels in plants
treated at an equivalent application rate with two commercial
formulations of the fungicide, Raxil and Mystique. However, as the plant
continued to develop these differences became less and levels of
tebuconazole were seen to become comparable in plants treated with
all three formulations. These results supported those of another trial
investigating the potential for seed applied tebuconazole to cause
phytotoxicity. The findings of this trial showed the microencapsulated
formulation to have a significantly less phytotoxic effect on emerging
plants than both commercial formulations when applied at the same
rate. It was suggested that the reasons for this may be attributed to the
protection of the seed from direct contact with the fungicide by the yeast
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cells which may also have conferred a slower release of tebuconazole
into the surrounding environment.
Analysis of the distribution of tebuconazole within individual plants
showed that all three formulations possessed good levels of systemic
distribution. It would appear that the availability and distribution of
tebuconazole from the microencapsulated formulation did not differ
from that from the two conventional formulations. Initially concentrations
were higher in older leaves but as plant development continued a more
even distribution between leaves was observed. Analysis of individual
leaves showed that in all three formulations tested, there were higher
concentrations of tebuconazole observed in leaf tips. This supported
the hypothesis that the fungicide was carried throughout the plant in the
transpiration stream and concentrated at the plant's peripheral regions.
The redistribution of the fungicide from these regions into other areas of
the plant was thought to be unlikely as tebuconazole is relatively
hydrophobic and as such is likely to be bound in lipid concentrations
within the leaves (McFarlane, 1995b).
A high degree of variability, between replicate samples and between
growth stages, in the initial experiments investigating plant uptake of
the fungicide led to the planning and execution of a series of
experiments to examine the effects of growth environment on
tebuconazole uptake. The hypothesis that the environment in which the
plant was grown would affect the rate of transpiration and could
therefore drive the rate of tebuconazole uptake was tested. Specifically,
the effects of different temperature, air flow over leaf surface and seed
sowing density. The results, however, did not show that there was any
effect caused by the conditions tested. It is therefore assumed that the
rate of tebuconazole uptake is not solely related to the rate of
transpiration. A longer time course or a combination of conditions could
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have been investigated to see if any effect could be found long term;
however, the level of variability between replicate samples grown in the
same population of plants, suggests that the differences and variation
could be caused by another factor or combination of factors. Similarly
the effect of watering regime was not investigated, however the plants
were watered once daily and as such the soil in the pots did not
become dry at any point. The constant source of sufficient water in the
pots should have allowed a consistent phase of potential uptake of the
fungicide as the chemical was released into surrounding water and
subsequently into plant roots. The chemical classification of
tebuconazole would suggest that the amount of water applied to
growing plants would not affect the rate of uptake. Tebuconazole has a
solubility limit of 36 ~g mL-1 in water, which is classed as low (P.P.D.S.,
2010). Tebuconazole also has a high tendency to bind to organic
components in the soil making the compound classed as only slightly
mobile in the soil environment (P.P.D.S., 2010). This data suggests that
the tebuconazole is not likely to be washed out of the soil dissolved in
water. The presence of higher water volumes in the soil may have led
to an increased availability of tebuconazole for uptake by the plant
roots. However, when increased seed sowing densities were tested,
increasing the total amount of tebuconazole available for plant uptake
there were no apparent differences fungicide accumulation observed. It
would, therefore, appear that the rate of tebuconazole uptake is driven
by another factor. It is known that uptake of organic chemicals from the
soil via the roots includes an initial equilibration phase whereby the
chemical must first pass into and saturate lipophillic components of
cells in the plants roots (Paterson et al., 1991). It is therefore likely that
the rate of uptake and distribution of tebuconazole in the plant is driven
by root development and not by the rate of transpiration. The availability
of the fungicide to the plant from the soil could also be a factor in
uptake. As the fungicide has a relatively high tendency to bind to
carbon elements in the soil and is not very mobile it may also be less
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available for uptake by the plant. The distribution and density of
individual plants root coverage could affect the uptake of tebuconazole.
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CHAPTER 4: ASSESSMENT OF LONG-TERM UPTAKE
OF TEBUCONAZOLE FROM MICROENCAPSULATED
FORMULATIONS
4.1 INTRODUCTION
To fully investigate and compare the long term behaviour and uptake of
both the microencapsulated and commercial formulations of
tebuconazole it was also necessary to understand by what mechanism
the fungicide enters the plant and also how the fungicide behaves in the
environment. The likely behaviour of tebuconazole in the environment,
specifically in soil, can be related to its known chemical properties.
Understanding this behaviour may also help explain the availability of
tebuconazole for uptake by plants.
Soil is an important environmental sink for organic chemicals, such as
tebuconazole, added to the environment as plant seed treatments. In
general, the amount of a given compound in these environments is
seen to decrease over time, but many chemicals applied to the
environment form extremely persistent and sometimes permanently
bound residues (Northcott and Jones, 2000). These bound residues
have a direct affect on the longer term partitioning behaviour,
bioavailability, and toxicity of compounds such as fungicides in the soil.
Residues may be subsequently released from the soil by the
continuous turnover of the organic carbon in the soil. It is recognised
that soil organic matter dominates the sorption or binding of non-ionic
chemicals in soils with organic carbon contents of >0.1% (Chiou, 1998).
Sorption processes can be driven by several forces or combinations of
forces such as Van der Waals forces, electrostatic forces, hydrogen
bonding and ligand exchange reactions (Collins et al., 2006). The
importance of the organic carbon content of the soil may be expressed
by using a partition co-efficient approach or Koc for describing the
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partitioning behaviour of organic compounds in soil or sediment/water
systems. The chemical values shown in Table 4.1. indicate that
tebuconazole is very likely to bind with organic carbon components and
is also relatively persistent in a soil environment.
Table 4.1 Chemical properties of tebuconazole in soil
Tebuconazole property
Koe - organic carbon sorption constant (a.u.) 769
DT 50
(typical) 232
Soil degradation (days) (aerobic) (d) DT50
(lab at 20·C) 365
DT50
(field) 55.S
A Koc value of 75-500> means a compound has a high tendency to bmd to orgamc
carbon elements in the environment. Soil degradation (DT50) in the time required (in
days) for the concentration of a pesticide in the soil to reduce to half the concentration
at application. A DT50 value of 30-100 is classed as moderately persistent. 100-365
as persistent and >365 as very persistent. A 'typical' DT50 value is given as the mean
value obtained from al/ studies performed on a pesticide in the field and laboratory.
Adapted from: The Pesticide Properties Database (P.P.D.B.). (P.P.D.B., 2010)
The uptake of organic chemicals, such as fungicides, by plants is
profoundly influenced by the soil (Collins et al., 2006), and may be
predicted by the following. The concentration in the soil water of a
compound is described by the Kd, which is the partition distribution
coefficient between the soil and soil water. Non-ionized organic
pollutants are principally sorbed onto the organic fraction of the soil's
solid phase, thus the K, can be defined in terms of the soil organic
carbon content (Kd)Koe - foe, where Koe = organic carbon to water
partition coefficient and foe = fraction organic carbon. The Koe is readily
calculated and linearly related to the Kow. Therefore soil sorption will
increase with Kow, reducing the availability of high Kow compounds for
plant uptake (Bromilow and Chamberlain, 1995).
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Organic chemicals can be taken up by plant roots via the vapour or
water phases of soil. The uptake of anthropogenic organic chemicals by
plant roots has been shown to be a passive, diffusive process, with the
exception of a few hormone-like chemicals such as the phenoxy acid
herbicides, for which there is some evidence of active uptake (Bromilow
and Chamberlain, 1995). Experiments involving the uptake of non-
ionized chemicals from hydroponic solution into plant roots have
demonstrated that the uptake process consists of two components: (1)
"equilibration" of the aqueous phase in the plant root with the
concentration in the surrounding solution; and (2) "sorption" of the
chemical onto lipophillic root solids (Briggs et al., 1983). Once uptake
has occurred water and solutes are transported upwards from the root
into other parts of the plant through the plants xylem tissue. For a
chemical to reach the xylem it must penetrate a number of plant tissue
layers and at least one membrane (Northcott and Jones, 2000). Uptake
of azole fungicides and their subsequent relocation through the plant
occurs via the apoplastic and symplastic pathways (Dahmen and
Staub, 1992). The degree of this uptake is dependent on a combination
of solubility of the chemicals in the water and their solubility within the
lipid rich cell membrane. This interaction, in turn, dictates the degree of
movement of chemicals into the roots themselves and subsequently
into the rest of the plant (McFarlane, 1995b).
The basic release of tebuconazole from a microencapsulated
formulation into water and the ability of this formulation to provide
tebuconazole which is available for uptake by plants have been tested
during the course of this project. However, it was unclear how the
microencapsulated formulation would perform over a longer time
period. The potential for the microencapsulated formulation to release
tebuconazole in a sustained manner, for an extended period, could
prove beneficial by potentially providing extended disease protection
and reducing the need for repeated applications of fungicides. To test
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and compare the ability of the novel microencapsulated formulation to
provide this effect, a long term growth trial was undertaken. Several
experiments were also undertaken to assess the behaviour of the
fungicide in a soil environment and also to assess what effect this
behaviour would have on the uptake of the fungicide by plants. An
experiment was undertaken to assess and compare the amount of
tebuconazole accumulated by plants over an extended period of time
when treated with seed dressings of microencapsulated tebuconazole
and a commercial formulation, Raxil. It was hypothesised that the
performance of the two treatments may differ with the
microencapsulated formulation releasing tebuconazole for a longer
period of time when compared to the commercial formulation. Following
on from this several experiments were also carried out to establish the
propensity of the growth medium to affect the availability of
tebuconazole for uptake by plants.
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4.2 SUMMARY OF AIMS AND OBJECTIVES
• Assess long term release potential of the microencapsulated
tebuconazole formulation and compare this with a commercially
available formulation.
• Assess the behaviour of tebuconazole in a soil environment and
what impact this behaviour has on the uptake of tebuconazole
from the soil.
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4.3 MATERIALS AND METHODS
4.3.1 Assessment of tebuconazole uptake and accumulation in
plants over a longer time course
Two populations of plants were grown from wheat seed (variety Claire)
treated with microencapsulated tebuconazole and a commercial
formulation, Raxil at an application rate of 40 g AI per 100 kg seed. It
was decided not to include Mystique in this trial, due to the lack of
significant differences observed between the two commercial
formulations up to this point in the research and also Mystique is not
commercially employed as a seed dressing. Seeds were planted in 5 L
pots, using John Innes No. 3 compost at a sowing density of 5 seeds
per pot. Plants were then grown in the glasshouse set to maintain a day
temperature of 18°C, a night temperature of 12°C and a minimum day
length of 12 h and watered once, daily. When this day length could not
be provided with natural light, artificial light was provided by sodium
bulbs with an irradiance measured at 69 umot m2 S-1. Replicate samples
of the population were selected randomly and harvested over a time
course with consecutive sampling points between 2 and 19 weeks after
sowing then frozen at -20°C until required for analysis.
4.3.1.1 Sample preparation, extraction and analysis
Individual plant samples were thawed, weighed and larger plants split
into several parts. Samples of flag leaves, taken from mature plants
were also analysed individually. Plant material was ground to a powder
using a pestle and mortar in liquid nitrogen to break up tougher sections
of the plant. Powdered samples were suspended in 10 mL HPLC grade
MeOH (Fisher Scientific, Loughborough, U.K.) and the f1usilazole
internal standard added at an equivalent concentration of 2 J.jgmL -1.
Samples were then further homogenised using a Polytron homogeniser
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for 20 s before dilution by 50% v/v with SOW. The solid content was
removed by filtration using grade 1, 11 urn cellulose filter papers
(Whatman, Maidstone, England) and the tebuconazole and flusilazole
extracted using SPE and analysed by GC-MS using the method refined
earlier in the research, detailed in chapter 3.
4.3.2 Analysis of the potential of growth medium to adsorb
tebuconazole
The ability and capacity of the growth medium used during this project,
loam based John Innes No.3 compost, to adsorb and retain
tebuconazole was tested under laboratory conditions. Samples of the
compost were first prepared by air drying at room temperature in a
laminar flow cabinet, small stones were removed by sieving and
conglomerates of soil were broken up. Several 50 mL plastic syringes
were conditioned prior to use by repeated washing with methanol
followed by SOW to remove any silicon held on the internal surfaces
and plunger head. Syringes were then packed with a cotton wool plug
only or with a cotton plug followed by 5 g of pre-dried compost. A total
of 35 ~g of tebuconazole dissolved in methanol was mixed with a 10
mL volume of SOW, this was then passed through each syringe and the
sample collected. The effect of time on the ability of the soil to retain
tebuconazole was also assessed; 5 g masses of prepared soil were
mixed with identical 10 mL volumes of water, containing 35 ~g of
tebuconazole and left for 24 and 48 h before extraction and analysis of
the water phase of the samples. The total capacity of the compost to
hold tebuconazole was also tested. Increasing masses - 0, 5, 10 and
20 g - of compost were thoroughly mixed with 20 mL SOW containing a
total of 100 ~g of tebuconazole and incubated for 24 h at room
temperature. All samples containing soil were centrifuged at 3400 g for
3 min and filtered using grade 1, 11 prn cellulose filter papers
(Whatman, Maidstone, England) to remove the solid content. The
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f1usilazole internal standard was added at this stage (20 I-Ig per
sample). The fungicides were then extracted from samples using the
SPE extraction method prior to quantification of the amount of
tebuconazole they contained using GC-MS. The SPE and GC-MS
method were identical to those detailed in Chapter 3.
4.3.3 Recovery of bound tebuconazole from compost
The mobility of tebuconazole in soil was tested in the laboratory; soil
samples, loaded with known quantities of tebuconazole, were washed
with solutions containing increasing quantities of MeOH. Soil was pre
dried overnight in a laminar flow cabinet and sieved to remove any
stones/debris. Soil was weighed into 25 g samples and thoroughly
mixed with a 5 mL volume of water containing a total of 25 I-Ig of
tebuconazole. Each soil sample was set aside and stored at room
temperature for 24 h (allowing the compost to dry) after which, it was
mixed with 20 mL of 25, 50 75 or 100% v/v MeOH:water solution or
pure SOW. Replicate samples were placed in a sonicleaner 644i sonic
bath (Ultrasonics Ltd. Kettering, England) for 15 min, then centrifuged
for 3 min at 3400 g and then filtered using grade 1, 11 I-Imcellulose
filter papers (Whatman, Maidstone, England). The f1usilazole internal
standard was added (20 I-Igper sample) and the fungicides extracted
from samples using the SPE and GC-MS methods detailed earlier.
4.3.4 Tebuconazole uptake from pots containing a treated layer of
soil over 8 weeks
The ability of growing plants to adsorb tebuconazole from the soil was
investigated. John Innes No.3 compost was prepared as before by
drying and sieving to remove debris. The compost was weighed into
several 200 g samples which were mixed with a solution of water
containing a total of 160 I-Ig tebuconazole (equivalent to 20 I-Ig per
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seed), the soil was then left to dry in a laminar flow cabinet for a
minimum of 12 h. Plastic pots (1 Land 5 L) were half filled with
measured amounts of John Innes No.3 compost. Treated soil samples
were then layered evenly on top of the untreated soil and all pots were
filled to the top with more untreated compost, this method is
summarised in Figure 4.1. Each pot was sown with 8 untreated wheat
seeds (variety Claire) and grown over an 8 week period in a growth
room with a daytime temperature of 18°C, a night temperature of 12°C
and a day length of 12 h. The plants were watered once daily, light was
provided by sodium bulbs with a radiance measured at 69 umol m2 S·1.
After the growth period the amount of tebuconazole accumulated by
plants was assessed using the SPE and GC-MS analysis methods
described earlier.
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Untreated soil layers
Untreated wheat seeds
planted and allowed to grow
for 8 weeks
.i->
Treated soil layer -
containing an
equivalent dose of 20
",g tebuconazole per
seed
Figure 4.1 Summary of method used in initial investigation of tebuconazole
uptake from soil treated with the fungicide
4.3.5 Further analysis of uptake and accumulation of
tebuconazole from soil by wheat plants from 1 m columns
containing tebuconazole treated layers of compost at
varying depths
The ability of wheat plants to adsorb and accumulate tebuconazole
from soil was further tested using soil columns containing layers of soil,
treated with tebuconazole, at different depths. Each column was
prepared from two, commercially available, 1 m longitudinal sections of
plastic guttering which were combined to make one column. The sides
of each column were sealed using adhesive tape to render them water-
tight, one end of each column was also sealed, with perforated PVC
plastic, to contain soil but still allow excess water to pass through.
Design Expert 7 (Stat-Ease Inc. Minneapolis, USA) was used to plan a
D-optimal, cubic point exchange design model encompassing a series
of combinations of growth time (from 2 - 8 weeks) and depth of layer
(from 1-5, one being the top of the column). The maximum soil holding
capacity of each column was measured in litres. This total was split into
five fractions allowing the accurate placing of treated layers within each
column and to ensure each column contained comparable total soil
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volumes. Measured volumes of soil were thoroughly mixed with 50 mL
volumes of SDW containing a total of 200 I-Igof tebuconazole and then
placed into the column at the appropriate depth. The boundaries of
each treated layer were clearly marked by adding a thin layer of perlite
to allow easy assessment of when the plant roots had grown into the
treated layer. A total of 30 columns - detailed in Table 4.2 - containing
treated layers of soil containing tebuconazole were used in the
experiment. The method is summarised in Figure 4.2 below.
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Figure 4.2 Profile of soil column used in analysis of tebuconazole from different
depths of soil
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Table 4.2 Experimental details of soil column experiment
Column Growth Time Depth of treated soil(weeks) layer
1 2 1
2 2 1
3 _2 3
.t 2 5
5 2 5
6 3 2
7 _3_ 3
8 3 4
9 _4 1
10 4 4
11 4 5
12 5 2
13 _5 3
1.t 5 3
15 5 4
16 6 1
17 _6 2
18 6 4
19 6 5
20 _"/_ 2
21 7 3
22 r 4
2~ 8 1
24 _8 1
25 8 2
26 8 3
27 8 3
28 _8_ 4
29 8 5
30 _8_ 5
Three untreated wheat seeds, variety Claire, were sown in each of the
completed columns which were mounted vertically in a wheeled rack
with a water tray at the base. The experimental plan randomised the
placement of each column and also included a perimeter of columns
containing untreated soil and seeds to act as control plants. The
columns were placed in a growth room set with identical conditions to
those used previously (section 4.2.4) and watered daily from above for
the first 7 d of the experiment to promote germination of the wheat
seeds. After this time plants were irrigated by provision of 5 cm of water
around the base of the columns. Upon germination two of the three
seedlings, including the seed coat and roots, were removed to leave
one plant per column.
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At the point of harvest, each column was split open and the extent of
the root growth measured, the weight and length of each plant was also
recorded. Plants were then analysed for their total tebuconazole
content by SPE extraction and GC-MS analysis as previously. Results
obtained were then statistically analysed using Design Expert 7. A
series of plants were grown in untreated columns placed in a boundary
layer around the experimental columns. These plants were analysed for
their development in terms of root length, plant weight and height to
assess if there was any phytotoxic effect on plants grown in the
tebuconazole treated columns.
4.3.6 Analysis of movement of tebuconazole within soil columns
containing layers of compost treated with the fungicide
Soil columns were split open after 8 weeks to measure the depth of
penetration of plant roots. The boundaries (upper and lower) of the
layer of the fungicide treated layer of compost in each column had been
clearly marked with the addition of a thin layer of perlite. Samples of the
compost (20 g) were taken 5 cm below the lower boundary of the
treated layer (marked by a layer of perlite). Replicate samples (3) were
then mixed with 20 mL methanol and placed in a sonicleaner 644i sonic
bath (Ultrasonics Ltd. Kettering, England) for 15 min, then centrifuged
for 3 min at 3400 g and then filtered using grade 1, 11 IJm cellulose
filter paper (Whatman, Maidstone, England). The flusilazole internal
standard was added at a (20 IJg per sample) and the fungicides
extracted from samples using the SPE and GC-MS methods detailed
earlier.
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4.4 RESULTS AND DISCUSSION
4.4.1 Analysis of tebuconazole uptake by plants grown from
treated seed between 2 and 19 weeks after sowing
Plants were grown from seeds treated with microencapsulated
tebuconazole and Raxil at an application rate of 40 g AI per 100 kg of
seed. The seeds were grown over a time course between 2 to 19
weeks. Plant samples were then prepared and analysed to assess the
concentration of tebuconazole they contained using SPE and GC-MS.
The long term growth trial tested the ability of the microencapsulated
formulation to release tebuconazole over a sustained period of time and
how this release compared to that of a commercial formulation, Raxil.
The increase in tebuconazole accumulation in plants as they aged can
be clearly seen in Figure 4.3, where the average recovery, of the
fungicide, from Micap treated plants grown from 2-19 weeks increased
from 0.055 to 15.7 ~g and 0.056 to 16.8 ~g from Raxil treated plants.
There was, however, little difference in the total amount of
tebuconazole detected in whole plants when comparing the
microencapsulated and conventional formulation (Raxil). Indeed,
statistical analysis of the results, using a two way ANOVA, showed
there to be no significant differences (P= >0.05) between the amount of
tebuconazole recovered from plants treated with the Micap formulation
compared to Raxil. Both treatments exhibited a good ability to provide
tebuconazole for plant uptake throughout the growth course analysed.
There was also a marked increase in the amount of tebuconazole in
plants treated with both formulations of the fungicide after 8 weeks of
growth. This profile of tebuconazole uptake was observed previously
(Chapter 3 - Figure 3.11). There was also an increase in the amount of
tebuconazole accumulated in the plants treated with both the
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microencapsulated and conventional formulations, between 17 and 19
weeks.
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Figure 4.3 Mean total tebuconazole recovered from whole plant samples grown
from seeds treated with microencapsulated tebuconazole (Micap) and a commercial
formulation of tebuconazole (Raxil) over a time course between 2 and 19 weeks. Data
bars are an average of five replicate samples. Error bars show standard deviation
Results given in Figure 4.4, which illustrate changes in the
concentration (I-Ig g-1 foliar plant material) of tebuconazole accumulated
over the time course showed a more constant increase. The highest
concentrations of tebuconazole per gram recovered from plants treated
with both formulations were observed at two weeks and 19 weeks.
Between 8 and 17 weeks the amount of tebuconazole observed per
gram of plant tissue did not change as the plants grew larger showing
that the fungicide was still available for uptake by the plants.
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Figure 4.4 Mean concentration of tebuconazole recovered from whole plants
grown from seeds treated with microencapsulated tebuconazole (Micap) and a
commercial formulation of tebuconazole (Raxil). Data bars represent the average
result of five replicate samples. Error bars show standard deviation.
There were no significant (P= >0.05) differences observed between
plants treated with the Micap formulation compared to those treated
with the commercial formulation, Raxil. However, there was a trend for
lower accumulation of tebuconazole concentrations in plants treated
with the Micap formulation compared to those treated with Raxil in the
earlier stages of the experiment. The levels of tebuconazole recovered
from plants in the later stages of the experiment (weeks 15, 17 and 19)
were comparable between the two treatments. The higher
concentrations of tebuconazole observed in plants after 2 weeks of
growth could have been delivered as a result of tebuconazole present
in the endosperm of the seed as a result of the fungicide application
process. However, it is more likely that this uptake is a result of the
uptake active apical section of the early development of the plants roots
passing through the zone of tebuconazole that had developed around
the root. This was also supported by other research into the uptake of
another triazole fungicide, triticonazole, applied as a seed dressing to
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wheat seed (Ouerou et al., 1998). The greatest increase in the amount
of tebuconazole recovered from the plants between sampling points
was observed at the end of the growth period between 17 and 19
weeks, Figures 4.3 and 4.4. The amount of tebuconazole recovered
from the samples increased three fold in plants treated with both the
Micap and the commercial formulation. The profile of the uptake of
tebuconazole was also, overall, very similar between the two
formulations, especially in the later stages of the time course.
The results seen in Figures Figure 4.3 and Figure 4.4 suggested that
the tebuconazole was available for uptake for a sustained period
regardless of treatment. However, it was unknown whether the
fungicide had been distributed evenly throughout the plants; the
analysis of entire plant samples gave no indication of the whether the
fungicide had been accumulated in the primary leaves formed. It was
hypothesised that the distribution of the fungicide within plants treated
with the microencapsulated formulation, which could provide a
sustained release, might permit a longer window for foliar uptake and,
thus, provides a greater opportunity for accumulation in the plant. To
assess this possibility the flag leaves of plants were individually
analysed. Results for this analysis, Figure 4.5, showed that they
contained a high concentration of tebuconazole, per gram of tissue,
relative to plants analysed as a whole. The higher concentrations
observed, suggest that there was still tebuconazole available for uptake
during the later stages of growth. Although the increased
concentrations of tebuconazole could have been the result of the
relocation of the fungicide from other areas of the plant, this was
considered unlikely. The relatively low solubility of tebuconazole in
water allied with its hydrophobic nature suggests that once
accumulated in a given leaf the fungicide will remain here (McFarlane,
1995b; P.P.D.B., 2010).
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The source of this uptake, either from the treated seed or from fungicide
that may have leached into the surrounding environment, remained to
be determined. Once again there were no significant (P= >0.05)
differences observed between tebuconazole concentrations recovered
from flag leaves treated with the Micap or Raxil formulations of the
fungicide. These results relate back to those seen in Chapter 3 (Figure
3.10), where a higher accumulation of tebuconazole was observed in
the first two leaves to emerge from the seedling compared to those
emerging later. It would seem that this trend continues through plant
development and showed that, regardless of treatment, tebuconazole
continued to accumulate in plant leaves throughout the time course.
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Figure 4.5 Mean concentration of tebuconazole per gram of leaf tissue
recovered from the flag leaves of plants grown from seed treated with
microencapsulated tebuconazole and a commercial formulation of tebuconazole
(Raxil). Data bars represent an average result of five replicate samples. Error bars
show standard deviation.
The results seen in Figures 4.3,4.4 and 4.5, showed a late increase in
the amount of tebuconazole accumulated in the plant. The experiment
was undertaken a second time using an identical method and set of
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conditions to ascertain if this result was authentic. The effect of varying
environmental conditions encountered in the glass houses was
considered, however, results of experiments carried out earlier in the
research (Chapter 3) showed no apparent affect of different conditions
on fungicide uptake. Samples were taken at 2 weekly intervals,
between 3 and 19 weeks after sowing. Replicate samples were then
prepared for GC-MS as before and analysed. The results of the second
trial, Figure 4.6, showed an almost identical profile to those seen in the
first experiment. There was an initial release of tebuconazole in the
early stages of the growth time, followed by a sustained and steady
increase in the amount of fungicide in the plant tissue. This gradual
increase continues until the 17 weeks after sowing, where once again,
there was a notable increase in fungicide accumulation. Once again
there were no significant differences observed between the two
treatments assessed. The amount of tebuconazole recovered from
plants treated with the microencapsulated formulation in the first half of
the growth course were, on average, slightly lower than those
recovered from plants treated with the commercial formulation. In the
later stages of the growth period there are no detectable differences
between the two formulations. It was noted that, after 19 w of growth, all
treated plants had accumulated around 15 I-Ig of tebuconazole.
Assuming that individual treated seeds carried an average of 18 I-Ig
(Chapter 3 - Figure 3.5), this represented an uptake of approximately
83% of the total tebuconazole available.
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Figure 4.6 Mean total tebuconazole recovered from whole plant samples grown
from seeds treated with microencapsulated tebuconazole (Micap) and a commercial
formulation of tebuconazole (Raxil) over a time course between 2 and 19 weeks. Data
bars are an average of five replicate samples. Error bars show standard deviation.
The individual plant weights were recorded to determine the
concentration of tebuconazole recovered, per gram of plant tissue. The
results obtained, Figure 4.7, again showed a similar profile to the
preliminary experiment. The amount of tebuconazole per gram of tissue
was initially higher at the beginning of the growth course. This
decreased as the plants aged; suggesting that the rate of uptake of
tebuconazole is relatively constant and is not necessarily directly linked
to plant development. The total amount of tebuconazole per gram of
plant then continues to rise in a steady fashion until week 17 where
there was once again a large increase between weeks 17 and 19. A
notable increase in tebuconazole amounts was also observed at the 5
week point. This effect was observed in the initial experiment and also
in previous research carried out (Chapter 3 - Figure 3.10). Although
there were no differences observed between the two formulations, this
represented a good degree of overall uptake when increasing plant
biomass is considered. Previous research attributed lower
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concentrations of fungicide accumulation in developing plants to
increased retention of the chemical in lipid components of the plants
roots (McFarlane et al., 1990; Ouerou et al., 1998). It would appear
that this is not the case for tebuconazole.
1.4
~
1.2
Cl
:::l.
-e 1.00
:;:::
ra
...
....
c 0.8CI)
0
c
0
0
~
0.6
0
N
ra
e
0 0.4
0
::::J
.0
CI)
..... 0.2
0.0
3 5
.Micap
I.Raxii
'---
7 9 11 13 15 17 19
Growth time (weeks)
Figure 4.7 Mean concentration of tebuconazole per gram of plant tissue
recovered from plants treated with microencapsulated tebuconazole (Micap)
compared to those treated with a commercial formulation (Raxil). Data bars show the
average value of five replicate samples. Error bars show standard deviation.
The reasons behind relatively high concentrations of tebuconazole
recovered from plants later in the growth period and also in the younger
leaves of the plant were unclear as it was suggested that the amount of
tebuconazole available for uptake by plants would become reduced
during the growth period due to several sinks. Examples of these could
include degradation in the environment, for example by microflora in the
soil (Kahle et al., 2008), uptake by the plant and subsequent loses by
volatilisation to the air (Mc Farlane et al., 1990) and other factors such
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as losses to water washed through the soil during watering. Other
factors such as plant metabolism, oxidation, conjugation with other
compounds in the plant and sequestration into areas such as cell walls
may also affect the concentration of compounds within plants (Burken
and Schnoor, 1998). It was also hypothesised that the
microencapsulated formulation of tebuconazole could have the benefit
of releasing the tebuconazole in a controlled and sustained manner
thus prolonging the time that an effective dose of the fungicide could be
maintained and ensuring a more even distribution of the fungicide
throughout the plant. This was found not to be the case. The amount of
tebuconazole recovered from plants was comparable between the two
treatments across all sampling points. Therefore it could be concluded
that the sustained amounts of tebuconazole recovered from plants later
in the growth period were not available as a result of a controlled
release mechanism from the Micap product but from another source.
The results seen in Figures 4.6 and 4.7 were also interesting when the
concept of growth dilution is taken into account. Tebuconazole was
applied only once during the growth period as a seed treatment, it is
reasonable to assume that rate of unit mass increase of the plant is
higher than that of the rate of unit uptake of tebuconazole (Trapp and
Matthies, 1995). Therefore the reasons behind the late uptake of
tebuconazole needed to be further investigated.
4.4.2 Absorption and retention of tebuconazole by loam based
compost
One hypothesis explaining the late availability of tebuconazole is that it
is available from the soil. As the plant continues to develop the roots
begin to search out new nutrients in the soil, in the later stages of a
longer growth trial it is likely that the plants roots will occupy a high
percentage of the available soil when grown in a pot. The known
chemical properties of tebuconazole, displayed in Table 4.1.1, show
that the fungicide has a high Koc value. This means that the fungicide
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has a high tendency to bind with organic carbon elements in the soil
environment (P.P.D.S., 2010). Tebuconazole is also classed as being
moderately persistent in a soil environment and as being relatively
immobile in water due to its low water solubility (P.P.D.S., 2010).
Therefore it was suggested that that the tebuconazole was held in the
soil in a localised area around the seed on which the fungicide was
applied. This localised 'pocket' of tebuconazole could then be available
for uptake by the plant later in the growth stages of the plant when the
roots occupy fully the soil in the area where the tebuconazole is
available. It is also possible that this would not occur if the plants were
being grown in a field setting and not the contained environment of a
pot especially with more than one plant growing in each pot.
Analysis of the results of the long term plant growth trial showed that
tebuconazole was accumulated within the plant over the course of time
and also that the fungicide was still available for uptake in the later
stages of plant growth. There were, however, no clear differences in the
amount of tebuconazole recovered from plants treated with
microencapsulated and commercial formulations. It is known that
triazole fungicides such as tebuconazole are taken into the plant via a
passive uptake process through the roots (Collins et a/., 2006). This
allied with the fact that tebuconazole has a high tendency to bind with
organic carbon elements in the soil and a relatively low level of solubility
in water led to the planning of an experiment to test the soil as a
potential sink for seed applied tebuconazole which may then provide a
subsequent source of tebuconazole for growing plants. The ability of
the loam based compost used during plant growth experiments in this
project, John Innes No.3, to adsorb and retain tebuconazole was
therefore tested. Two experiments were undertaken; firstly an aqueous
solution containing a known amount of tebuconazole was passed
quickly through a pre dried sample of compost, the same amount of
tebuconazole was also mixed with samples of the compost and
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incubated for 24 and 48 h. The second experiment assessed the ability
of the compost to retain tebuconazole it had absorbed. Replicate
samples were then assessed for the amount of tebuconazole they
contained using SPE and GC-MS. For the purposes of discussion, John
Innes No.3 compost will be referred to as 'soil'.
Results of the initial experiment, given in Figure 4.8, show that the
amount of tebuconazole in samples that had come into contact with soil
was significantly (P = <0.05) less than those that had not been in
contact with soil. Although a small amount of tebuconazole was still
present in the samples that had been pushed through a syringe
containing soil, labelled '(fast run through in the figure)', over 95% of
the total available tebuconazole was removed by the soil. Samples that
were mixed with soil and left for a period of 24 or 48 h contained no
detectable tebuconazole.
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Figure 4.8 Mean concentration of tebuconazole recovered from solutions
containing the fungicide (35 iJg total) mixed with samples of loam based compost over
a time course. Data bars show an average value based on five replicate samples.
Error bars show standard deviation.
The second experiment examined the potential of increasing masses of
soil to retain tebuconazole when mixed with a more concentrated
solution of the fungicide. The results, given in Figure 4.9, showed that
only 5 g of soil adsorbed well over 60% of the tebuconazole contained
within the solution, 10 g of soil bound on average 90% of the
tebuconazole from the solution and 20 g of soil almost 95%.
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Figure 4.9 Mean concentration of tebuconazole (100 I-Ig) recovered from
increasing masses of compost mixed with a concentrated aqueous solution of the
fungicide. Data bars represent an average of 5 replicate samples. Error bars show
standard deviation.
The results of the two experiments seen in Figures 4.8 and 4.9 clearly
showed that the compost used during the research had the ability to
remove tebuconazole from an aqueous solution containing the
fungicide. The results of the preliminary aqueous release profiling,
carried out on the microencapsulated formulation of tebuconazole
(Chapter 2), concluded that on contact with water the fungicide was
freely released from the yeast microcapsules. Therefore it is possible
that when seeds are watered, the release of tebuconazole from yeast
microcapsules commences and, once free within the soil environment,
the fungicide becomes bound to carbon elements within the soil. A
similar process is likely to occur with commercial formulations of
tebuconazole when used as a seed dressing. As the uptake of
tebuconazole from the soil via the roots is known to be a passive
process (Collins et al., 2006), roots would have to be in close proximity
to the tebuconazole for uptake to occur. This is, however, highly likely
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to be the case in the closed growth environment of a pot where the
plants roots utilise available space and nutrients, especially later in the
growth period.
4.4.3 Recovery of bound tebuconazole from compost
The mobility of tebuconazole in the soil was tested by washing samples
of soil treated with known amounts of tebuconazole with increasing
concentrations of MeOH. Results, illustrated in Figure 4.10, show that
tebuconazole was not very mobile within the soil environment. On
average 1.3% of the total available tebuconazole was recovered from
treated soil samples washed in water only Tebuconazole was not easily
leached from carbon elements within the compost by water. Recovery
was, however, achieved with increasing concentrations of MeOH. Pure
MeOH recovered approximately 90% of total tebuconazole. As
tebuconazole has a high Koc value (P.P.D.B., 2010) it has a greater
tendency to bind to organic carbon elements in the soil. This, allied to a
relatively low water solubility limit of 361-1gmL-1(P.P.D.B., 2010) means
that tebuconazole is unlikely to be mobile in the soil. There is some
potential for the movement of tebuconazole as a bound residue on soil
components; however for the purposes of this research, which has
been carried out entirely in the relatively contained environment of pots
and not in a field setting this was thought unlikely to affect results.
Previous work, researching the environmental fate of the triazole
fungicide propiconzole, which has similar chemical properties to
tebuconazole (P.P.D.B., 2010), in different soil conditions produced a
similar findings (Kim et al., 2002). The experiment used radio-labelled
14C02and [U-14C]-propiconazole applied to the soil surface of two soil
Iysimeters. The fate of the fungicide in Iysimeters was then assessed by
measuring total radioactivity leachate collected and evolved 14C02and
14Cresidues in the soil and rice plant grown in the soil. The findings of
the research showed that, despite propiconazole having a solubility limit
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· -1In water of 100 J,JgmL (P.P.D.S., 2010) i.e. three times higher than that
of tebuconazole, there were no detectable levels of the fungicide in
leachate collected from the Iysimeters (Kim et a/., 2002).
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Figure 4.10 Mean recovery of tebuconazole from samples of soil treated with
known amounts of tebuconazole and washed with aqueous solutions containing
increasing concentrations of MeOH. Data bars show the average value taken from
three replicate samples. Error bars show standard deviation.
4.4.4 Tebuconazole uptake from pots containing a treated layer of
soil over 8 weeks
The method for this experiment involved thoroughly mixing untreated
compost with a solution containing tebuconazole at an equivalent rate
of 20 J,Jg/seed.The treated compost was then placed in pots between
two layers of untreated compost. Untreated wheat seed were then
grown for 8 weeks harvested and the level of tebuconazole they had
accumulated assessed. The results, Figure 4.11, showed that there
were easily detectable levels of tebuconazole present in the plants. On
average plants had accumulated around 50% of the total tebuconazole
available after only 8 weeks of growth. As the seeds planted were
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untreated and were also sown in untreated compost this uptake can
only have occurred via the roots from the soil. Uptake of fungicides from
the soil is a passive diffusive process (McFarlane, 1995b), the roots of a
plant must, therefore, be in close proximity to tebuconazole molecules
bound in the soil for uptake to occur. The amount of tebuconazole
accumulated in plants grown in this experiment (Figure 4.11) was
around five times higher when compared to those seen in Figures
Figure 4.4 and 4.7 even in plants grown for twice the number of weeks.
However, the amount of tebuconazole per gram of plant tissue was
comparable between these results and those seen in Figures 4.5 and
4.6. As the seeds were untreated it was unlikely that there would have
been any effect of phytotoxicity as had been seen in previous
experiments (Chapter 2 - Figures 3.6, 3.7 and 38), where the fungicide
had been applied directly to the seed. The plants analysed in this
experiment were, as a result, better developed than those grown from
seed treated with tebuconazole explaining the comparable amounts of
fungicide per gram of plant tissue observed in Figure 4.11.
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Figure 4.11 Mean amounts of tebuconazole in plants grown from untreated seed
in pots (1 or 5L) containing a layer of compost treated with an equivalent dose rate of
20 ~g fungicide per seed. Data bars show an average value of 5 replicate samples.
Error bars show standard deviation.
It is reasonable to assume that the tebuconazole was more evenly
distributed within the treated soil layer in each pot than the distribution
of the fungicide applied as a seed treatment. It would appear that this
distribution of the fungicide led to the higher uptake rates observed.
These results may also help to explain the late increased uptake of
tebuconazole into plants grown from treated seed (Figures 4.4 and 4.7).
The distribution of tebuconazole available for uptake from treated seeds
is likely to be localised to the region immediately adjacent to the seed.
The high tendency of tebuconazole to bind to carbon elements within
the soil supports this. As a plants root structure develops it is likely that
the uptake active regions at the tips of the roots are likely to pass
through this zone relatively quickly. A more even distribution of the
fungicide in the soil would mean that there is a higher likelihood that
developing roots, especially those that are confined by the finite space
in a pot, would come into contact with tebuconazole and subsequently
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accumulate higher levels of the fungicide. It would not be until later in
the development of plant roots grown in the finite space of a pot that the
roots would again come into contact with this localised zone of
tebuconazole around the seed as the plant competes for resources.
The level of uptake was virtually identical between the large and small
pots; this was an interesting result as the layer of treated soil was more
thinly distributed in the larger pots which also had more space available
in which plant roots could develop. It was noted that when plants were
being disposed of, especially after growth trials that run for longer
periods of time that the soil in the pots was completely filled with roots.
It was clear the root architecture of the plants were becoming confined
within the pots. This suggests that the rate of uptake of tebuconazole
from the soil is driven by plant, or more specifically root, development
and not by the amount of tebuconazole available for uptake. This was
not, however, consistent with the theory that uptake is driven by root
development alone. If this was the case the results would have shown a
higher accumulation of tebuconazole in plants grown in the smaller size
of pot as the roots would have filled this space more completely and at
a faster rate than those grown in the larger pots. It was clear that
another factor was acting upon the rate offungicide uptake,
Other research carried out investigating the uptake of non-ionised
chemicals from a hydroponic solution into plant roots have shown that
the process consists of two components: a) equilibration, whereby the
aqueous phase of the plant root and the surrounding solution become
balanced and b) sorption of the chemical onto lipophillic root solids
found in the cell membranes of and cell walls of cells in the roots
(Paterson et a/., 1991). The rate at which lipids in cell membranes in the
plants roots become saturated will therefore have an impact on the
subsequent rate at which the fungicide can enter into other areas of the
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plant. It would seem that the rate of tebuconazole uptake is a
combination of distribution of the fungicide within the soil environment
but also linked to the behaviour of the compound within the plant cells
and water phase of the soil.
4.4.5 Further analysis of uptake and accumulation of
tebuconazole from soil by wheat plants from 1 m columns
containing tebuconazole treated layers of compost at
varying depths
The effect observed in Figure 4.11 whereby tebuconazole was taken up
by plants directly from a layer of compost treated with a known amount
of tebuconazole was further tested. An experiment was undertaken
whereby tebuconazole accumulation was assessed, over a time course,
in plants grown in individual soil columns containing a layer of compost
treated with 200 ~g aliquot of the fungicide at varying depths in the
column. The experiment also aimed to assess the amount of
tebuconazole taken up by plants when grown in a deeper (1 m), more
open soil environment compared to the finite environment of a pot.
Plants were also measured for their development in terms of length,
weight and root length to test for any phytotoxic effects caused by
uptake of the fungicide.
The amount of tebuconazole found in plant samples, Figure 4.12, were
analysed and plotted on a response surface (contour) graph using the
experimental design program. The figure shows the amount of
tebuconazole recovered by the plants over a time course and the
relationship of this to the depth of the treated layer of soil within the
column (Layer 1 being the top layer of soil in the column). The contour
lines show the link between growth time and layer depth and how this
association affects the amount of tebuconazole at a given combination
of these variables. Experimental design points are marked as red
circles on the figure and a colour key is shown, depicting red as a
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higher tebuconazole concentration changing to blue which is the lowest
concentration.
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Figure 4.12 Amount of tebuconazole per sample recovered from plants grown in
individual soil columns containing layers of soil treated with a total of 200 f-lg
tebuconazole.
Analysis of the results showed that there was a statistically significant
(P> <0.05) effect on the amount of tebuconazole in plants caused by
the relationship between the depth of the treated soil layer and growth
time. The highest accumulation of tebuconazole was found in plants
grown for 8 weeks in columns where the treated soil was at level 1, or
the top of the column. The amount of tebuconazole recovered from
plants grown in other columns followed this trend with the lowest
amounts recovered from samples grown in columns with the treated soil
at levelS. Some tebuconazole was recovered from plants grown in
columns containing the treated soil at layer 5. However, this was only
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observed in plants that had been grown for the full 8 week period. The
roots of plants grown for a shorter time had not reached this depth in
the column and therefore showed no uptake of tebuconazole. Results
of the analysis of the concentration of tebuconazole recovered from
plant tissue grown in the soil columns, given in Figure 4.13, showed the
highest concentrations of the fungicide were to be found in plants
grown for 2 weeks in columns where the treated layer was at level one.
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Figure 4.13 Concentration of tebuconazole recovered from plants grown in
individual soil columns containing layers of soil treated with a total of 200 I-Ig
tebuconazole.
This did not follow the trend seen in Figure 4.12, where the amount of
tebuconazole was seen to increase in plants over the time course. This
suggests that the rate of tebuconazole uptake was lower in the soil
columns than seen in previous experiments. A total of 200 I-Ig of
tebuconazole was applied to each treated layer. As only one plant was
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grown in each column this meant that there was 10 times more total
tebuconazole available for plant uptake than in previous experiments
where a maximum of 20 I-Ig per plant was applied. Each column
contained five, 1.4 L volumes of compost, one of which was treated with
the fungicide. This was comparable to the amount of soil available for
each plant grown in the long-term uptake trial, which was approximately
1.2 L. A comparison was made between the amount of tebuconazole
accumulation in plants grown as part of the long term uptake trial
(Figures 4.3, 4.4, 4.5, 4.6 and 4.7) and this data can be seen in Table
4.3. The comparison was made between plants grown for the same
number of weeks and in columns where the treated soil layer was at the
top of the column (Le. immediately available for plant uptake as would
be the case with a seed application method). This showed that in the
early stages of the growth period, more tebuconazole was found in
plants grown in the columns than in the pots. However after 8 weeks
there were comparable amounts of tebuconazole in plants from both
experiments.
Table 4.3 A comparison between the amounts of tebuconazole per plant and
per gram of plant tissue recovered from plants grown in soil columns containing layers
of soil treated with tebuconazole and those grown during an assessment of the long
term potential of uptake of tebuconazole by plants (grown in pots)
Tebuconazole I-Ig/plant I-Igg-1
Growth time Long term Soil column Long term Soil
(weeks) growth trial experiment growth trial column
experiment
2 0.105 0.17 0.625 0.78
4 0.21 0.38 0.078 0.30
8 0.551 0.41 0.133 0.04
It would seem that the more even distribution of tebuconazole and the
higher rates applied in the soil column experiment led to higher uptake
of the fungicide in the early stages of growth. The roots would have had
a higher likelihood of coming into contact with tebuconazole residues in
the soil columns earlier in the growth period explaining this difference. A
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previous experiment investigating the effect of increased seed sowing
density on tebuconazole uptake found there to be no apparent increase
in fungicide accumulation in the plants. However, the zone of
tebuconazole available for uptake in this experiment would have been
localised around individual seeds therefore would not have been
available for uptake until later in the growth period. Initially the amounts
of tebuconazole per gram of plant tissue are comparable between the
two experiments; however, after 8 weeks of growth, the amount of
tebuconazole per gram of tissue is more than 75% less in plants grown
in the columns.
The reason for this may be explained by the different manner in which
the roots have developed in the plants grown in the soil columns
compared to those grown in pots. The watering regime used during the
soil column experiment, whereby the columns were watered from below
7 d after emergence, encouraged the roots to develop along the length
of the column. Indeed it was only after 8 weeks that the roots were able
to grow the full length of the 1 m columns used. Uptake of tebuconazole
would have occurred as the developing roots passed through the layer
of treated soil, however as the roots continued to develop the rate of
uptake would slow as the tebuconazole available immediately around
the roots of the plants becomes exhausted.
The roots of the plants grown in the columns had more space available
for growth and, as such, did not fill the entire volume of soil in the
column. In comparison, the plants grown in pots had a finite amount of
space and nutrients as well as competing alongside other plants grown
in the pots for these resources. As a result there was a higher density of
root distribution in plant grown in pots compared to those grown in the
columns. This further explains the late uptake of tebuconazole seen in
the long term uptake trial. Although the plants grown in the soil column
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could have been grown for a longer time course it is unlikely that any
further uptake of the fungicide would have occurred as the roots would
not have filled the entire soil volume within the column.
Overall, it appears that the uptake of tebuconazole is dependent on the
development of the root system of the plant. The greatest uptake of
tebuconazole occurred in samples that had been in contact with the
treated soil layers for the longest period of time. These results are also
supported by previous results shown in Chapter 3. The effect of growth
environment on tebuconazole uptake was investigated by growing
plants in growth rooms at different temperatures (Figure 3.13) and by
artificially increasing the rate of transpiration in plants (Figure 3.14). The
results showed that neither of these factors significantly increased the
amount of tebuconazole accumulated by plants. It would seem that
even though it is known that tebuconazole is carried within the
transpiration stream that the distribution of the fungicide in the soil allied
with root development and the behaviour of the fungicide once in the
plant are primarily responsible for uptake.
4.4.6 Analysis of potential phytotoxic effect of tebuconazole in
treated soil on plant development
The potential effect of phytotoxicity or the hindrance of plant
development, caused by tebuconazole applied to the soil was
assessed. Untreated seeds grown in columns containing no
tebuconazole were measured for their length and compared to those
grown in experimental soil columns over a time course. The results,
given in Figure 4.14, showed that there were no differences between
plants grown in untreated or treated soil columns. This suggested that
the phytotoxic effect observed earlier in the research (detailed in
Chapter 3) was not caused by the process of tebuconazole uptake itself
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but by the presence of high concentrations of the fungicide when
applied as a seed treatment in direct contact with the seed.
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Figure 4.14 Mean height of plants grown in columns containing a layer of compost
treated with 200 I-1gtebuconazole compared to plants grown in untreated columns.
Error bars show standard deviation. Sample details showed in Table 4.2.
Results of the analysis of plant weights grown in the soil column, data
not shown, also showed there to be no measurable effect of high
concentrations of tebuconazole in the soil on plant weight.
4.4.7 Analysis of movement of tebuconazole within soil columns
containing layers of John Innes No.3 compost treated with
the fungicide
The lower uptake of tebuconazole exhibited in the results of the soil
column experiments (Figures 4.12 and 4.13) could have been
explained by movement of the fungicide within the column and out of
the treated layer. The low water solubility and high affinity of
tebuconazole to bind with organic carbon in a soil environment, allied
with results of previous experiment testing the ability of the compost
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used during the research to retain tebuconazole (Figure 4.8 and 4.9)
meant that it was thought unlikely that tebuconazole would be mobile
within the soil columns. However, an experiment testing samples of soil
from the tebuconazole treated soil columns was undertaken to test this.
It was subsequently suggested that if the fungicide had moved within
the column at all, then it would only move a short distance and this
movement would most likely become apparent after longer periods of
time. Results of the analysis of samples taken from the soil columns,
Table 4.4 showed that there was little movement of the fungicide within
the columns meaning that the results of the column experiment could
be attributed to root distribution. Tebuconazole was successfully
recovered using the method for its extraction from the soil as seen
earlier in this chapter. This is concurrent with results seen earlier in this
chapter (Figures 4.8 and 4.9) and with research previously carried out
by Kim et al., (2002) discussed earlier.
Table 4.4 Mean amount of tebuconazole recovered from within and below
layers of compost treated with the fungicide in individual soil columns. Data shown is
an average of three replicate samples. Variation shown is standard deviation of the
averages.
Tebuconazole AI sample" (1-19) AI (1-19g-1)
Sample
Treated Layer 1.06 (to.32) 0.05 (to.016)
Below layer 0.05 (to.019) 0.0 to.OOO)
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4.5 CONCLUSIONS
Tebuconazole was seen to be available for uptake from both
microencapsulated and commercially available formulations of the
fungicide over an extended period of time. However, it would appear
that there was not a prolonged release of the fungicide from the
microencapsulated formulation as had been hoped. Although there
were no significant difference between the two formulations this was
never the less an encouraging result, showing that the
microencapsulated product did have the ability to deliver tebuconazole
at concentrations that were comparable to a commercial product. An
increase in tebuconazole amounts found in plants during the later
stages of the growth course was investigated by undertaking a second,
identical, experiment which confirmed the results of the initial trial. The
reasons for this were initially unclear as it was hypothesised that the
amount of tebuconazole available for uptake would have become
reduced over the course of time. As a result, a subsequent reduction in
the amount of fungicide per gram of plant tissue would have been
expected as uptake slowed and the plant continued to increase in mass
as it developed. The steady accumulation (and late increase in uptake
rate) of the fungicide of the time course observed in these experiments
appears to have been caused as a result of growing the plants in the
finite environment of a pot.
Analysis of the ability of the growth medium in which the plants were
grown during this research to absorb and retain tebuconazole showed
that the compost had a strong ability to bind tebuconazole. This was
consistent with the known chemical properties of the fungicide and lead
to the suggestion that the soil itself might prove, initially, to be a sink for
seed applied fungicides and, later in the growth period, provide a
subsequent source for plant uptake of tebuconazole. The ability of
plants to absorb tebuconazole directly from the compost was assessed
and the findings showed that this was possible. Further experimentation
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involving the use of individual soil columns containing layers of
fungicide treated compost, applied at a rate 10 times higher than that
applied as a seed dressing showed the uptake of tebuconazole to be
lower than that seen in plants grown in pots. It was, therefore
concluded that the total amount of tebuconazole uptake and
accumulation was not directly related to the amount applied. As it is
known that the uptake of tebuconazole from the soil is a passive
process the level of uptake is directly related to the number of roots that
come into contact with the fungicide in the soil. This, in turn, is
dependent on the manner and degree to which the roots have
developed but also the behaviour of tebuconazole within lipid
concentrations in the plants cells.
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CHAPTER 5: GENERAL DISCUSSION AND
CONCLUSIONS
Previous work led by Micap PLC had illustrated the potential for the use
of yeast cells to provide the sustained release of materials such as
flavour volatiles, essential oils and pharmaceutical products (Nelson et
al., 2006). The primary aim of this research project was to assess the
release and uptake of the triazole tebuconazole from a novel
encapsulated formulation of the fungicide. The formulation was
produced using a method patented and developed by Micap PLC and
utilised yeast cells as preformed microcapsules into which the fungicide
was loaded. There were perceived to be several potential benefits of
formulating tebuconazole in this manner such as protection of the AI
from environmental degradation, controlled release of the AI and a
potential for the reduction of phytotoxic effects caused by the use of
seed treatments such as tebuconazole (8ahadir, 1990; Asrar et al.,
2004; Markus and Linder, 2006).
Tebuconazole is used extensively as a fungicidal seed dressing in
cereals using formulations such as Raxil (Clark et al., 2004). However
the rate at which these treatments may be applied is limited. If applied
excessively tebuconazole is known to prevent or delay emergence and
cause stunting of young plants (McGee, 1995; Ashley et al., 2003).
Further to this, losses of the fungicide due to effects of environmental
degradation in the soil and concerns over pesticides residues in soil
and groundwater determines that tebuconazole based products, such
as Raxil, cannot be applied at sufficiently high doses to provide
adequate protection of plants beyond the stages of germination and
early development (Kenawy et al., 1992; Asrar et al., 2004). To avoid
these effects tebuconazole is typically applied as a 'seed hygiene'
treatment at a rate of 3 g AI per 100 kg seed (8ayerCropScience,
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2010). It was proposed that by producing a microencapsulated
tebuconazole formulation, in a similar manner to that used by Micap
PLC for other compounds, these undesirable effects could be reduced.
This, in theory, could allow the application of tebuconazole at higher
than recommended rates, conferring a longer period of protection for
plants against disease and reducing the need for further application of
fungicides later in the growing season. Further to this, it was anticipated
that the use of higher application rates could potentially confer an
extended period of fungicide availability for plant uptake by reducing
losses associated with environmental factors and by controlling the rate
of release of tebuconazole. Unpublished research carried out
previously at the University of Nottingham had shown that
microencapsulated formulations of tebuconazole (batch #4564)
exhibited higher levels of efficacy against powdery mildew compared to
commercial formulations (Rossall, pers. comm.). Experiments were
planned and undertaken aimed at assessing the level of tebuconazole
uptake from commercial and microencapsulated formulations applied
as seed dressings in an effort to explain these results.
Unpublished research carried out by Micap had suggested that yeast
obtained as a bi-product from bio-ethanol production could provide the
optimum release profile of compounds (Duckham, pers. comm.).
Experiments were undertaken to investigate and quantify the release of
tebuconazole from the yeast microcapsules into water. Formulations
using yeast strains from different sources (two types used in baking and
hi-product yeast from bio-ethanol production) were assessed to
ascertain if there were any differences in the profile of tebuconazole
release. The results showed that there were no apparent differences in
the amount or the manner in which tebuconazole was released from the
different formulations into water. The release profiles did not follow
those observed by other researchers investigating the release of
various compounds from different types of microcapsules. Results of
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other research have, in general, found the release of Als from
microencapsulated formulations to follow a Fickian profile. This may be
defined as movement from a zone of high concentration to a zone of
lower concentration across a membrane (Kenawy et al., 1992; Trapp,
2004). Asrar et al. (2004) found the release of tebuconazole from a
formulation consisting of polymer matrix particles to follow this profile
(Asrar et al., 2004). Similar findings were observed by Dardelle et al.
when investigating the release of the flavour volatile limonene
encapsulated in yeast cells (Dardelle et al., 2007). Other examples of
this release profile have been observed by Suave et al. (2010)
investigating the controlled release of the pesticide malathion from
synthetic polymer microcapsules (Suave et al., 2010).
The formulations tested in this work permitted aqueous tebuconazole
concentrations that were far in excess of the published solubility limit in
water of 36 I-Ig mL-1• After a period of around two hours, the
concentration of the fungicide in solution was observed to reach a state
of equilibrium. Several repeats of the experiment, including a more
accurate internal standard quantification method, were undertaken,
giving identical results. It was proposed that the profile of release
observed may be explained by the physio-chemical properties of
tebuconazole as a molecule. Tebuconazole is known to be hydrophobic
in nature (Ni et al., 2004; P.P.D.B., 2010). It was therefore suggested
that the excess tebuconazole molecules in solution may have formed
micelle-like structures when released into water. Additionally, un-
encapsulated tebuconazole residues held on the surface of the yeast
cells may also have contributed to this effect. This was not found to be
the case in experiments carried out by Asrar et al. (2004).
Research carried out at Micap PLC investigating the release and
quantification of actives from yeast microcapsules indicated that un-
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encapsulated Als held on the surface could affect concentrations of the
of the encapsulated compound in solution, especially in the early
stages of the time course (Duckham and Wheeler, 2005a). The
reduction of tebuconazole concentrations in solution observed in the
later stages of the time course may have been the result of re-
encapsulation of the fungicide again caused by the molecule's
hydrophobic nature. This seems the most feasible explanation for the
results observed, as tebuconazole is extremely unlikely to have been
removed from the water by any partition effect caused by the glass test
tubes used or to have evaporated from the solution. A non-
encapsulated formulation of tebuconazole, such as Raxil, could
possibly behave in the same manner. However, the formulation of
commercial fungicide products as emulsifiable concentrates could lead
to the distribution of tebuconazole being more even.
Extended periods of storage may cause the yeast cells to become
degraded or compromised as microcapsules. This may have
contributed to the unusual release profile observed in initial
experiments. To test this, a new batch of microencapsulated
tebuconazole (batch # 8129) was prepared using bi-product yeast from
bio-ethanol production and the same method as used with other
batches. The release of tebuconazole from batch #8129 was assessed
before. Results showed there to be no differences between the new
and three older formulations tested, suggesting that the release profiles
observed were not a result of the age of the formulations. The older
formulations ranged in age from one and a half to three and a half
years old at the time of testing suggesting that the formulations were
relatively stable once formulated. The microencapsulated formulations
also showed a good potential for sustained release of tebuconazole into
water when repeatedly washed with fresh volumes of SDW. The yeast
formulations thus demonstrated an ability to release tebuconazole over
an extended time period. This may prove a very valuable property for
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use as a seed dressing, whereby gradual release into the plant might
reduce the known phytotoxic effect caused by conventional
formulations.
Although the microencapsulated formulations of tebuconazole could be
applied as a foliar spray the scope of this research was primarily aimed
at the use of the fungicide as a seed treatment. The use of seed
treatments may confer several benefits primarily that of targeted
application leading to lower required application rates (Taylor and
Harman, 1990; Brandl and Biddle, 2001). Before the company went into
administration in 2007, a collaborative agreement had been formed
between Micap PLC and the agrochemical company Nufarm. The
principle objective of the collaboration was to produce a controlled
release tebuconazole formulation that could be applied at rates
comparable to another triazole seed treatment formulation, Jockey,
produced by BASF, which is applied at rates of up to 75 g AI per 100 kg
seed (BASF, 2010). It was hoped that by microencapsulating
tebuconazole it could be applied at a higher rate without causing
detrimental effects on germination and young plant development
detailed by Tomlin (2003).
A series of experiments were undertaken to assess the emergence and
development of plants treated with the microencapsulated formulation
and compare these results to untreated controls and those treated with
commercial formulations of the fungicide. Microencapsulated
tebuconazole batch #4564 (used in previous research) and two
conventional formulations, Raxil and Mystique, both containing
tebuconazole only, were used for the research. An application rate of
40 g AI per 100 kg of seed was selected for the this research, being
over 8 times higher than the maximum recommended rate currently
used and comparable to Jockey. All three formulations tested exhibited
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some affect on emergence and development of plants when compared
to untreated controls. However, the plants that had been treated with
the microencapsulated fungicide were shown to be significantly less
affected by tebuconazole when applied at a dose rate of 40 g AI per
100 kg seed (Chapter 3 - Figures 3.6-8) when compared to the
commercial formulations. This result suggested that there may have
been a controlled release effect, conferred by the yeast cells, potentially
explaining the reduced phytotoxicity. The result also therefore implied
that the microencapsulated formulations could provide a sustained
uptake of the fungicide. However, results of an assessment
investigating the potential of the microencapsulated formulation to
provide of a longer period of tebuconazole availability for plant uptake
(Chapter 4) showed there to be no overall differences between
microencapsulated and commercial formulations. Further to this
assessment of potential phytotoxic effects caused by plant uptake of
tebuconazole directly from the soil, i.e. not seed applied, (Chapter 4 -
Figure 4.14) showed that there were no notable difference in
development between plants grown in soil containing the fungicide
compared to those grown in untreated control columns. It would
therefore appear that the lower phytotoxic effects observed were
caused by another factor. One potential explanation could be the
presence of the yeast cells themselves. McGee noted that the
fungicides applied directly to seed could easily penetrate the seed coat
causing damage to the endosperm (McGee, 1995). It is possible that
the presence of the yeast microcapsules have a protective effect,
isolating the fungicide from direct and immediate contact with the seed
before sowing and upon hydration in soil resulting in reduced exposure
and hence phytotoxicity observed. Results of GC-MS analyse of the
total tebuconazole content of plants in these preliminary experiments
showed that the plants treated with the microencapsulated formulation
contained less tebuconazole than those treated with commercial
formulations supporting the reduced phytotoxic effects on emergence
and development observed previously.
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The original sample of microencapsulated tebuconazole (batch #4564),
which had previously shown promising efficacy results in research
carried out in this department was used for the purposes of this
research. Application rates for tebuconazole applied as a seed
treatment used currently vary between 1 and 7.5 g AI per 100 kg seed.
Initial experiments examined the uptake of seed-applied
microencapsulated tebuconazole at rates that were several times
higher than this (40, BOand 160 g AI per 100 kg) to validate solvent
extraction/SPE cleanup, GC-MS detection and internal standard
quantification methods. Results showed that there were detectable
levels of tebuconazole in plants treated at an application rate of 40 g AI
per 100 kg of seed, authenticating the methods described above and
also confirming that uptake of tebuconazole from the yeast formulations
was possible. To further test the extraction, detection and quantification
methods, another experiment assessed application rates of between 5
and 40 g AI per 100 kg seed. The results also showed that higher
application rates conferred increasing levels of tebuconazole uptake in
plants. This was an encouraging result as other research investigating
the uptake of another systemic triazole fungicide, triticonazole, applied
as a seed treatment, had shown no increase in fungicide uptake with
higher application rates (Ouerou et al., 199B), who suggested that the
rate of uptake of the fungicide in the early stages of plant growth was
not dictated by the dose at which the fungicide was applied but by the
size of the 'dressing zone' around the seed.
The higher uptake of tebuconazole related to dose rate, observed in the
data presented in Chapter 3 (Figure - 3.4), may be related to the
release profiles examined earlier (Chapter 2). When the seeds are
watered, the yeast cells will become hydrated, allowing the
encapsulated tebuconazole to move from the microcapsules into the
surrounding water as exhibited in the release profiling experiments
(Chapter 2- Figures 2.B and 2.9). The rate of this release into soil is
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likely to be a dynamic process involving changing amounts of proximal
water to the seed allowing the movement of the fungicide from the site
of application on the seed coat into the surrounding soil, producing a
resultant dressing zone. Results obtained assessing the ability of the
John Innes compost used as a growth medium during the research to
retain tebuconazole (given in Chapter 4) and the low mobility of
tebuconazole in soil indicated by it Koc value of 769 mL g-1 (P.P.D.B.,
2010) mean that the dressing zone around the seed is likely to be
small. Other research carried out into the uptake of seed applied
fungicides such as triticonazole (Ouerou et al., 1997) and triadimenol
(Thielert et al., 1988) have shown that the primary uptake route is not
from seed coat to endosperm but by roots from the dressing zone
around the seed. This was further supported by work carried out by
Stein-Donecke et al. (1993), which showed that the size of the dressing
zone had a significant effect on uptake of the insecticide imidacloprid
from soil (Stein-Donecke et al., 1992). It would appear that application
of the microencapsulated formulation at higher dose rates meant that
there was more tebuconazole available in the soil around the seed,
leading to the higher uptake observed with higher application rates
reported in this research. However, the extent of this uptake will also be
limited by root development, whereby the distribution of uptake-active
regions of the root structure, such as root hairs around the apical
meristem, in the dressing zone around the seed will influence fungiCide
uptake. Similar observations were made by Ouerou et al., (1998), who
concluded that the rate of seed-applied triticonazole uptake was limited
primarily by root development.
Briggs et al. (1983) showed that the uptake of non-ionised organic
chemicals from a hydroponic solution into plants was potentially
influenced by the compound's behaviour in solution (Briggs et al.,
1983). Solubility, described by the n-octanol/water partition coefficient
(Kow) can impact not only the availability of a compound for uptake by
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plant roots but also the mobility of the compound within the plant as it
moves in the plant's vascular system (transpiration stream) and across
lipid-rich cell membranes (Collins et a/., 2006). With this in mind
several experiments were undertaken to assess the distribution of
tebuconazole in individual plants grown from seeds treated with
microencapsulated tebuconazole and the two commercial formulations.
Systemicity is an important attribute for any crop protection
agrochemical formulation (Klittich et a/., 2008). Briggs et a/. showed that
uptake and translocation of compounds in plants was related to
individual chemicals lipophilicity. Highly lipophillic compounds may
become bound to lipid rich domains within a plants roots limiting the
degree to which the compound can become distributed throughout the
plant (Briggs et a/., 1983). It was suggested that differing degrees of
tebuconazole availability, potentially conferred by the controlled nature
by which the fungicide was released from the yeast cells of the
microencapsulated formulation, could have an impact on uptake and
subsequent distribution of the AI within the plant. GC-MS analyse of the
plants grown as part of the phytotoxicity assessment also showed there
was less tebuconazole in plants treated with the microencapsulated
formulation of the fungicide, compared to those treated with the
commercial formulation. It was, however, not known if this trend would
continue as the plant developed. Leaves of different ages from plants
treated with the three formulations of tebuconazole were analysed for
their tebuconazole content.
Results of these experiments showed there to be initially higher
accumulation of tebuconazole in leaves one and two compared to
leaves three and four to emerge in plants treated with both
microencapsulated and commercial formulations. As plants continued
to develop the distribution of tebuconazole became more even through
out the plant. Higher amounts of tebuconazole were also found in the
tips of leaves analysed when compared to the mid and base sections of
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the same leaf. These findings were also supported by other research
carried out into the uptake and distribution of fungicides and other
chemicals in the early stages of plant growth (Briggs et al., 1983;
Ouerou et al., 1998). There was also found to be initially less
tebuconazole in the plants treated with the microencapsulated
formulation confirming the results seen previously showing reduced
phytotoxicity in plants treated with the microencapsulated formulation.
As the plants continued to develop, the amount of tebuconazole in
plants treated with the microencapsulated formulation became
comparable to those treated with the commercial formulations. These
results were encouraging as it appeared that the microencapsulated
formulation was providing the optimum combination of reduced
phytotoxicity at higher dose rates whilst maintaining a good degree of
systemic distribution and comparable level of uptake to commercial
formulations.
Results of the experiments examining plant uptake of tebuconazole
applied as a seed treatment sometimes showed a high level of variation
between replicate samples. There was also an effect observed where
the amount of tebuconazole accumulated in plants rose steeply
between GS 14 and 16. This raised the question of the potential of the
growth environment to affect uptake of tebuconazole. As uptake and
distribution of the fungicide occurs via a passive diffusion process into
the roots from water in the soil (Collins et a/., 2006) it was suggested
that artificially increasing the rate of transpiration, by increasing
temperature and airflow, could in turn lead to an increased
accumulation of the fungicide in plant tissue. Further to this the
controlled release characteristics seemingly conferred by the
microencapsulated formulation could have had an impact on this
uptake. This was found not to be the case, results showed no increase
in fungicide accumulation as a result of changed environmental
conditions. Although tebuconazole is transported in the transpiration
166
stream from the soil through the roots and into the rest of the plant it
would appear that rate of uptake of the fungicide into the plant is limited
by the root distribution. This is supported by the results seen in Chapter
4 (Table 4.3) showing that even when there were comparably high
concentrations of tebuconazole available for uptake from the soil, in a
large dressing zone, this did not lead to increased concentrations of
tebuconazole in plants. Other work carried out by several authors has
found that several factors related to plant roots can limit uptake. Strang
and Rogers (1971) observed that after root treatment of cotton and
soybean, 14C labelled trifluralin was retained on the root surface by
binding to the epidermis and entrance to the roots of the compound
was mainly facilitated by breaks in the epidermis (Strang and Rogers,
1971). Further to this lignin and suberin have both been shown to
adsorb lipophillic compounds; adsorption was shown to increase with
the lipophilicity of compounds (Barak, et a/., 1983a; Barak, et a/.,
1983b; Lulai and Morgan, 1992). This effect may well have affected the
uptake of tebuconazole from the soil around the seed in the later stages
of growth.
An examination of the long term release and uptake of tebuconazole
into plants was undertaken. It was hoped that the microencapsulated
formulation would confer a longer window of fungicide release, and
therefore uptake, when compared to commercial formulations. This was
not found to be the case. Results showed that there was the potential
for uptake of tebuconazole into plant tissue in the later stages of plant
development. However, comparisons between the microencapsulated
and a commercial formulation showed there to be no clear differences
in the amount of tebuconazole accumulated. The results also
highlighted an unexpected late increase in the rate of fungicide uptake,
leading to a repeat of the same experiment, which showed the same
results.
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The results of the long term uptake experiment led to the testing of the
soil (compost) as a potential sink for tebuconazole. The results obtained
showed that the growth medium used during the research had a strong
ability to absorb tebuconazole dissolved in water. It would appear that
as the treated seeds were irrigated the fungicide becomes solubilised in
water and moved away from the seed. The chemical characteristics
(Koc -Table 4.1 - Chapter 4) of tebuconazole mean that the fungicide is
then likely to preferentially bind with organic components in the soil
environment, meaning that the distribution of the fungicide within the
soil is likely to be localised around treated seeds. This effect is likely to
be observed in both the commercial and microencapsulated
formulations of tebuconazole. This factor appeared to affect the long
term uptake of the fungicide into plants grown in pots (Chapter 4 -
Figures 4.3-7). Roots initially emerge and pass through the zone of
tebuconazole immediately adjacent to the treated seed. The roots
continue to develop and take in tebuconazole throughout the growth
period. It is proposed that as the resources of space and nutrients
become reduced in the later stages of the growth period the roots
proliferate to occupy every available free space in the soil environment
leading to the late increases in fungicide uptake observed. This finding
was further supported by the results of the soil column experiment,
investigating fungicide uptake from fungicide treated layers of soil at
differing depths contained within a 1m column over a time course.
Uptake of tebuconazole was initially higher in the plants grown in the
columns but concentrations of the fungicide declined as growth
continued. It would therefore appear that the sustained uptake
observed in the long term release experiments may be an artefact
produced by growing plants in pots where the roots developed in a
finite growth environment. Thus it would also seem possible that
application rate does not have a direct impact on the long term
availability or uptake of tebuconazole applied as a seed dressing. The
treated layers used in the soil column experiment contained a total of
10 times more tebuconazole than that applied to each seed used in
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previous experiments but did not exhibit higher concentrations of the
fungicide as a result. The suberisation of roots in the soil columns may
have had an impact on the uptake of tebuconazole reducing uptake due
to the fungicide becoming retained by the suberin itself. Overall, the
uptake of tebuconazole applied as a seed treatment into plants would
appear to be a complex combination of factors including the size of the
dressing zone around treated seeds but also root distribution.
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5.1 FINAL CONCLUSIONS AND FUTURE WORK
From the results of this research there is no clear indication that the
beneficial efficacy results observed in previous work can be attributed
to an increased or sustained uptake of the tebuconazole from a
microencapsulated formulation of the fungicide. A field experiment,
whereby plants would not be grown in the finite environment of a pot,
could show different results. A series of plots could be utilised using
seeds treated with different rates of the microencapsulated and
commercial fungicides. Plants exhibiting lower infection rates could then
be tested for their tebuconazole content using the methods refined in
this research. However, the results of the soil column experiment
discussed earlier would suggest that there would not be an increased
uptake of the fungicide treated with the microencapsulated formulation
in plants grown in the less restrictive conditions offered by field growth.
Further to this, the use of radio-labelled fungicides could possibly give a
more precise understanding of fungicide distribution within plants.
However, the production of such a formulation would be expensive and
time consuming.
Research carried out to date on the efficacy of the Micap PLC
formulation of tebuconazole applied as a seed treatment have only
studied the impact on foliar diseases. Many losses associated with
pathogens affecting food crops are those caused by seed or soil borne
fungi (Clark et al., 2004). The 'burst release' effect of the fungicide from
the yeast microcapsules observed during the preliminary release
profiling undertaken as part of this research may have another benefit.
The use of seed treatments is primarily for the purposes of seed
hygiene, reducing the potential impact seed and soil-borne pathogens
may have on subsequent yields. Where systemic products are applied
this can also confer protection in the early stages of plant growth. The
microencapsulated formulations did not appear to perform any
differently to commercial formulations in terms of fungicide uptake.
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However, the initial burst of release from the yeast microcapsules could
provide protection from seed and soil-borne pathogens by producing a
zone of high fungicide concentration not only on the surface of the seed
but also in its immediate vicinity. This would require further research but
could, in theory provide beneficial results.
Microencapsulated formulations could also potentially be employed in
systems where plants are grown in fixed environments. Examples of
this could include hydroponic systems and plants grown commercially
in pots. The sustained nature in which the microencapsulated
formulation released tebuconazole when repeatedly washed with fresh
volumes of SDW (Chapter 2) could mean that they would be suitable for
the application of other chemicals, such as nutrients or growth
regulators to hydroponic solutions. Equally the formulation of
microencapsulated tebuconazole into a pellet which could be inserted
into the soil of pots in which plant are grown could provide the
possibility of sustained release and uptake of fungicides or other
chemicals from the soil via the plants root system.
With the demise of Micap PLC, other formulations that might confer
advantageous uptake profiles of crop protection chemicals such as
tebuconazole and reduced detrimental effects such as phytotoxicity
could be highly sought after. One formulation method that could provide
this is that of a nano suspension/dispersion of tebuconazole produced
by the UK-based company called IOTA NanoSolutions (IOTA, 2010).
The company has produced such a formulation of tebuconazole for the
purposes of research. Preliminary experimentation carried out as a side
line to the research on the microencapsulated formulation have shown
that the IOTA formulation displayed a good degree of efficacy in vitro
against Fusaruim culmorum (the casual agent of seedling blight) and
Septoria tritici, in planta, compared to commercial formulations
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Overall the research has shown that microencapsulated fungicides can
be applied as a seed treatment at higher dose rates than currently
employed, without causing the problem of phytotoxicity associated with
tebuconazole to the same degree as commercial formulations. Uptake
and systemicity (distribution) of the fungicide within treated plants was
shown to be comparable in all formulations tested. Testing also
included an evaluation of the possible extended long-term release that
may have been provided by the microencapsulated formulation which
found comparable amounts of tebuconazole in both plants treated with
the microencapsulated and commercial formulations. However, this was
also found to be caused by the limited environment of the pots in which
the plants were grown. Although the Micap PLC product did not fulfil all
expectations that it could have potentially provided, there were still
positive results gained as part of this research project. However, with
the failure of Micap PLC as a company it would appear unlikely that a
microencapsulated formulation of tebuconazole, as studied in this
project, will become a commercial reality without further investment.
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